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BASF Group  
Million € 1999 1998 Change in %
Sales 29,473 27,643 6.6
Income from operations 2,009 2,624 –23.4
Income before taxes 
and special items 2,795 2,572 8.7
Income before taxes and minority interests 2,606 2,771 – 5.9
Net income 1,237 1,699 –27.1
Cash provided by operating activities 3,255 3,744 –13.0
Capital expenditures 3,253 3,722 –12.6
Research and development expenses 1,333 1,309 1.8
Dividend of 
BASF Aktiengesellschaft 702 693 1.3
Dividend per share (€) 1.13 1.12 0.9
Number of employees (December 31) 104,628 105,945 –1.2
Segments
Sales in million € 1999 1998 Change in %
Chemicals 4,393 4,255 3.2
Plastics & Fibers 8,533 7,573 12.6
Colorants & Finishing Products 6,395 6,188 3.3
Health & Nutrition 5,602 5,097 9.9
Oil & Gas 3,051 2,685 13.6
Other* 1,499 1,845 –18.7
29,473 27,643 6.6
Income from operations in million € 1999 1998 Change in mill. €
Chemicals 698 922 – 224
Plastics & Fibers 640 539 101
Colorants & Finishing Products 608 642 – 34
Health & Nutrition – 588 383 – 971
Oil & Gas 741 276 465
Other* – 90 –138 48
2,009 2,624 – 615
Regions (location of customer)
Sales in million € 1999 1998 Change in %
Europe 17,041 16,672 2.2
• Thereof Germany 7,147 7,011 1.9
North America (NAFTA) 6,765 6,249 8.2
South America 1,837 1,640 12.0
Asia, Pacific Area, Africa 3,830 3,082 24.2
29,473 27,643 6.6
* Sales and earnings of the fertilizers business and of other businesses, as well as
expenditures, earnings and assets not allocated to the segments
BASF is a return-focused global company occupying a leading posi-
tion in the chemical industry. Chemicals are the foundation of our con-
tinuous long-term growth. We are further expanding our businesses in
health & nutrition and are strengthening our oil & gas operations in 
Europe and other markets.
We offer our customers a range of high-performance products,
including innovative and high-value-added chemicals, plastics, color-
ants, automotive and industrial coatings, crop protection agents, 
pharmaceuticals and fine chemicals as well as crude oil, natural gas
and petrochemicals.
Our comprehensive chemical and technological know-how as
well as our customer-focused and future-oriented research ensure the
development of new products and improved processes. These
activities are all supported by our Verbund, BASF’s highly developed
approach to integration, which is one of the company’s greatest
strengths.
Our operations are guided by the principles of Sustainable
Development.
BASF is strengthening its position in
butanediol, which is used to manufacture
elastomeric fibers, for example. Capacity
expansions, such as the one at our site in
Ludwigshafen, Germany (photo), and new
plants in the United States and Asia will
secure BASF’s position in this market. 
Dear shareholders and friends of BASF:
For the chemical industry, 1999 was a turbulent year full of challenges. We recognized
these challenges as opportunities and made further advances toward increasing the
company’s value through profitable growth:
• We significantly increased sales and earnings before special items.
• Our share price rose 46 percent.
• We are reshaping our portfolio and taking advantage of the rapid changes in our
industry.
Today, we are more successful and in a position of greater strength.
Actively managing our portfolio is one of our most important business tasks. We con-
stantly review the profitability and growth potential of all our operations. Our long-term
future will include only those operations that meet our high earnings requirements and
can occupy a leading position in their markets or offer profitable growth.
We are consistently implementing our clearly defined strategy by:
• taking advantage of opportunities and expanding our leading market and technologi-
cal position in growth areas,
• strengthening our cyclically resistant businesses, and
• seeking cost and technological leadership in our businesses that are sensitive to
cyclical factors.
This strategy can be seen in important decisions we made last year. For example, we
reached an agreement to create a joint venture with Shell to establish one of the
world’s largest polyolefin manufacturers. We reorganized our colorants operations, 
vigorously expanded our activities in acrylates and superabsorbers, and we signed 
a memorandum of understanding to build a petrochemical Verbund site in Nanjing,
China.
We are leading the company
successfully and
independently into the new
millennium – with our own
unique identity.
Dr. Jürgen F. Strube
Chairman of the Board of Executive Directors
The capital markets recognized our consistent efforts to improve the company with a
significant increase in our share price.
Our operations performed well in a difficult global environment. Sales rose 6.6 percent
and income from operations before special items climbed 16 percent.
Substantial special items incurred during 1999, however, reduced our earnings. We
had to pay significant fines and made provisions for claims for damages related to
violations of antitrust laws in the vitamins business.
My fellow Executive Directors and I regret these violations. They are contrary to BASF’s
business principles. We have learned from this incident and have implemented a num-
ber of measures, including a worldwide employee training program and internal audits,
to ensure that nothing like this happens again.
We are leading BASF into the new millennium as a successful and independent com-
pany. We want to maintain BASF’s own unique identity. Crucial to this identity is our
Verbund. To me, Verbund means more than just being cost-efficient and creating value
by integrating production plants. It also means people of different disciplines and edu-
cational backgrounds cooperating across organizational and geographical boundaries.
Verbund is a major factor in ensuring our success.
Our business has improved noticeably in recent months, and all indicators point to this
trend continuing. We have prepared our company to benefit from the economic up-
swing. As a result, we will achieve good earnings in 2000 and beyond.
I would like to extend my sincere appreciation to our employees, who once again
demonstrated their high level of commitment. I would also like to thank you, our
shareholders, for placing your confidence in us, and also thank our business partners
for their valuable cooperation. We see all of this as confirmation that we are on the 
right track.
Yours sincerely,
We acknowledge Germany’s historical and moral responsibility. This is why BASF is among the found-
ing members of the initiative “Remembrance, Responsibility and the Future.” Together with the German
federal government, German industry wants to provide compensation to those who suffered injustice
as forced laborers under the National Socialist regime. BASF will make a significant contribution to this
initiative.
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Dr. Jürgen F. Strube
Chairman of the Board of Executive Directors
Dear shareholders:
Once again in 1999, our company operated against a
background of many changes, some of them far-reach-
ing. BASF sees this process of change as an opportunity
to shape its future and create conditions to generate
continuing profitable growth. In line with its strategic
objectives, BASF again strengthened its core businesses
through acquisitions and capital expenditures, and opti-
mized its portfolio by entering into new cooperations as
well as making divestitures. The Supervisory Board
actively accompanied this continuing process of change.
The Supervisory Board carefully and regularly monitored
company management during the year. To this end, the
Board of Executive Directors provided the Supervisory
Board with detailed information at meetings as well as
through written and oral reports. The topics included the
progress and profitability of the company and its major
subsidiaries, the company’s policies and corporate plan-
ning. This also included planning of BASF’s finances,
capital expenditures and human resources. In addition to
the Supervisory Board meetings, the Chairman of the
Board of Executive Directors regularly informed the
Chairman of the Supervisory Board about current busi-
ness developments and important business events.
Meetings and committees
The Supervisory Board met five times during 1999. At
least 19 of the 20 members attended each of these
meetings.
At these meetings, the Supervisory Board discussed
reports from the Board of Executive Directors in detail.
Report of the Supervisory Board
Professor Dr. Berthold Leibinger 
Chairman of the Supervisory Board
The Supervisory Board also discussed the company’s
prospects as a whole and its individual businesses with
the Board of Executive Directors. Where specific trans-
actions and measures proposed by the Board of Execu-
tive Directors required decisions by the Supervisory
Board, votes were taken at the Supervisory Board meet-
ings. The Supervisory Board gave its consent to a total
of six measures or proposals.
We also obtained detailed reports from three of the
company’s division presidents on the current situation
and prospects in their respective businesses.
The Supervisory Board established two joint committees:
the Committee for the Personal Affairs of the Board of
Executive Directors and the Granting of Credits, which
was created in accordance with Paragraph 89, Section 4
of the German Stock Corporations Act (Personal Affairs
Committee), and the Mediation Committee created in 
accordance with Paragraph 27, Section 3 of the German
Codetermination Act. Each of these committees was
made up of equal numbers of representatives elected by
shareholders and employees. The Personal Affairs 
Committee met twice in 1999. The Mediation Committee
did not have to be convened.
Financial Statements of BASF Group 
and BASF Aktiengesellschaft
We have examined the Financial Statements of BASF
Aktiengesellschaft for 1999, the proposal by the Board of
Executive Directors for the appropriation of profit, the
BASF Group Consolidated Financial Statements and
Management’s Analysis for BASF Aktiengesellschaft and
BASF Group. Deloitte & Touche GmbH, the auditors
elected by the Annual Meeting, have examined the
Financial Statements of BASF Aktiengesellschaft and 
the BASF Group Consolidated Financial Statements,
including the bookkeeping, and Management’s Analysis
and have approved them free of qualification. The audi-
tors also found that the Board of Executive Directors, by
introducing binding Group-wide accounting and report-
ing guidelines as well as instituting a clearly structured
reporting system, had taken appropriate and adequate
organizational measures to ensure that the Financial
Statements were prepared properly. The auditors also
noted that the Board of Executive Directors, in accor-
dance with Paragraph 91, Section 2 of the German
Stock Corporations Act, had instituted a suitable infor-
mation and monitoring system which met the needs of
the company and appeared suitable, both in design and
in the way it had been applied, to provide early warning
of developments that pose a threat to the continued 
existence of the company.
Dr. Hans Albers  †
Dr. Hans Albers, Chairman of the Supervisory Board of BASF Aktiengesellschaft,
died on October 14, 1999. He was 74 years old.
He devoted his creative energies to the company for more than four decades and
left his mark on BASF.
Hans Albers was born in 1925 in Lingen, Germany. After studying chemistry, he
joined BASF in 1953. In 1974, he was appointed to the Board of Executive Direc-
tors. From 1980 to 1982, he was responsible for the company’s operations in
North America and became the first member of BASF’s Board of Executive Direc-
tors to be based abroad.
In 1983, he was appointed Chairman of the Board of Executive Directors, and he
became Chairman of the Supervisory Board in 1990. Hans Albers was determined
to expand BASF into an international company, extensively developing BASF’s 
activities in the United States and setting its sights on Asia.
Hans Albers always maintained personal contact with the employees of “his” BASF.
His open-minded nature and modesty were particularly beloved by employees,
and he was known for his exceptional professional talents as well as his charisma
that accompanied his unflagging commitment.
We mourn the loss of a great person. His name will be inseparably linked to our
company.
The documents to be examined and the auditors’ report
were given to every member of the Supervisory Board.
The auditors attended the accounts meeting of the
Supervisory Board and reported on the main findings of
their audit. The auditors also provided detailed explana-
tions of their report on the day before the accounts
meeting.
We have approved the auditors’ report. The results of
our own examination fully concur with those of the audit.
The Supervisory Board sees no grounds for objection to
the management of the company or the Financial State-
ments presented.
At today’s meeting, we approved the Financial State-
ments of BASF Aktiengesellschaft drawn up by the
Board of Executive Directors, making the Financial State-
ments final. We concur with the proposal of the Board of
Executive Directors regarding the appropriation of profit.
Composition of Supervisory Board 
and Board of Executive Directors
Dr. Hans Albers, Chairman of the Supervisory Board,
died on October 14, 1999, at the age of 74. Dr. Hans
Albers guided the Supervisory Board for nine years with
exceptional skill, tireless commitment and great 
integrity. He drew on his profound knowledge of BASF
as a former Chairman of the Board of Executive Direc-
tors as well as his experience in the chemical industry.
We mourn the passing of a great person.
To replace Dr. Hans Albers, the Supervisory Board elect-
ed one of its members, Professor Dr. Berthold Leibinger,
to be the new Chairman. Professor Dr. Marcus Bierich,
Chairman of the Supervisory Board of Robert Bosch
GmbH, was newly appointed to the Supervisory Board.
The District Court of Ludwigshafen am Rhein approved
his appointment on October 15, 1999, made in a joint
application by the Supervisory Board and the Board of
Executive Directors. Professor Dr. Bierich had previously
been a member of the Supervisory Board until May 19,
1998.
As of April 30, 1999, Lothar Hick and Gerhard Sebastian
left the Supervisory Board and were replaced by Günter
Klein and Konrad Manteuffel, who had been elected by
employees as replacement members.
With effect from January 1, 2000, the Supervisory Board
appointed Dr. John Feldmann to the Board of Executive
Directors. Dr. Volker Trautz will leave the Board of Execu-
tive Directors as of May 1, 2000, to become head of the
new polyolefin joint venture between BASF and Shell.
Ludwigshafen, March 7, 2000
The Supervisory Board
Professor Dr. Berthold Leibinger
Chairman of the Supervisory Board
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Dividend payments to our shareholders
1.40
0.40
0.60
0.80
1.00
1.20
800
200
400
600
’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99
Million €
per share in €
Inclusion in the Dow Jones EURO STOXX 50sm index
Since August 1999, BASF shares have been included in
the Dow Jones EURO STOXX 50sm, one of the most
important European share indexes. This index is com-
prised of the 50 companies with the highest market capi-
talization in countries within the euro zone.
Good share price performance
BASF shares rose 46 percent during 1999, performing
significantly better than the Dow Jones EURO STOXX
50sm index and Germany’s DAX index. Our share price
reached a record high of € 52.20 in December and
ended the year at € 51.90. BASF shares, including the
per share dividend payment of € 1.12, yielded a perfor-
mance in 1999 of 64 percent compared with only a
39 percent return for the DAX index and a 49 percent
return for the Dow Jones EURO STOXX 50sm index.
Dividend remains high
BASF shares, when measured by dividend yield, contin-
ue to occupy a leading position among DAX shares. The
Board of Executive Directors and the Supervisory Board
are proposing to the Annual Meeting a dividend payment
for 1999 of € 1.13 per share, virtually unchanged over
1998. Based on the 1999 year-end share price of
€ 51.90, BASF’s dividend yield was 2.2 percent. In addi-
tion to the dividend, shareholders subject to German
income or corporation tax will receive a tax credit of
€ 0.48, increasing their dividend yield to 3.1 percent.
Attractive long-term investment
A shareholder who made a single investment of
€ 10,000 (about DM 20,000) in BASF shares five years
ago and reinvested dividends (excluding tax credits) in
additional BASF shares would have increased the value
Key BASF share data 
1999  1998
Number of shares as of December 31
Million shares 621* 624
Per share information in €
Dividend 1.13 1.12
Dividend with tax credit 1.61 1.60
Earnings per share 2.00 2.73
Earnings per share 
according to U.S. GAAP 2.14 2.84
Cash provided by 
operating activities 5.27 6.02
Stockholders’ equity 22.26 20.71
Year-end share price 51.90 32.49
High 52.20 47.50
Low 30.19 29.81
BASF shares – 
an attractive, 
high-yielding 
investment
BASF shares
* Number of shares still to be issued for the
exercise of stock warrants: 9 million 
of the holding to € 37,177 by the end of 1999. This is
equivalent to an annual return of 30 percent compared
with a 27 percent return for the DAX index.
Stock option program and 
employee share purchase program
BASF employees and executives are benefiting from the
company’s success. Since April 1999, we have offered a
stock option program to approximately 1,200 BASF
Group executives; more than 80 percent of those eligible
have already participated by investing a portion of their
variable compensation in BASF shares. For each share
purchased, BASF grants stock option rights that can be
exercised if ambitious share price targets are achieved.
Other employees of BASF companies in Germany (see
page 41) can participate in the new “plus” employee
share purchase program, giving them an attractive
opportunity to invest in BASF.
Share buy-back
We are increasing the value of BASF shares through our
stock repurchase program. In January 1999, after clarifi-
cation of German tax laws, BASF was one of the first
German companies to buy back shares. We repurchased
7.9 million shares during 1999 at an average price of
€ 32.37, reducing stockholders’ equity by canceling the
shares. We intend to continue buying back shares when
appropriate.
Preparing for New York Stock Exchange listing
We plan to list our American Depositary Receipts (ADRs)
on the New York Stock Exchange in June 2000, a move
that will emphasize the global orientation of BASF, broad-
en our shareholder base and create strategic room for
maneuver, particularly in the United States. We have
adapted our Annual Report to make it more consistent
with U.S. accounting standards.
Delisting from stock exchanges
In Europe, we have delisted our shares on the Amster-
dam, Brussels and Vienna stock exchanges, and we
have started the delisting process in Paris. With increas-
ing European integration and the introduction of the euro,
we do not believe it is necessary to list BASF shares on a
number of European stock exchanges. We have also
withdrawn our shares from trading on the Tokyo Stock
Exchange. BASF shares remain listed on the major inter-
national stock exchanges in Frankfurt, London and
Zurich.
Reporting in euros
This is BASF’s first Annual Report in euros. Quarterly
reports in 1999 were already in euros.
Information on BASF shares
Our Investor Relations staff informs investors and finan-
cial analysts actively and openly about company devel-
opments.
Tel.: +49 621 60 48230 
Fax: +49 621 60 22500
E-Mail: investorrelations@basf-ag.de
Further information can be found on the Internet at
http://www.basf.de/share
Dates
April 27, 2000
➔ Annual Meeting, 
Ludwigshafen
➔ First quarter report 2000
April 28, 2000
➔ Conference call for
investors and analysts
August 8, 2000
➔ Media conference call
➔ International analysts’ 
conference, London
➔ Second quarter 
report 2000
November 9, 2000
➔ Fall news conference 
➔ International analysts’ 
conference
➔ Third quarter report 2000
March 14, 2001
➔ Annual news conference,
Ludwigshafen
➔ International analysts’ 
conference, Ludwigshafen
➔ Publication of 2000 
Annual Report
April 26, 2001
➔ Annual Meeting
➔ First quarter report 2001 
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Our aim is profitable growth.
Dr. Jürgen F. Strube Max Dietrich Kley Helmut Becks Dr. John Feldmann
Dr. Jürgen F. Strube, 60, 
Chairman since 1990, lawyer. With BASF for 31 years.
Max Dietrich Kley, 60, Deputy Chairman, lawyer. With
BASF for 31 years. Responsible for the Finance, 
Oil & Gas, Coatings, and Raw Materials Purchasing divi-
sions as well as the Eastern Europe, Africa, West Asia
division.
Helmut Becks, 55, physicist. With BASF for 28 years. Responsible for
the Human Resources; Engineering; Ludwigshafen Site Engineering;
Environment, Safety & Energy; Logistics; Corporate Information Ser-
vices & Communications Technology; and Occupational Medicine &
Health Protection divisions as well as the BASF Schwarzheide site. Also
responsible as of May 1, 2000, for the BASF Antwerp site.
Dr. John Feldmann, 51, chemist. With BASF for 12 years. Board
member since January 1, 2000. Responsible as of May 1, 2000, for the
Styrenic Polymers, Engineering Plastics, and Polyurethanes divisions as
well as the Polymers Laboratory.
Board of 
Executive 
Directors
Dr. Jürgen Hambrecht Dr. Stefan Marcinowski Peter Oakley Dr. Volker Trautz Eggert Voscherau
Dr. Jürgen Hambrecht, 53, chemist. With BASF for 24 years. Responsible
for the Petrochemicals & Inorganics, Industrial Chemicals, and Intermediates
divisions as well as the Ammonia Laboratory. Responsible until April 30,
2000, for the BASF Antwerp site. Also responsible as of May 1, 2000, for the
East Asia, Japan, and Southeast Asia/Australia divisions.
Dr. Stefan Marcinowski, 47, chemist. With BASF for 21 years. Research
Executive Director and responsible for the Dispersions, Colorants, and Spe-
cialty Chemicals divisions as well as the Colorants Laboratory.
Peter Oakley, 47, economist. With BASF for 23 years. Responsible for the
Fiber Products division as well as BASF’s businesses in North and South
America.
Dr. Volker Trautz, 55, chemist. With BASF for 26 years. Based in
Singapore. Responsible until April 30, 2000, for the Styrenic Polymers,
Engineering Plastics, and Polyurethanes divisions as well as the Poly-
mers Laboratory and the East Asia, Japan, and Southeast Asia/Aus-
tralia divisions. Future head of the BASF-Shell polyolefin joint venture.
Eggert Voscherau, 56, economist. With BASF for 34 years. Respon-
sible for the Pharmaceuticals, Crop Protection, Fine Chemicals, and
Fertilizers divisions as well as the Main Laboratory and the Northern,
Southern, and Central Europe divisions.
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After a difficult first six months of 1999, business gained 
momentum during the remainder of the year. Income from 
operations before special items climbed 16 percent and 
income before taxes and special items rose nine percent. 
Special items required high financial expenditures, but 
proceeds from the divestiture of non-strategic businesses 
largely offset these expenses.
Sales
The business climate improved considerably during the
year and growth returned to Asia in particular. Demand,
already at a high level, increased worldwide, but
depressed sales prices only began to improve slightly at
the end of the year. We succeeded, however, in raising
sales volumes by 5.8 percent. BASF Group sales totaled
€ 29.473 billion, an increase of € 1.830 billion, or 6.6
percent, over 1998.
Sharply higher crude oil prices significantly increased
sales of the Oil & Gas segment, contributing 1.3 percent-
age points to the improvement in BASF Group sales.
Portfolio changes and additions to the scope of consoli-
dation contributed € 869 million, or 3.1 percentage
points, to the higher sales. Acquisitions were responsible
for adding € 627 million in sales compared with 1998,
while divestitures reduced sales by € 331 million. The
inclusion of companies consolidated for the first time
added sales of € 573 million, or 2.1 percentage points 
of the increase.
Earnings
Price increases at the end of the year were not sufficient
to compensate for the sharp rise in raw material costs;
as a result, pressure on margins continued. Nonetheless,
our income from operations before special items climbed
15.6 percent. The main contributor was the large earn-
ings increase in the Oil & Gas segment. Higher sales vol-
umes and cost-cutting measures, as well as improve-
ments in efficiency in all segments, stabilized earnings.
Sales/Earnings
The increase resulted from the following changes:
Million € %
Volumes 1,597 5.8
Prices –1,078 – 3.9
Currency 442 1.6
Scope of consolidation 869 3.1
1,830 6.6
1 The auditors have approved the Financial Statements of BASF Aktien-
gesellschaft free of qualification. The Financial Statements are published in
the Federal Gazette and filed at the Commercial Registry of Ludwigshafen
(Rhine) HRB 3000. A reprint may be obtained by contacting:
BASF Aktiengesellschaft
67056 Ludwigshafen, Germany
Tel.: +49 621 60-0, Fax: +49 621 60-42525
E-mail: info.service@basf-ag.de
Internet: http://www.basf.de/mediaorders 
Income from operations after special items fell 23.4 per-
cent to € 2.009 billion. We were burdened with high
special items of more than € 700 million for fines and
provisions for claims for damages related to violations of
antitrust laws in the vitamins business in the United
States and other countries as well as to largely settle
lawsuits in the United States involving the thyroid drug
Synthroid®. Some of these settlements still require court
approval.
Additional charges arose from site closures – especially
in Colombia, the United Kingdom and Belgium – and
from unscheduled write-downs on intangible assets of
the lysine business we acquired. These charges totaled
€ 310 million.
We received income of € 980 million from the sale of
businesses and holdings, which is reflected in the finan-
cial result and income from operations.
Income tax expenses rose 22.9 percent over last year,
mainly due to higher non-deductible taxes on increased
crude oil production as well as to the reduction in de-
ferred tax assets and liabilities resulting from changes in
tax rates. As a result, net income was € 1.237 billion,
down 27.2 percent from the previous year. 
Proposed appropriation of profit
BASF Aktiengesellschaft1 achieved net income of
€ 1.007 billion, of which € 304 million was allocated to
retained earnings and € 703 million to profit retained.
The Board of Executive Directors and the Supervisory
Board are proposing to the Annual Meeting on April 27,
2000, a dividend payment of € 1.13 per qualifying share.
The tax credit for entitled shareholders is € 0.48 per
share. If shareholders approve this proposal, the divi-
dend payable on 620,984,640 shares qualifiying for a
dividend will be € 702 million. We propose that the 
remaining profit retained of € 1 million be carried
forward.
Sales and earnings
Million € 1999 1998
Sales 29,473 27,643
Income from operations 2,009 2,624
Financial result 597 147
Income before taxes
and minority interests 2,606 2,771
Income taxes –1,361 –1,107
Minority interests – 8 35
Net income 1,237 1,699
Earnings before special items
Million € 1999 1998
Income from operations 
before special items 2,950 2,553
Special items – 941 71
Income from operations 2,009 2,624
Financial result before special items –155 19
Special items 752 128
Financial result 597 147
Income before taxes 
and special items 2,795 2,572
Net special items –189 199
Income before taxes
and minority interests 2,606 2,771
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Our European organization has been realigned to create
marketing units with Europe-wide responsibilities. We are
improving delivery times by adding regional distribution
centers and developing customized logistics solutions.
E-commerce, the trading of goods and services through
new media, is becoming increasingly an additional pur-
chasing and distribution channel for our company. We
see great opportunities to streamline our business pro-
cesses and become even closer to our customers.
Growth continues in North America
Our sales last year in North America (the United States,
Canada and Mexico) rose 8.3 percent. On a U.S. dollar
basis, sales rose almost four percent. All segments con-
tributed to this increase, in part due to acquisitions. The
Health & Nutrition segment exhibited particularly strong
growth, posting a sales increase of nearly 14 percent.
Declining sales prices, especially in the Chemicals and
Plastics & Fibers segments, dampened sales growth.
Income from operations before special items fell slightly
to € 578 million. The Health & Nutrition segment again
made the largest contribution to earnings. Both the
Colorants & Finishing Products and the Plastics & Fibers
segments improved earnings. The Chemicals segment
again achieved a high level of earnings, but reported
lower income than in 1998 due to pressure on sales 
European business thriving
In Europe, our most important market, sales rose
2.2 percent. After a weak start, business improved 
significantly during the second half. Margins, however,
remained unsatisfactory. 
The Chemicals segment’s sales declined slightly in Eu-
rope, while the Plastics & Fibers segment’s sales ex-
panded substantially. Sales in the Health & Nutrition seg-
ment increased, particularly in the Pharmaceuticals
division due to expansions in the scope of consolidation.
Crop protection product sales, however, fell short of the
previous year’s levels due to the weather but in total re-
mained at a high level. Sales improved in the Colorants &
Finishing Products segment, especially in the Coatings
and Dispersions divisions.
Our European companies improved their income from
operations before special items by 9.6 percent and con-
tributed 70 percent to BASF’s adjusted earnings. The
rapid implementation of our cost-cutting program began
to make a positive impact in 1999.
For 2000, we want to generate higher sales and improve
earnings while also benefiting from a more favorable 
economic climate.
Successful in all regions 
Regions
We increased sales in all regions, achieving double-digit sales growth in
Asia and South America and more than an eight percent gain in North
America. Sales in Europe met expectations, rising a good two percent. In-
come from operations before special items improved despite higher raw
material costs and intense price pressure.
For 2000, we want to increase sales and earnings in all regions. We have
greatly improved our competitiveness and will further optimize our portfolio.
Regions Sales based on Sales based on Income from operations 
location of customer location of company
Million € 1999 1998  1997 1999 1998 1997 1999 1998 1997
Europe 17,041 16,672 17,441 19,119 18,508 19,897 1,258 2,033 2,302
• Thereof Germany 7,147 7,011 7,352 12,718 12,188 13,558 542 1,301 1,555
North America (NAFTA) 6,765 6,249 5,966 6,783 6,210 5,940 481 515 350
South America 1,837 1,640 1,676 1,484 1,305 1,275 126 16 72
Asia, Pacific Area, Africa 3,830 3,082 3,437 2,087 1,620 1,408 144 60 7
29,473 27,643 28,520 29,473 27,643 28,520 2,009 2,624 2,731
* Investments in tangible and intangible assets
Customers in more than 170 countries know and trust
BASF products and services. We operate production
sites in 38 countries. We are aware of our respon-
sibility as a transnational company operating in
countries with different political, economic and social
environments and conduct our business accordingly.
prices and higher raw material costs. The impact of our
cost-cutting program to reduce fixed costs helped offset
this decline.
We remain on course for continued growth. During each
quarter of the next two years, we will begin operating a
new large chemical plant in North America to strengthen
our market position and improve our cost structure.
Expansion in South America despite economic crisis
Our business in South America developed satisfactorily,
with sales rising 12 percent despite the region’s eco-
nomic stagnation. A major factor for this increase was
the first-time consolidation of the natural gas business of
Wintershall Energía S.A. of Argentina. 
Brazil overcame its financial crisis more quickly than ex-
pected, and the economy is now set for growth. Thanks
to the introduction of new products, the Health & Nutri-
tion segment’s business developed well throughout the
region. Our polystyrene business and natural gas opera-
tions both profited from significantly positive price devel-
opments.
Income from operations before special items improved
considerably, mainly due to the contribution of the natu-
ral gas business. Foreign exchange losses were also
lower than in 1998; we had already made provisions in
our 1998 financial results for expected exchange rate
losses resulting from the overvaluation of the Brazilian
real.
In Brazil, we want to expand our market position through
capital expenditures. We are building a butyl acrylate
plant and plan to manufacture superabsorbers. In addi-
tion, we are expanding our polystyrene and EPS produc-
tion capacities in 2000 to strengthen our market position.
Significant improvement in Asia
Our sales in Asia rose 24.3 percent, with all segments –
particularly Health & Nutrition and Plastics & Fibers –
contributing to the growth.
The improvements in our business were spurred by the
swift economic recovery in Korea. We improved our
sales substantially in this country, particularly by adding
new production capacity for ABS plastics and PolyTHF®.
In China, sales surged 42 percent. Higher sales in Japan
were due mainly to a higher valuation of the yen.
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We increased income from operations before special
items one-and-a-half times over 1998 and we will build
on this success in 2000.
In China, negotiations to build a new Verbund site in
Nanjing and an MDI/TDI site in Shanghai are proceeding
as planned. These sites are scheduled to begin opera-
tions in 2004/2005. Construction of the Verbund site in
Kuantan, Malaysia, is making rapid progress. We are 
also strengthening BASF’s position through the creation
of BASELL Eastern, a joint venture in Singapore between
BASF and Shell that manufactures styrene and propy-
lene oxide.
Capital expenditures worldwide
In 1999, we invested worldwide € 2.764 billion in tan-
gible assets and € 489 million in intangible assets (fig-
ures include additions from acquisitions). The 1999
spending level was a decline of 12.6 percent from the
record year of 1998 when we made extensive
acquisitions. 
We invested 49 percent of our capital expenditures in
tangible and intangible assets in Germany and another
11 percent in the rest of Europe. The percentage of capi-
tal expenditures at our sites in North America continued
to increase, rising from 29 percent to 34 percent of
worldwide spending. South America accounted for 
2.5 percent, while the Asia, Pacific Area, Africa region 
received 3.5 percent of worldwide capital expenditures.
The percentage of worldwide capital expenditures for the
Asia, Pacific Area, Africa region does not include invest-
ments for the Verbund site in Kuantan, Malaysia, be-
cause it has not yet been consolidated. We made € 153
million available for the Kuantan site in 1999.
Following the high capital expenditures in 1998 and
1999, we plan to invest about € 2.5 billion in tangible
assets in 2000.
Regions Income from operations Capital expenditures* Assets
before special items
Million € 1999 1998  1997 1999 1998 1997 1999 1998 1997
Europe 2,060 1,880 2,434 1,950 2,214 1,447 18,744 17,842 17,005
• Thereof Germany 1,278 1,112 1,672 1,595 1,840 1,073 12,959 12,313 12,062
North America (NAFTA) 578 593 443 1,105 1,092 888 7,062 5,478 5,309
South America 160 21 72 83 69 56 1,438 1,065 1,045
Asia, Pacific Area, Africa 152 59 25 115 347 173 2,765 2,317 1,177
2,950 2,553 2,974 3,253 3,722 2,564 30,009 26,702 24,536
Further information about the regions can be found in the Notes to the BASF Group Consolidated Financial Statements on page 65.
BASF sites
Country Site Operating Division 
Denmark Ballerup Fine Chemicals
Grenaa Fine Chemicals
France Berre Polyolefins
Clermont de l’Oise Coatings
Colorants
Fos Polyolefins
Lillebonne Polyolefins
Mitry-Mory Polyurethanes
Notre-Dame-de-Gravenchon Polyolefins
Italy Bibbiano Styrenic Polymers
Burago Coatings
Cesano Maderno Coatings
Colorants
Dispersions
Cinisello Balsamo Colorants
Liscate Pharmaceuticals
Villanova d’Asti Polyurethanes
Zingonia Polyurethanes
Netherlands Apeldoorn Dispersions
Moerdijk ➁ Polyurethanes
Rozenburg Polyolefins
Spain Guadalajara Coatings
Hospitalet Colorants
Madrid Pharmaceuticals
Rubi Polyurethanes
Tarragona ➀ Crop Protection
Industrial Chemicals
Intermediates
Styrenic Polymers
Engineering Plastics
Polyolefins
Dispersions
Switzerland Liestal Pharmaceuticals
San Antonino Pharmaceuticals
United Kingdom Alfreton Polyurethanes
Carrington Polyolefins
Seal Sands Fiber Products
Slinfold Colorants
Wilton Polyolefins
Major BASF 
production sites 
Europe
Country Site Operating Division 
Germany Ludwigshafen ➀ Petrochemicals  
& Inorganics
Fertilizers
Industrial Chemicals
Intermediates
Specialty Chemicals
Styrenic Polymers
Engineering Plastics
Fiber Products
Colorants
Dispersions
Fine Chemicals
Crop Protection
Besigheim Colorants
Cologne Colorants
Cologne-Knapsack Polyolefins
Frankenthal Styrenic Polymers
Frankfurt Polyolefins
Lemförde Polyurethanes
Ludwigshafen Pharmaceuticals
Minden Pharmaceuticals
Münchsmünster Polyolefins
Münster-Hiltrup Coatings
Schwarzheide Intermediates
Styrenic Polymers
Dispersions
Engineering Plastics
Polyurethanes
Coatings
Crop Protection
Stuttgart-Feuerbach Colorants
Uetersen Pharmaceuticals
Wesseling Polyolefins
Styrenic Polymers
Willstätt Colorants
Belgium Antwerp ➀ Petrochemicals  
& Inorganics
Fertilizers
Industrial Chemicals
Intermediates
Specialty Chemicals
Styrenic Polymers
Engineering Plastics
Polyurethanes
Fiber Products
Dispersions
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➀ Verbund site, ➁ Under construction, ➂ Planned
South America
Country Site Operating Division 
Brazil (cont’d) Jacarepagua/
Rio de Janeiro Pharmaceuticals
São Bernardo do Campo Coatings
Polyurethanes
São Jose dos Campos Styrenic Polymers
Chile Concon Industrial Chemicals
Styrenic Polymers
Dispersions
Santiago Styrenic Polymers
Asia Pacific
Country Site Operating Division 
China Caojing ➂ Polyurethanes
Nanjing Styrenic Polymers
Nanjing ➀, ➂ Petrochemicals 
& Inorganics
Industrial Chemicals
Polyolefins
Dispersions
Specialty Chemicals
Intermediates
Panju ➂ Polyurethanes
Shanghai Colorants
Fiber Products
Coatings
Dispersions
India Goa Pharmaceuticals
Mangalore Colorants
Dispersions
Mumbai (Bombay) Pharmaceuticals
Thane Styrenic Polymers
Colorants
Specialty Chemicals
Indonesia Ceng Kareng Dispersions
Japan Katsuyama Pharmaceuticals
Shinshiro Polyurethanes
Totsuka ➂ Coatings
Yokkaichi Intermediates
Colorants
Polyurethanes
Fine Chemicals
Korea Kunsan Fine Chemicals
Ulsan Intermediates
Styrenic Polymers
Engineering Plastics
Polyurethanes
Yeochun Polyurethanes
Malaysia Kuantan ➀, ➁ Industrial Chemicals
Intermediates
Dispersions
Petrochemicals 
& Inorganics
Pasir Gudang Styrenic Polymers
Engineering Plastics
Shah Alam Polyurethanes
North America
Country Site Operating Division 
Canada Blackie, Alberta Polyurethanes
Toronto, Ontario Polyurethanes
Windsor, Ontario Coatings
Mexico Altamira Styrenic Polymers
Engineering Plastics
Colorants
Dispersions
Lerma Polyurethanes
Specialty Chemicals
Mexico City Pharmaceuticals
Tultitlán Coatings
United States Anderson, South Carolina Fiber Products
Beaumont, Texas Crop Protection
Bishop, Texas Pharmaceuticals
Carrollton, Texas Polyurethanes
Clemson, South Carolina Fiber Products
Polyurethanes
Freeport, Texas ➀ Industrial Chemicals
Intermediates
Styrenic Polymers
Engineering Plastics
Fiber Products
Dispersions
Geismar, Louisiana ➀ Petrochemicals 
& Inorganics 
Industrial Chemicals
Intermediates
Polyurethanes
Specialty Chemicals
Joliet, Illinois Styrenic Polymers
Monaca, Pennsylvania Dispersions
Morganton, North Carolina Coatings
Port Arthur, Texas ➁ Petrochemicals 
& Inorganics
Shreveport, Louisiana Pharmaceuticals
South Brunswick, 
New Jersey Styrenic Polymers
Whippany, New Jersey Pharmaceuticals
Wyandotte, Michigan Styrenic Polymers
Polyurethanes
Engineering Plastics
Fine Chemicals
South America
Country Site Operating Division 
Argentina Buenos Aires Polyurethanes
General Lagos Rosario Styrenic Polymers
Colorants
Dispersions
Specialty Chemicals
Tortuguitas Coatings
Brazil Camaçari Industrial Chemicals
Intermediates
Guaratinguetá Industrial Chemicals
Intermediates
Styrenic Polymers
Colorants
Dispersions
Crop Protection
Specialty Chemicals
Chemicals 
Petrochemicals & Inorganics Mainly for captive use: petrochemical feedstocks such as ethy-
lene, propylene and benzene; organic and inorganic basic chemicals such as methanol, acety-
lene, ammonia and sulfuric acid as well as inorganic specialties; catalysts.
Industrial Chemicals Plasticizers and plasticizer raw materials such as 2-ethylhexanol, phthal-
ic anhydride and higher oxo alcohols; oxygenated solvents such as butanol; glues and impreg-
nating resins, formaldehyde and melamine. 
Intermediates Amines, diols, polyalcohols, carboxy and dyestuff intermediates, carboxylic
acids and precursors for fine chemicals.
Specialty Chemicals Alkylene oxides, glycols, surfactants, complexing agents, detergent 
raw materials, automotive chemicals, fuel and lubricant additives, biocides and electroplating
chemicals.
Fertilizers Straight nitrogen fertilizers, compound fertilizers of the Nitrophoska® line, specialty
fertilizers and COMPO® products for plant care in the home and garden as well as commercial
gardening and landscaping. (At the end of 1999, sales, earnings and assets were transferred to
“Other”.)
Plastics & Fibers
Styrenic Polymers Styrenic and styrene-based polymers such as polystyrene and Styrolux®; ex-
pandable polystyrene (Styropor®) and specialty foams such as Styrodur®, Neopolen® and Basotect®.
Engineering Plastics Construction materials: copolymers such as ABS (acrylonitrile-butadiene-
styrene) and SAN (styrene-acrylonitrile), nylons, PBT (polybutylene terephthalate), POM (polyoxyme-
thylene) and high-temperature thermoplastics.
Polyurethanes Basic polyurethane products: polyols and isocyanates; polyurethane systems; 
polyurethane elastomers; polyvinyl chloride (as of January 1, 1999, in a joint venture with Solvay).
Fiber Products Fiber intermediates such as caprolactam, adipic acid and hexamethylene-
diamine; nylon-based fibers and filaments.
Polyolefins Organizationally independent subsidiaries carry out these operations:
• Polyethylene: Elenac (joint venture with Shell, BASF share 50 percent)
• Polypropylene: Targor (until December 1999 joint venture with Hoechst/Celanese, BASF share now
100 percent)
We are incorporating these subsidiaries into a joint venture with Shell.
Our segments, operating divisions 
and their products
Segments
Segments Sales Income from operations Income from operations
before special items
Million € 1999 1998  1997 1999 1998 1997 1999 1998 1997
Chemicals 4,393 4,255 4,471 698 922 1,089 735 903 1,095
Plastics & Fibers 8,533 7,573 7,395 640 539 368 638 520 450
Colorants & Finishing Products 6,395 6,188 6,540 608 642 480 682 623 528
Health & Nutrition 5,602 5,097 4,587 – 588 383 348 408 391 457
Oil & Gas 3,051 2,685 3,198 741 276 473 603 257 500
Other** 1,499 1,845 2,329 – 90 –138 –27 –116 –141 – 56
29,473 27,643 28,520 2,009 2,624 2,731 2,950 2,553 2,974
* Investments in tangible and intangible assets
** Sales and earnings of the fertilizers business and of other businesses as well as expenditures, earnings and assets not allocated to the segments
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Oil & Gas 
Wintershall AG and its affiliates conduct the operations of our Oil & Gas 
segment, which include:
• the exploration and production of crude oil and natural gas,
• crude oil and natural gas trading,
• the leasing of natural gas transportation and storage capacity,
• until the end of 1999: oil refining at the Emsland refinery in Lingen, Germany,
and
• until the end of 1999: petroleum product marketing.
Health & Nutrition
Pharmaceuticals Drugs for treating thyroid insufficiency, obesity-related dis-
orders, diseases of the cardiovascular and central nervous systems; analgesics;
pharmaceutical active ingredients.
Fine Chemicals Vitamins, carotenoids, nutraceuticals, amino acids, en-
zymes, organic acids; flavors and fragrances; UV absorbers and specialty 
polymers and other fine chemicals for the pharmaceuticals, food and cosmetics
industries.
Crop Protection Crop protection products to control weeds (herbicides) and
plant diseases caused by fungi (fungicides); growth regulators.
Colorants & Finishing Products
Colorants Dyes and process chemicals for textiles, leather and office use;
pigments and specific pigment preparations; printing inks and printing plates
for the graphics industry.
Dispersions Acrylic acid and acrylates, acrylate and styrene/butadiene 
dispersions; raw materials for paints, coatings and glues; dyes and process
chemicals for the paper industry; superabsorbers.
Coatings Automotive OEM and refinish coatings; industrial coatings;
decorative paints.
Segments Income from operations Capital expenditures* Assets 
before special items 
and depreciation
Million € 1999 1998  1997 1999 1998 1997 1999 1998 1997
Chemicals 1,209 1,355 1,479 763 587 490 4,050 3,354 3,142
Plastics & Fibers 1,230 1,071 870 998 746 673 6,811 4,957 4,397
Colorants & Finishing Products 1,082 1,002 880 324 348 256 4,343 3,981 4,052
Health & Nutrition 1,030 925 869 281 1,002 398 5,174 4,882 4,006
Oil & Gas 883 495 711 524 505 322 3,003 2,622 2,503
Other** – 21 – 49 27 363 534 425 6,628 6,906 6,436
5,413 4,799 4,836 3,253 3,722 2,564 30,009 26,702 24,536
Further information about the segments can be found in the Notes to the BASF Group Consolidated Financial Statements on page 64.
Sales
Million €
4,471 4,255 4,393
’97 ’98 ’99
Income from operations 
before special items
Million €
1,095 903 735
’97 ’98 ’99
Capital expenditures
Million €
490 587 763
’97 ’98 ’99
Chemicals
Excellence in chemistry and technology, a highly
developed Verbund and a strong presence in the
world’s markets form the basis for the success of
our Chemicals segment.
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The Chemicals segment’s sales rose slightly to € 4.4 billion, while
income from operations before special items fell to € 735 million
due to a drop in sales prices during the first half of the year and
considerably higher raw material prices in the second half.
Lower sales prices in the first half of the year were due mainly to
oversupply caused by weak global demand. Business improved
considerably worldwide during the second half. Sales prices
improved slightly, but they could not fully compensate for higher
raw material costs.
For 2000, we want to increase sales and improve earnings. We
are expanding our Verbund, investing in innovative products, con-
structing new plants in growth markets such as Asia and North
America and are reinforcing our already healthy global position.
We restructured our fertilizers business at the end of 1999. We
sold our COMPO® business in specialty fertilizers for the home
and garden to K+S Aktiengesellschaft, which in the future will also
market our agricultural fertilizers. As a result, the sales, earnings
and remaining assets of the Fertilizers division were transferred
from Chemicals to “Other” at the end of 1999, and the 1998 
figures have been adjusted accordingly.
From pantyhose to cable sheathing: PolyTHF® (polytetrahydrofuran) offers
a wide range of possible applications. But these elastomeric fibers look
good in more than just swimwear and tracksuits. As a precursor for plas-
tics such as thermoplastic polyurethanes, it can also be found in the 
door panels of automobiles as well as in sports equipment such as in-
line skates and ski boots. BASF is the only supplier of PolyTHF® with
its own production facilities in every important industrial region.
With plants in Ludwigshafen, Germany; Geismar, Louisiana;
Yokkaichi, Japan; and Ulsan, Korea, our annual total
PolyTHF® capacity in 2000 will be approximately 
84,000 metric tons. Further capacity expansions 
are planned in Europe and Asia.
Plant supervisor Wolfgang
Remmet and his colleagues
ensure that the PolyTHF® plant
runs smoothly at our site in
Ludwigshafen, Germany. 
The product is processed into
elastomeric fibers that are used
to manufacture products such
as pantyhose and swim- and
sportswear.
scale plants based on leading-edge technologies that are
integrated into our Verbund sites. To this end, we will close
three small formaldehyde plants at our Ludwigshafen site
and replace them with the world’s largest formaldehyde
plant, which is scheduled to begin operations in 2001.
We are strengthening our global presence in plasticizers
and solvents by building plants at our sites in Kuantan,
Malaysia, and Nanjing, China.
Intermediates set for expansion
In 1999, we demonstrated our strength in chemical inter-
mediates in fiercely contested markets. Although the
chemical industry’s economic climate was weak at the
start of the year, we improved our sales volumes and 
market position. The Intermediates division’s sales once
again rose slightly.
The division’s earnings remained good in 1999 but failed
to reach the previous year’s level. For 2000, we want to
achieve higher sales and earnings.
New diol suppliers entered the market in 1999, putting
heavy pressure on prices worldwide. We strengthened our
market position, however, through our expansion program
and by making structural improvements. In 1999, we built
new plants or expanded capacities at our sites in the 
United States, Korea and Ludwigshafen, Germany. We are
equipped to achieve above-average growth in our prod-
ucts used in the growing markets for specialty plastics,
powder and waterborne coatings, acrylates and organic
peroxides.
In our carboxy and dyestuff intermediates business, we
achieved higher sales and earnings despite competitive
pressures. We have entered new application areas that we 
expect will further improve our global market position in
2000.
Prices recovered in the carboxylic acids business, and we
expect sales and earnings to further increase in 2000.
Sales in the amines business rose due to new major cus-
tomers in the gas scrubber and coatings businesses. We
recorded particularly strong demand for aMDEA®, aniline,
ethanolamines, ethyleneamines and isophoronediamine.
Demand for our innovative products, such as optically
active amines, also increased.
Specialty Chemicals gains strength
After a modest start in 1999, the Specialty Chemicals
division’s business picked up steadily as the year pro-
gressed. Sales rose six percent, particularly due to new
products such as polymeric concrete fluidizers and newly
acquired complexing agent operations. Earnings remained
steady at the previous year’s levels. 
Monoethylene glycol prices began improving in mid-1999
due to rising demand. A recovery in eastern Asia followed
the upward trend in western industrialized markets. We
took advantage of increased demand in Asia, particularly
Sales by divisions
Million € 1999 1998
Petrochemicals & Inorganics 747 734
Industrial Chemicals 765 752
Intermediates 1,472 1,441
Specialty Chemicals 1,409 1,328
Chemicals 4,393 4,255
Petrochemicals & Inorganics capacities fully utilized
The vast majority of products in our Petrochemicals &
Inorganics division are manufactured for captive use, with
sales to third parties accounting for about 30 percent of
the division’s total sales when including intersegment
transfers.
Prices for naphtha, the feedstock for our steamcrackers,
rose sharply in 1999, which eroded our cracker margins
and depressed earnings. In the course of the year, how-
ever, olefin prices rose and unsatisfactory margins im-
proved, especially in the fourth quarter. 
Due to strong demand from external customers and from
within BASF, our plants operated at full capacity.
Sales of inorganic chemicals to external customers im-
proved noticeably during the second half of the year. Our
catalyst products sold to third parties achieved double-
digit growth rates in both sales and earnings.
We are strengthening our existing Verbund structures and
building new Verbund sites by making substantial capital
expenditures. These investments, which are being made
at a time of steady improvement in the global economy,
will increase our earnings in 2000, especially for petro-
chemical products. We expect crude oil prices to fall
during the second half of the year.
Industrial Chemicals improvement in sight 
The Industrial Chemicals division’s sales rose approxi-
mately two percent in 1999. Sales volumes increased
slightly, particularly in the growth markets of the Americas
and Asia. We maintained our existing position in our core
market of Europe. Earnings declined due to ongoing price
pressure.
Business in 1999 was characterized by excess production
capacity and intensified competition in virtually all product
lines. The price erosion that had started in 1998 continued
during the first half of 1999. Melamine was particularly 
affected, and, as a result, some of our glue and impreg-
nating resin products. Price increases helped improve
margins from mid-1999 in the plasticizers business.
For 2000, we expect volumes, sales and earnings to rise. 
Efficient manufacturing is crucial to profitability in our 
large-volume products. Amid tougher competition, we will
achieve or expand cost leadership by producing in world-
for specialties such as electroplating chemicals, concrete
additives and polyethylene waxes.
For 2000, we want to achieve higher sales and earnings.
We are expanding production capacity at our Verbund
sites, reaffirming our strategy to strengthen cyclically
resilient product lines within our important value-adding
chains.
In our nonionic surfactant operations, we strengthened our
market positions in North America and Europe. We are
building a new plant in Geismar, Louisiana, and last year
we acquired BP Amoco’s European polyethylene glycol
business.
Our European and U.S. production capacities for ethylene
oxide and ethylene glycols were again fully utilized in 1999.
Demand for polyester fibers, and particularly strong de-
mand for PET packaging and bottles, is underpinning the
need for these products. We plan to build an ethylene 
oxide/ethylene glycol plant at our site in Nanjing, China.
By acquiring the engine coolant business of the French
company Acia, we are strengthening our business with
major automotive manufacturers. We increased produc-
tion capacity at our propylene glycol plant in Germany to
meet growing demand.
In the strongly contested gasoline additives market, we
did well with our polyisobutene-based products and
increased our market share for lubricant additives. Our
plants are operating at full capacity.
Fertilizers business sold 
At the end of 1999, we sold our COMPO® business in
specialty fertilizers for the home and garden to K+S
Aktiengesellschaft, which also took over the marketing
and sales of agricultural fertilizers manufactured by BASF.
This transaction will allow us to concentrate on the manu-
facture of fertilizers within our Verbund.
In 1999, excess production capacity and enormous price
declines for agricultural fertilizers characterized the fertiliz-
ers market. Despite these difficult conditions, we per-
formed well and increased sales volumes. We also
achieved higher sales and improved earnings in the
COMPO® specialty fertilizers business.
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Chemicals capital expenditures
Capital expenditures remained high in 1999 and were € 763 million, a 
30 percent increase over 1998. The main capital expenditures were as 
follows: 
Europe
At our site in Ludwigshafen, Germany, we began operating new plants to
manufacture alkylene carbonate and hydroxylamine. We expanded produc-
tion capacity for sodium methylate, methylamines, butylamines and di-
methylacetamide. Starting in mid-2000, production capacity for chlorofor-
mates as well as acid and alkyl chlorides will be increased. We have started
building new plants to manufacture dimethylhexanediol and trimethylolpro-
pane and are expanding capacity for formaldehyde, butanediol and optical-
ly active intermediates.
At our site in Antwerp, Belgium, an aromatics extraction unit within the
steamcracker was completed at the end of the year. We are expanding pro-
duction capacity for ethyleneamines.
At our site in Tarragona, Spain, we are constructing a plant together with
SONATRACH to manufacture propylene by dehydrogenating propane.
North America
At our site in Geismar, Louisiana, we started operating a new acetylene
plant and are expanding production capacity for butanediol and PolyTHF®.
Capacity expansions for nitrobenzene, aniline, ethylene oxide and ethylene
glycol are under construction. At our site in Freeport, Texas, we are building
a new plant to manufacture hexanediol and caprolactone. The neopentyl-
glycol plant at this site will be replaced by a larger unit in 2002. We are also
building the world’s largest steamcracker in a joint venture with TOTALFINA
in Port Arthur, Texas. The steamcracker is scheduled to begin operations in
the second quarter of 2001. In another new joint venture at the Port Arthur
site, BASF and its partners Shell and TOTALFINA plan to build the world’s
largest butadiene extraction plant. 
Asia
At our site in Ulsan, Korea, a new plant for butanediol and tetrahydrofuran
began operations at the end of 1999. A capacity expansion project at the
site’s PolyTHF® plant will be completed during the first quarter of this year.
At our site in Kuantan, Malaysia, we are building plants with our partner
Petronas to manufacture syngas, oxo alcohols, phthalic anhydride and
plasticizers. These plants are to begin operations in 2001. Plants to
manufacture butanediol and formic acid are scheduled to begin operations
in 2002.
At our site in Yokkaichi, Japan, a new plant to manufacture N-methylpyrro-
lidone (NMP) will be completed by mid-2000.
In Nanjing, China, we intend to build a Verbund site with our Chinese
partners.
Plastics & Fibers
These simple-looking foam boards being stacked by Rüdiger Hahn at our site 
in Ludwigshafen, Germany, have a dual purpose: The BASF plastic Basotect®
provides sound as well as heat insulation. It can be found in the stations of the
Paris Metro.
Sales
Million €
7,395 7,573 8,533
’97 ’98 ’99
Income from operations 
before special items
Million €
450 520 638
’97 ’98 ’99
Capital expenditures
Million €
673 746 998
’97 ’98 ’99
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Reducing background noise to a tolerable level is one of the
jobs that the BASF plastic Basotect® performs. This flexible mela-
mine resin foam is used wherever sound insulation is a primary con-
cern, so Basotect® is just as much at home in the Paris Metro as in
loud factories, airports and sound studios. Basotect® is increasingly
being used for sound insulation in luxury vehicles. In addition,
Basotect® has another advantage: The plastic not only keeps
unwelcome noise within limits but also provides good thermal
insulation.
We will be among the 
best global competitors in 
plastics and fibers with 
leading-edge technology 
and low costs.
In the Plastics & Fibers segment, sales rose nearly 13 per-
cent to € 8.5 billion, in part due to operations acquired in
1998 and 1999. Income from operations before special
items climbed € 118 million to € 638 million.
For 2000, we will further increase sales and earnings on a
comparable basis.
A key success for our plastics business is our ability to use
state-of-the-art technology in world-scale plants to
achieve cost leadership; we translate this ability into a
strong market position. In addition to building new plants
and expanding existing capacities, we place special im-
portance on partnerships.
BASF and Shell plan to combine their subsidiaries Elenac,
Targor and Montell to create one of the world’s largest
polyolefin companies. Formation of the new joint venture,
in which BASF and Shell will each hold a 50 percent
ownership stake, is subject to approval by antitrust
authorities. For reporting purposes, BASF intends to
account for the new joint venture on an equity basis,
meaning that sales, earnings and assets from BASF’s
polyolefin operations will be eliminated from the segment.
In addition to realigning our polyolefin activities, we began
implementing in 1999 capital expenditures for extensive
structural improvements that will continue in 2000. We are
modernizing old plants and building new ones in Europe,
North America and Asia.
Through these measures, we are making good progress
toward achieving our goal of technology and cost leader-
ship. At the same time, we are implementing our strategy
of achieving profitable growth in all important economic 
regions.
compared to the previous year, but earnings increased
due to improved cost structures and expansion of our
business.
We strengthened our global market position in styrenic
copolymers. We successfully integrated DSM’s ABS
plastics business, which we acquired in spring 1999. Our
large-scale ABS plant in Korea reached full capacity
during its second year of operation. In the Ultraplast poly-
mers unit, compounding plants for nylon and polyester
began operations at the end of 1999 in Malaysia and the
United States.
For 2000, we will expand our styrenic polymers business.
Following the startup of our new copolymers plant in 
Mexico, we are the first producer to supply identical
products worldwide based on local production. We are
constantly optimizing our manufacturing processes to
increase productivity and further improve earnings.
Polyurethanes increases productivity
In the Polyurethanes division, sales increased nearly
11 percent. Sales volumes rose, while prices fell. In addi-
tion to a notable improvement in Europe, we benefited
from a strong market recovery in Asia. We improved on
the previous year’s good earnings.
For 2000, we will further increase sales. We will also
improve earnings even though raw material costs are
rising and price increases for our products will be difficult
to implement. 
In Europe, we improved productivity and made good
progress toward achieving cost leadership. The construc-
tion of world-scale plants for isocyanates in the United
States will help us achieve this goal. We are building a
propylene oxide plant in Singapore with Shell to expand
our supply of basic products in Asia.
Effective January 1, 1999, we placed our PVC activities in
the Solvin joint venture with Solvay of Belgium. BASF has
a 25 percent ownership stake and Solvay a 75 percent
stake. This venture shows that we are expanding our 
Verbund beyond our own manufacturing plants to improve
our earning power.
Fiber Products earnings up
The Fiber Products division’s sales rose noticeably and
earnings improved significantly.
We offset declining textile fiber sales in North America,
which were caused by price pressure, by increasing sales
volumes of textile intermediates. In Europe and Asia, sales
of fiber intermediates used to manufacture nylon 6,6 re-
mained at the previous year’s level, but sales of interme-
diates for nylon 6 rose noticeably.
Styrenic Polymers restructuring and expanding
Our Styrenic Polymers division almost reached the earn-
ings level of the previous year despite continuing price
pressure. The division achieved this result mainly through
volume increases and advances in productivity.
Global sales volumes of polystyrene and styrene were at 
a high level. The division’s earnings improved after a weak
start to 1999, due in part to rising prices during the
second half. We were particularly successful in Asia and
South America.
Sales volumes of Styropor® rose worldwide thanks to
higher demand. Margins, however, remained unsatisfac-
tory during the year as a whole. As a result, we are
modernizing our plants, particularly in Europe and the
United States.
Styrodur® and all our other product lines for specialty
foams were successful. Since 1999, the only Styrodur®
sales in Germany have been Styrodur® C, which is
foamed using environment-friendly carbon dioxide. This
product now accounts for more than 60 percent of our
total sales volumes of Styrodur® in Europe.
In 2000, demand for styrenic polymers will rise in all re-
gions and, as a result, we will further increase our sales
volumes.
We implement cost-cutting measures on an ongoing basis
to increase productivity. The globalization of our business
continues, and we are strengthening our operations in
Asia and Latin America, regions with above-average
growth. Our goal remains cost leadership and we will 
improve earnings in 2000.
Engineering Plastics stronger worldwide
The Engineering Plastics division made rapid progress,
especially during the second half of 1999. The capacity
utilization of our plants was high due to increased sales
volumes. The division’s sales rose 20 percent, with sales
volumes growing at an even faster rate. Sales prices fell
Sales by divisions
Million € 1999 1998
Styrenic Polymers 1,827 1,666
Engineering Plastics 1,276 1,062
Polyurethanes 2,157 1,946
Fiber Products 1,193 1,180
Polyolefins 2,080 1,719
Plastics & Fibers 8,533 7,573
Prices for caprolactam, the intermediate for nylon 6, fell to
an all-time low at the beginning of the year. Growing
demand starting in mid-1999 led to a recovery in prices 
for fiber intermediates, first in Asia and then Europe. The
higher sales volumes led to better earnings in these
regions; in North America, earnings rose more significantly
because we were able to reduce fixed costs.
For 2000, sales will rise slightly and we want to noticeably
improve earnings. Demand in Asia and Europe will prob-
ably stabilize, and we expect rising caprolactam prices to
improve earnings in this division.
We are now examining the possibility of building a fiber
products plant on our own or with a partner after aban-
doning plans for a joint venture with DuPont. We want to
use a new cost-effective process developed by us and
based on butadiene to manufacture nylon 6 and nylon 6,6
and their intermediates. It is more cost-efficient than the
previous process and generates no by-products.
Defined Polyolefins strategy
In our Polyolefins division, we want to achieve economies
of scale through acquisitions and mergers as well as by
building large-scale, state-of-the-art plants in order to
become a leading low-cost producer. We made progress
toward this goal through a series of measures that includ-
ed Elenac, our polyethylene joint venture, integrating the
Hostalen operations that it acquired from Hoechst in early
1999. We also bought Celanese’s stake in our polypropy-
lene joint venture Targor and are building two large-scale 
polyethylene plants that will begin operations in 2000. In
polypropylene, we began building a large-scale plant at
our site in Tarragona, Spain. The division also made good
progress in implementing cost-cutting programs.
The Polyolefins division raised sales 21 percent and
reported a large increase in earnings, as our own mea-
sures and improved market conditions offset a steep rise 
in raw material prices. For 2000, we are optimistic; we 
expect to achieve higher earnings.
We are still awaiting antitrust approval for the proposed
joint venture with Shell that will merge the companies
Elenac, Montell and Targor.
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Plastics & Fibers capital expenditures
In 1999, worldwide capital expenditures of the Plastics & Fibers segment
were € 998 million. The main capital expenditures were as follows:
Europe
At our site in Ludwigshafen, Germany, we are modernizing the polysty-
rene production plants as well as our nylon 6 production and compound-
ing plants.
At out site in Schwarzheide, Germany, we are building a new TDI plant
and expanding production capacity for PBT in our joint venture with
General Electric.
At our site in Wilton, England, Targor began operating a new plant to
manufacture polypropylene compounds. At our site in Tarragona, Spain,
Targor began building a new polypropylene homopolymers plant.
At our site in Wesseling, Germany, Elenac streamlined its polyethylene
production and is building a new plant for high-density polyethylene. At
our site in Berre, France, a new plant for low-density polyethylene is under
construction.
At our site in Antwerp, Belgium, we are expanding production capacities
of the polyetherols plant and the nylon 6 polymerization unit. We are also
restructuring our polystyrene plant.
North and South America
In the United States, we expanded our site in Wyandotte, Michigan, for
compounding engineering plastics and finished expanding the caprolac-
tam plant at our site in Freeport, Texas. At our site in Geismar, Louisiana,
we are building an additional plant to manufacture MDI and intend to
replace the existing TDI plant with a new one. At our site in Anderson,
South Carolina, we are expanding and modernizing our textile fibers
production plants. In Theodore, Alabama, we will expand our production
capacity for POM in mid-2000. 
In the first quarter of 2000, we started up a new styrene copolymers plant
at our site in Altamira, Mexico.
At our site in Guarantinguetá, Brazil, we are expanding our Styropor®
production capacity.
Asia
At our site in Pasir Gudang, Malaysia, we successfully started up new
compounding plants for engineering plastics.
In Singapore, the joint venture BASELL Eastern between BASF and Shell
has begun building a styrene and propylene oxide plant similar to the
BASELL joint venture plant for the same chemicals already in operation in
Moerdijk, the Netherlands.
In Shanghai, China, BASF Hua Yuan Nylon Company completed the first
stage of nylon production for carpet fibers. We are expanding the poly-
styrene plant at our joint venture Yangzi-BASF Styrenics.
Colorants & Finishing Products
Our colorants and finishing
products add special properties 
to our customers’ products such
as color, brilliance and durability.
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Completely new color impressions are being created
through the use of BASF’s Variocrom® and Sicopearl®
Fantastico ranges of color-variable pigments (CVP™), which
are being marketed successfully worldwide. Depending on
how light falls on them and the angle from which they are
seen, these pigments change color almost like a chameleon.
“Magic Red” can shimmer red, then gold, creating a play of
colors whose grandiose effects are fascinating. This innova-
tion is used in automotive coatings, colored plastics as well
as in film and sheeting, furniture, leather and decorative 
cosmetics.
The Colorants & Finishing Products segment’s business
suffered from sharply declining prices, particularly in the
first half of the year, but improved during the second half
as sales volumes rose significantly.
Sales in this segment rose € 207 million to € 6.4 billion.
The Dispersions division was a major contributor to this
increase.
Income from operations before special items climbed
€ 59 million to € 682 million. The segment’s special items
were for restructuring measures in the textile dyes
business.
We are continuing to pursue our strategy of building on
the strengths within our portfolio and eliminating weak-
nesses. Our goal is to improve earnings in 2000, support-
ed in part by the improving general economic climate.
In our Colorants division, we are reorganizing our world-
wide textile dye operations. Our intention is to merge this
operation into DyStar, a joint venture between Bayer and
Hoechst. We also intend to sell our masterbatch business
for specialist pigment preparations used to color plastics.
In our Coatings division, after our successful restructuring
in previous years, we are concentrating on automotive
OEM (original equipment manufacturer) and refinish coat-
ings, two businesses where we are among the world lead-
ers, as well as industrial coatings and the decorative
paints business in South America.
In our Dispersions division, we intend to improve our acryl-
ic acid value-adding chain through our planned acquisition
of the Chemdal superabsorbers business of AMCOL Inter-
national Corporation of the United States.
BASF's special-effect
pigments are produced
at our site in Besigheim,
Germany. In nail polish,
for example, they form
the basis for a spec-
tacular display of color.
Sales
Million €
6,540 6,188 6,395
’97 ’98 ’99
Income from operations 
before special items
Million €
528 623 682
’97 ’98 ’99
Capital expenditures
Million €
256 348 324
’97 ’98 ’99
New direction for Colorants
The Colorants division’s sales remained steady, but
income from operations rose.
Business in Asia picked up following the region’s
recovery during the first half of the year. In Europe and
the United States, however, we suffered setbacks. With
the goal of improving earnings, we are implementing a
series of measures to combat ongoing price pressure on
textile dyes and changes in the industry, which include
the relocation of textile production.
In the second half of 2000, we intend to combine our
textile dyes business with that of DyStar, a joint venture
in which Bayer and Hoechst each have a 50 percent
ownership stake. The proposed joint venture with DyStar
would create a more competitive supplier of textile dyes
with annual sales of more than € 1 billion.
We slightly increased sales in our pigments as well as
leather chemicals and dyes businesses, while sales in
our printing systems business rose considerably. Sales 
of textile chemicals and textile dyes, however, declined
again in 1999.
We increased our efficiency and improved our cost struc-
tures in all operations by closing sites and relocating pro-
duction. We sold our PVC stabilizers business and trans-
ferred production of azo standard pigments from our site
in Besigheim, Germany, to Shanghai, China. At the
Besigheim site, we started manufacturing Variocrom®
special-effect pigments, which are attracting great inter-
est for many application areas.
As part of our new direction for the Colorants division,
we want to sell our masterbatch business, which has an-
nual sales of approximately € 100 million.
Restructured Coatings on course for success
The Coatings division’s sales increased slightly in 1999,
although business varied among the regions. We experi-
enced significant gains in Europe and North America 
but a substantial decline in South America due to the 
devaluation of the Brazilian real.
Business developed well. After adjustments for special
items, income from operations remained high but did not
match the previous year’s level due to losses in South
America.
We have strengthened our leading positions in our core
business areas through acquisitions and cooperations.
We are expanding our business in innovative, higher-
value products, and we will support this process through
an ambitious capital expenditures program.
Sales by divisions
Million € 1999 1998
Colorants 2,217 2,201
Coatings 1,876 1,855
Dispersions 2,302 2,132
Colorants & Finishing Products 6,395 6,188
Extreme absorbency is a must for diapers and other sanitary care products. The answer: superabsorbers made from acrylic acid. BASF is one of the leading suppliers of both
acrylic acid and superabsorbers. We acquired the superabsorbers business of Clariant in 1998 and are building new plants in Antwerp, Belgium, and Brazil to reinforce our market
position. In 1999, we also increased our acrylic acid production capacity in Europe and North America (photo shows the plant at our site in Freeport, Texas). A new plant in 
Kuantan, Malaysia, which will soon begin operations, will add another 160,000 metric tons to our current total annual production capacity of 730,000 metric tons. 
The planned acquisition of the U.S. company Chemdal, a subsidiary of AMCOL International Corporation, will strengthen BASF’s position as a supplier of superabsorbers.
We are vigorously implementing measures to improve
efficiency and streamline processes. Noticeable
increases in productivity have already been achieved in
our production plants. As a result, our earnings will
improve in 2000, in part due to the expansion of our
industrial coatings business.
We again increased sales volumes of automotive coat-
ings in 1999. As a result of our environmentally and eco-
nomically efficient coating systems as well as close
cooperation with customers, we have strengthened our
position with many automotive manufacturers.
We intend to expand our market position with automo-
tive manufacturers in Asia and Australia. In Japan, we are
taking advantage of the trend toward waterborne coat-
ings. We want to expand our proven partnership with
Nippon Oil and Fats (NOF) in a proposed joint venture. In
Australia, we are planning to establish a joint venture with
Akzo Nobel to manufacture automotive OEM coatings.
In the automotive refinish business, we maintained high
earnings with our Glasurit® and R-M® product lines. We
have radically modernized our product portfolio and
improved distribution channels.
Our decorative paints business is concentrated in South
America. We successfully expanded the market leader-
ship of our Suvinil® brand in Brazil despite a difficult eco-
nomic environment.
We acquired coil coatings businesses from Rohm and
Haas as well as Norsk Hydro, making us one of the
world’s leading suppliers. This future-oriented technology
allows coating to take place at an early production stage.
We are preparing for rapid and sustainable growth in
powder coatings through capacity expansions at our
European and South American sites and through the
planned startup this year of a new powder coatings plant
in Morganton, North Carolina.
Dispersions advancing well
The Dispersions division’s sales rose due to the acquisi-
tion of Clariant’s superabsorbers business. Income from
operations remained steady at the previous year’s high
level despite a sharp increase in raw material prices.
We significantly increased sales volumes of acrylic
monomers and dispersions for adhesive raw materials,
paints and coating raw materials. For 2000, we want to
expand our business in all regions and further increase
earnings.
Acrylic acid and its derivatives, namely acrylates and
acrylic dispersions, are one of BASF’s strong-growth 
and cyclically resistant businesses. We are investing in
new production plants as well as in research and 
development.
Acrylic acid is the precursor for superabsorbers, which
are cross-linked polyacrylics that can absorb liquid many
times their own weight. This feature makes them an 
essential component of diapers and other sanitary care
products. The superabsorbers market continues to grow
globally at an annual rate of approximately seven percent
and is largely cyclically resilient.
We want to expand our position in this area by acquiring
the Chemdal superabsorbers business of AMCOL Inter-
national Corporation of the United States. This acquisi-
tion is subject to antitrust approval.
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Colorants & Finishing Products capital expenditures
In 1999, capital expenditures of the Colorants & Finishing Products seg-
ment were € 324 million, and we will increase capital spending in 2000.
The main projects concluded or initiated were as follows: 
Europe
At our site in Ludwigshafen, Germany, we expanded the production
capacity for a quinophthalone yellow pigment in spring 1999. A plant to
manufacture isoindoline yellow pigments, which are from the same Palio-
tol® line, will start operations in the third quarter of 2000. We completed
projects to build a plant to manufacture chlorophenylphosphine and ex-
panded production capacity for Lucirin®. As part of our expansion in
paper chemicals, we are building new plants to manufacture vinylform-
amide and polyvinylamines. In the first half of 2000, new plants for the
manufacture of polymer dispersions will begin operations.
At our site in Antwerp, Belgium, we expanded production capacity for
polyetherols, and a superabsorbers plant is currently in the planning
stage. 
In Hamina, Finland, a paper coating dispersions plant is expected to start
operations by the end of 2002.
North and South America
In the United States, we are expanding a plant at our site in Monaca,
Pennsylvania, which manufactures acrylate and styrene/butadiene disper-
sions. At our site in Morganton, North Carolina, we are building a new
powder coatings plant.
At our site in Altamira, Mexico, a new plant for the production of paper
dyes will start operations by the end of 2000.
In Brazil, we plan to build a superabsorbers plant, and we are also con-
structing a butyl acrylate plant at our site in Guarantinguetá.
Asia
At our new Verbund site in Kuantan, Malaysia, construction of the acrylic
acid/acrylate complex will be completed and start operations by mid-
2000.
We are determined to seize the
opportunities offered by our
health and nutrition
products to grow profitably. 
Health & Nutrition
Sales and earnings by divisions
Sales Income Income  Income 
from operations from operations from operations
before special items before special items
and depreciation
Million € 1999 1998 1999 1998 1999 1998 1999 1998
Pharmaceuticals 2,483 2,091 11 66 175 70 451 317
Fine Chemicals 1,374 1,256 – 794 114 35 112 209 241
Crop Protection 1,745 1,750 195 203 198 209 370 367
Health & Nutrition 5,602 5,097 – 588 383 408 391 1,030 925
With a practiced eye
- and supported by
modern technology -
Isolde Böh examines
rice plants at BASF’s
Agricultural Center
Limburgerhof  in 
Germany.
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In the Health & Nutrition segment, sales rose approximate-
ly 10 percent to € 5.6 billion due to increases in the Phar-
maceuticals and Fine Chemicals divisions.
Income from operations before special items rose approxi-
mately four percent to € 408 million. However, we in-
curred substantial special items resulting from antitrust 
law violations in the vitamins business, unscheduled write-
downs on intangible assets from the acquisition of the
lysine business, and costs to settle lawsuits involving the
thyroid drug Synthroid®. As a result of these special items,
the segment incurred a loss of € 588 million.
Our businesses in drugs as well as specialties for the cos-
metics and pharmaceutical industries were very success-
ful, as were our new active ingredients for crop protection
products. We made further advances in plant biotech-
nology. For 2000, we want to slightly increase both sales
and earnings in this segment.
We are reorganizing our worldwide pharmaceutical busi-
ness to make it more efficient, faster and more flexible.
Research and development are crucial to the Health &
Nutrition segment’s long-term performance and profit-
ability. In 1999, we invested nearly € 664 million in re-
search and development in this segment, which accounts
for almost 50 percent of total R&D spending at BASF.
Sales
Million €
4,587 5,097 5,602
’97 ’98 ’99
Income from operations 
before special items
Million €
457 391 408
’97 ’98 ’99
Capital expenditures
Million €
398 1,002 281
’97 ’98 ’99
Quick to prepare and good to eat: Rice is popular the world over. In many
Asian and Latin American countries, the main rice-growing areas of the world,
rice is an important nutritional staple and not just a side dish. BASF’s crop pro-
tection products increase rice yields, helping to feed the world’s population.
Specially developed rice herbicides prevent other plants from growing and
competing for light, water and nutrients. In addition to its well-established and
proven products, BASF has successfully launched a new product in Latin
America under the brand name Aura®. This herbicide is now also being mar-
keted in Asia under the brand name Tetris®. Fungicides that protect rice crops
from harmful fungi complement these herbicides. In addition to the well-known
Bavistin® brand name product, BASF sells the fungicide Duett® in Latin 
America and introduced it in Thailand in 1999. This product will also soon be
available to rice growers in other Asian countries.
Pharmaceuticals on course for growth
The Pharmaceuticals division’s sales once again rose vig-
orously. Our business picked up specifically in the United
States and Japan, the world’s most important pharma-
ceutical markets.
Income from operations before special items improved
significantly. Special items included payments to largely
settle a series of lawsuits in the United States involving the
marketing of the thyroid drug Synthroid®. Other special
items resulted from structural measures, including the clo-
sure of our production site in Beeston, England.
Sales of Synthroid®, our best-selling drug used to treat
thyroid disease, developed very well. Thanks to innovative
marketing measures, this drug again made a great contri-
bution to our business in the United States last year. In
Japan, we successfully began marketing our new product
Hokunalin Patch® for the relief of asthma. Our pharmaceu-
tical active ingredients business strengthened, particularly
due to the acquisition of Boehringer Ingelheim’s purine
business.
Sales of Reductil®/Meridia® for the treatment of obesity
remained at the previous year’s level and did not meet our
expectations. We remain convinced that this is an attrac-
tive product and intend to exploit its potential more
effectively through increased marketing efforts, particularly
in the United States. In 1999, we also successfully
launched Reductil®/Meridia® in Germany, Switzerland,
Poland, South Africa, Turkey, Hungary and several Latin
American countries. We expect to receive approval in
2000 to market this drug in other European countries.
We continued to build partnerships in 1999. We are devel-
oping a substance for the treatment of Parkinson’s dis-
ease with DevCo Pharmaceuticals. A new drug for the
treatment of rheumatoid arthritis is under development
with Eisai for later marketing in certain Asian countries.
Both of these products contain active ingredients devel-
oped through our own research efforts. Kos Pharmaceuti-
cals has been helping us market our two drugs Mavik®
and Tarka® for hypertension in the United States since 
August 1999. We are also cooperating with EVOTEC 
BioSystems AG to search for lead structures for use in
pharmaceutical active ingredients.
For 2000, we want to improve earnings. The new organi-
zational structure for our Pharmaceuticals division, as well
as a program to generate sustainable earning power, will
contribute to this improvement. 
We have a number of highly promising projects in late-
stage clinical development. We currently estimate the
annual worldwide sales potential of projects close to
market launch to be € 1.2 billion. These projects will help
expand our position as a global pharmaceuticals specialist
in specific areas with high medical need.
Fine Chemicals suffers loss
In the Fine Chemicals division, sales rose more than nine
percent due to healthy growth in sales volumes and the
introduction of new products. However, higher sales vol-
umes were largely offset by falling prices, especially for
vitamins and the amino acid lysine, which reduced mar-
gins and burdened earnings. Special items (see page 80)
led to a substantial loss for the division.
Falling prices in the vitamins business particularly affected
the vitamins B2 and E. To respond to price pressure and
increasing competition, especially from vitamins manufac-
tured in China, we are building high-performance synthe-
sis plants to make our production more cost-effective.
We introduced a new product, Lucantin® pink (astaxan-
thin), to our range of carotenoids. This product is used as
a color pigment in salmon farming.
In our animal nutrition enzymes business, intensive mar-
keting efforts led to double-digit sales growth.
BASF is the leading supplier of specialty polymers for cos-
metics and pharmaceuticals. We achieved good growth
rates for Divergan® in the beverage clarification market.
Sales of fine chemicals for the cosmetics industry grew
faster than the division’s overall business. We offer our
customers a wide range of products for hair and skin care
as well as sunscreen products. We strengthened our posi-
tion in ultraviolet light (UV) absorbers by acquiring the
worldwide UV absorbers business of sunSmart of the
United States, making BASF one of the world’s leading
suppliers of UV protection products. We are continuing to
expand this business.
In our flavors and fragrances business, demand for the
fragrance citral and its derivatives improved. We increased
our production of these fragrances through capacity
expansions, which enabled us to significantly extend our
business during the second half of the year.
In the area of nutraceuticals, which are health-maintaining
and improving food supplements, we successfully
launched S-adenosylmethionine (SAMe) in the United 
States.
As we develop our fine chemicals businesses, we are fo-
cusing on innovative products and manufacturing pro-
cesses. The pharmaceuticals and cosmetics industries are
the most promising markets for our product lines.
The pharmaceutical active ingredients business, formerly
part of the Pharmaceuticals division, is being integrated
into the Fine Chemicals division, giving us new opportu-
nities and increasing our attractiveness as a partner of the
pharmaceuticals industry.
For 2000, our goal is to achieve high single-digit sales
growth and seize opportunities to improve earnings
through our products in the cosmetics, pharmaceuticals
and food industries as well as through specific product
lines in animal nutrition.
Crop Protection remains at high level
Our Crop Protection division remains focused on develop-
ing innovative fungicides and herbicides as well as
expanding its presence in plant biotechnology. 
In the Crop Protection division, sales reached the same
level as in the previous year despite a noticeable drop in
demand, particularly in the important regions of North
America and Western Europe. The downturn in the U.S.
herbicide business and one-time charges for structural
measures led to reduced, but still satisfactory, earnings.
In our herbicide business, sales fell due to a combination
of reduced sales volumes and lower prices. This was
caused by increased use of total herbicides in North
America instead of selective herbicides, which prompted
more intense competition. Nonetheless, Micro Flo, the
generic crop protection products supplier in which we
acquired a majority stake in 1998, benefited from this
trend.
In our fungicide business, our sales rose again. We
strengthened our leading market position in Western
Europe despite reduced demand resulting from lower 
incidence of fungus in cereal crops due to weather 
conditions.
We are realigning our U.S. business to concentrate on
profitable market segments and are implementing cost-
cutting measures.
We successfully launched three new herbicides in time for
the 1999 growing seasons. The product Aura® has sup-
plemented our product range for rice farmers, and we 
introduced it initially in Latin America. We are marketing a
new corn herbicide in the United States and Canada
under the brand name Distinct®. In important west Euro-
pean markets, we were successful in introducing and sell-
ing the cereal herbicide Lotus®.
These new product launches, together with our products
in development, are evidence of the innovative strength of
our research operations: By 2004, we plan to introduce
four new herbicides and four new fungicides.
For 2000, we want to achieve steady sales due to our
good position despite a stagnant world market. Business
will be affected by falling agricultural subsidies in Europe
and continuing low prices in the United States. In the
coming years, we want to increase our sales and earnings
significantly by launching a number of new products,
especially a new strobilurin fungicide for specialty crops
and cereals.
We made good progress in our plant biotechnology oper-
ations. We acquired a 40 percent stake in the Swedish
seed breeding company Svalöf Weibull and transferred
our plant biotechnology research to BASF Plant Science
GmbH, a joint venture with Svalöf Weibull in which BASF
has a majority stake.
We are researching which plant genes control certain bio-
logical functions. The next step will be to determine the
principles for using these genes in crops. After this stage,
we intend to develop crops with improved agronomic
properties, such as resistance to cold or drought. Another
objective of our research is to increase yields of oils, pro-
teins and carbohydrates as well as to enrich and improve
plant constituents, such as vitamins and fatty acids.
Our goal is to become one of the leaders in plant biotech-
nology by 2010, and we are making considerable invest-
ments to achieve this objective. We have a sound founda-
tion through our broad expertise in research and
agriculture, especially in crop protection, as well as in
human and animal nutrition.
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Health & Nutrition capital expenditures
In 1999, the Health & Nutrition segment spent  € 281
million on investments and acquisitions, substantially less
than in 1998 when we made a series of acquisitions. In-
vestments in tangible assets will remain at the same level
in 2000. The main capital expenditures were as follows:
Europe
At our site in Ludwigshafen, Germany, a plant to manu-
facture a precursor for a new grass herbicide began
operations, and plants are being built to manufacture a
new rice herbicide as well as an essential precursor for
strobilurin fungicides. We are expanding production
capacities for the citral and Lysmeral® fragrances. The
carotenoid plant was also expanded. A new plant is
under construction for the ultraviolet light (UV) absorber
Uvinul® MC 80. In addition, we are modernizing our
pharmaceutical manufacturing plants and expanding our
capacity.
At our site in Schwarzheide, Germany, we are building a
plant to manufacture a new fungicide from the strobilurin
class of active ingredients.
At our site in Tarragona, Spain, a formulation plant for
fungicides started operations.
Asia
In China, NEGPF-BASF Shenyang Vitamins Co. Ltd.
started operating a new plant to manufacture vitamin 
powders and blends.
Öl und GasOil & Gas
Our Oil & Gas segment significantly increased sales
and earnings. We made considerable progress
toward our goal of long-term growth and cyclically
resilient earnings.
In the Oil & Gas segment, sales (excluding petroleum and
natural gas taxes) rose nearly 14 percent to more than 
€ 3 billion. Income from operations before special items
improved to € 603 million, with higher crude oil prices
supporting this positive trend. 
For 2000, crude oil prices will probably drop again. Never-
theless, we will further increase sales and earnings in the
medium term due to expansions in our core areas of natu-
ral gas trading as well as exploration and production of
crude oil and natural gas. 
We have set ambitious growth targets for this segment,
and, as a result, capital expenditures were high in 1999
and rose to € 524 million.
Despite unsatisfactory margins, our marketing and refinery
business considerably exceeded the previous year’s earn-
ings due to cost-cutting measures and a positive impact
from inventory levels. We sold this business, including our
stake in Aral AG, a German gasoline station network,
effective the end of 1999.
Technological know-how and extreme care are part of 
a day’s work for the employees of EUROPIPE, the
German pipeline specialist based in Muehlheim, Ger-
many. Construction of the large pipes
requires great precision because they
are used to carry Russian natural gas under
high pressure to the west European market. EURO-
PIPE supplied the large-diameter pipes for the JAGAL pipe-
line, which was completed in 1999 and represents a further stage
in the expansion of the WINGAS pipeline network. The joint venture be-
tween the BASF subsidiary Wintershall AG of Germany and Gazprom of Russia
ensures that its natural gas customers enjoy pleasant temperatures and hot meals.        
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Sales
Million €
3,198 2,685 3,051
’97 ’98 ’99
Income from operations 
before special items
Million €
500 257 603
’97 ’98 ’99
Capital expenditures
Million €
322 505 524
’97 ’98 ’99
Higher earnings from oil and gas production
We spent € 58 million exploring for new oil and gas
deposits. We focused our efforts on the regions of North
Africa, Argentina and Western Europe. Income from 
operations improved considerably compared to the
previous year.
Our total crude oil and natural gas production was
10.7 million metric tons of oil equivalent, a decline of
almost three percent from 1998 since we were affected
by OPEC’s adherence to strict production quotas.
The major contributors to our oil production were once
again North Africa and Germany. We have a 50 percent
stake in the Mittelplate offshore oil field, which is located
in the North Sea and is Germany’s largest. A project to
develop oil-bearing deposits in this field from onshore 
locations is proceeding as planned. This project will be-
gin operations during 2000, increasing the field’s current
annual production from 800,000 metric tons to 1.8 mil-
lion metric tons. 
Our total natural gas production in 1999 remained steady
at 3.6 billion cubic meters. We further expanded produc-
tion in Argentina, a new strategic region for gas produc-
tion that accounted for more than 50 percent of our total
gas output. We are pursuing an integrated growth strate-
gy in Argentina by expanding natural gas production and
developing downstream operations through our subsid-
iary Wintershall Energía. In a first project of its kind, we
are participating in a pipeline project from Buenos Aires,
Argentina, to Montevideo, Uruguay. This pipeline may
eventually be extended to Brazil, which is South
America’s largest growth market for natural gas.
In Germany, our second strategic gas region, production
fell 10.6 percent due to the natural depletion of deposits.
We have a 49.95 percent stake in the A6/B4 field in the
German sector of the North Sea. Our annual production
volume from this field, which will be the first German off-
shore gas field, will be 600 million cubic meters. Our total
gas production in Germany will increase noticeably when
operations begin in this field, which is scheduled for 
fall 2000.
In our exploration and production operations, we intend
to expand oil and gas production considerably in the
medium term while maintaining a ratio of reserves to
production of approximately 10 years. We will accom-
pany this expansion by further optimizing our portfolio.
Some of these measures include developing new strate-
gic areas as well as divesting operations that offer only
limited potential. For example, we sold our subsidiary
Wintershall Canada at the end of 1999. We have similar
plans for our affiliates in the United Kingdom, which we
intend to sell in 2000.
We spent funds to replace and expand oil and gas pro-
duction sites in current key areas and also extended our
strategic cooperation with our long-standing partner
Gazprom, the world’s largest natural gas producer, to
prepare for exploration and production in Russia. In
spring 1999, we signed an agreement to cooperate in
developing deposits together, representing the largest
economic cooperation agreement between Germany
and Russia. As a first promising project, we are examin-
ing opportunities in the Priraslomnoye oil field located off
the coast of northern Russia in the Arctic Ocean. We are
currently preparing plans on how to cost-effectively 
develop and transport more than 70 million metric tons
of crude oil from this field.
Natural gas trading expanded
In our natural gas trading business, we are building on
our success by consistently pursuing our strategic goals
and expanding our market position in Germany. Our lat-
est marketing efforts in the areas serviced by the WEDAL
gas pipeline have been successful, boosting our market
share of gas under long-term contract to more than 13
percent. As early as 2001 – much earlier than originally
planned – we will secure long-term supply contracts
representing a future 15 percent market share.
Last year, we again significantly extended our pipeline
network. With the completion of the JAGAL long-dis-
tance gas line at a cost of approximately € 600 million,
the WINGAS network now covers more than 1,800
kilometers and has opened up an additional link to the
important gas deposits in Siberia.
We purchase the majority of the gas that we market from
our joint venture partner Gazprom under long-term sup-
ply agreements.
In 1999, we completed the fourth expansion stage of the
Rehden natural gas reservoir, Western Europe’s largest,
with a storage capacity of 4.2 billion cubic meters. We
have invested € 383 million on developing the reservoir.
Another achievement in 1999 was extending our market-
ing operations into neighboring European countries.
Beginning in 2003, WINGAS will take over responsibility
for delivering gas to the power plant at BASF’s site in
Antwerp, Belgium. We also strengthened our natural gas
operations in Eastern Europe by acquiring shares in
regional supply companies in the Czech Republic.
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With a highly developed pipeline system, WINGAS
helps ensure the reliable supply of natural gas to
Germany and Western Europe. In October 1999, the
WINGAS joint venture completed its JAGAL natural gas
pipeline segment. As a result, the WINGAS pipeline net-
work now extends for more than 1,800 kilometers.
JAGAL is a new main line within the WINGAS pipeline
network, helping to meet growing demand for natural
gas in Germany by linking the country to enormous gas
supplies in Russia. Natural gas is transported more than
4,000 kilometers from Siberia through Belarus and
Poland to Germany, where an intricate pipeline network
delivers the gas to consumers. Wintershall and Gazprom 
have so far invested approximately € 2.5 billion to
expand the WINGAS infrastructure. This partnership
guarantees WINGAS direct access to the world’s largest
natural gas reserves.
Existing pipelines
Other projects
*Pipelines of DISTRIGAS
Existing underground reservoir
Planned underground reservoir
Hamburg
Berlin
Frankfurt/OderBielefeld
Kassel
PragueLudwigshafen
Aachen
Zeebruegge
Paris
London
Bacton
Warsaw
Munich
Minsk
Smolensk
Burghausen
Olbernhau
Bunde
Rysum
As a global company, we have a responsibility to society
and the environment. That’s why we have set out guide-
lines for our operations that apply throughout BASF. In
addition to following local legislation and regulations, our
employees at every site around the world are responsible
for complying with company standards.
New environmental protection facilities
At our sites in Geismar, Louisiana, and Altamira, Mexico,
we adapted the existing wastewater treatment plants to
meet changed requirements. A new plant was completed
at our site in Kuantan, Malaysia.
We started operating highly efficient combined cycle gas
turbine plants at our sites in Altamira, Mexico (10 mega-
watts), and Freeport, Texas (90 megawatts), helping
reduce carbon dioxide emissions and making power
generation more efficient. Through these activities, we are
protecting the environment and conserving resources.
Environment, safety and energy
We act responsibly by 
following the principles of
Sustainable Development
to protect resources and
the environment.
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Eco-efficiency analysis for products of the future 
Using eco-efficiency analysis, we look at the entire life
cycle of our products from both an economic and an
ecological perspective. The analysis focuses on raw
material and energy consumption, optimum performance
as well as the issue of recycling versus disposal. It con-
siders the ecological and economic advantages and dis-
advantages of competing products with similar functions
for the customer, indicating which product or process is
the most ecologically and economically efficient.
Our goal is to offer customers the best possible products
with the least environmental impact at the best price.
An eco-efficiency analysis gives a clear indication where
improvements can be made. And this applies not only to
existing products and processes but also to products still
in research and development. The analysis serves as a
strategic tool, helping us decide which product lines and
processes warrant future investment.
Our business operations are guided by the principles of
Sustainable Development. Eco-efficiency analysis plays
an important role here.
Safety, health and environmental management
In 1999, we conducted 119 safety and environmental
audits at 70 BASF sites around the world. Teams reviewed
work processes at these sites to ensure they complied
with safety and environment standards as well as
management structures. Without exception, the overall
results were positive, and we intend to rapidly implement
improvements.
Safety has a high priority at BASF. Every year, we set new
ambitious targets and constantly work to improve safety
awareness. At BASF’s sites worldwide, the number of
accidents in 1999 resulting in days off work fell nine per-
cent to 3.9 accidents per million hours worked, putting
BASF well below the chemical industry average.
Reporting
We will provide detailed information on our environmental
protection and safety activities in our report “Environment,
Safety and Health 1999” that provides results for BASF
Group as well as BASF Aktiengesellschaft.
Environmentally friendly and economical are the two features central to our products. 
At BASF, we wanted to know exactly whether, and to what extent, our products met
these requirements and how they compared with available alternatives. BASF was the
first chemical company to develop eco-efficiency analysis as a benchmark. The analysis
involves collecting all data on a product or manufacturing process and then reviewing
the environmental impact and associated costs. Clear finishes for furniture are just one
example. In a comparison between waterborne coatings and coatings containing high
levels of organic solvents, waterborne coatings have a definite ecological edge. They
also came out ahead in terms of cost. On the basis of these findings, BASF Coatings
has developed a portfolio of products marketed under the Glasurit® brand name and
targeted at woodworkers and their customers. 
Greg Lipton, a cabinetmaker from Cumberland, Maine, has an eye for detail when 
building quality wooden furniture. 
Employees
At the end of 1999, the number of BASF employees, in-
cluding those with limited-term contracts, was 104,628, 
a decline of 1,317 over the previous year. About 55.6 per-
cent of BASF’s workforce is located in Germany, and an-
other 14.9 percent work at BASF sites in Europe outside
of Germany. North America accounts for 15 percent of the
workforce, while 6.4 percent of the workforce is located in
South America and 8.1 percent in the Asia, Pacific Area,
Africa region.
Personnel costs
Personnel costs rose € 170 million to € 6.18 billion in
1999. These costs break down as follows: 
Million € Change in %
Wages and salaries 4,935 +2.0
Social security contributions 
and expenses for pensions 
and assistance 1,245 +6.4
• Thereof for pension benefits 389 +25.9
Total 6,180 +2.8
We offer our employees a number of opportunities
for career development and let them share in the
company’s success. We are also broadening the
scope of our employee share purchase program.
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No boundaries to cooperation
As a transnational company, we have customers in mar-
kets all around the world. We also manufacture products
in many countries and make sure they are marketed effi-
ciently and reliably. As a result, addressing the needs of
individual customers from different cultural backgrounds
is crucial to our business and will remain so. That’s why
promoting cooperation across national boundaries is an
important goal in human resources at BASF. We need
employees with international experience who are willing
to work in other parts of the world, and that is why it is
important to be open to different cultures when working
at BASF. At present, more than 900 BASF Group
employees are on international assignment. Language
and intercultural training is an important part of preparing
for their assignment abroad and integrating into the life-
style of their host country.
Training and career advancement
at German Group companies
In 1999, we invested approximately € 83.5 million on 3,403
apprentices in Germany, which matched the high number
of the previous year. We offered jobs to virtually all suitable
candidates.
As an innovative company, we encourage our employees
to take a positive approach to learning. In Germany 
alone, we invested € 26.4 million on training for 66,008
employees.
Employee share purchase program
In 1999, about 30 percent of all employees at BASF Ak-
tiengesellschaft and BASF companies in Germany took ad-
vantage of a new program to invest part of their annual bo-
nus in BASF shares. For every 10 shares an employee
purchases, the company awards up to five additional
shares during a 10-year period. More and more employees
at BASF companies outside of Germany will be able to 
participate. All employees who are not senior executives
are eligible for the program. A stock option program (see
page 81) is being offered to some 1,200 senior executives
worldwide.
BASF Aktiengesellschaft
In 1999, the number of employees at BASF Aktiengesell-
schaft, including those with limited-term contracts, fell by
1,167 to 42,789. We recruited 1,063 people from outside
the company. At the end of 1999, 2,644 young people
were being trained at the company.
In the “Agreement 2000,” BASF management and the
employees’ representatives at our site in Ludwigshafen,
Germany, agreed to achieve by the end of 2000 a person-
nel level, excluding trainees, of between 39,000 and
41,000 employees. The workforce reduction is being ac-
complished for the most part through socially responsible
measures without involuntary layoffs, including voluntary
short-time contracts for those approaching retirement.
These contracts are proving very popular, and 3,976
employees have chosen this option. For the period after
2000, BASF management and employee representatives
are seeking solutions that address the needs of both the
company and employees.
The three men on the construction site of the new steamcracker in Port
Arthur, Texas, are the German engineers Jürgen Fuchs and Dr. Andreas
Fried as well as their Belgian colleague Patrick Plehiers, a chemist. These
BASF employees have been sent from our sites in Ludwigshafen, Germany,
and Antwerp, Belgium, to spend four years working on this major project.
The three agree: “It’s a great experience – professionally and personally.”
Research & Development
Through research and development, we meet
customers’ needs by transforming new scientific
findings into innovative 
products and processes.
Research & Development expenses
Million €
1,303 1,309 1,333
’97 ’98 ’99
Innovative products that benefit our customers are the
driving force behind our business. Together with modern,
cost-effective processes, they create the foundation for
our company’s success.
In 1999, we spent € 1.3 billion on research and develop-
ment, and we expect to invest a similar amount in 2000.
Around the world, some 10,000 R&D employees make
up a tight-knit, global knowledge Verbund. We supple-
ment our own know-how by cooperating with univer-
sities, research institutes and industry partners.
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Nature as chemistry’s model is becoming an increas-
ingly important field of research. Microorganisms pro-
duce enzymes which, in optimized form, can be used as
biocatalysts for chemical syntheses. They are proving
their value in the production of optically active interme-
diates for pharmaceutical and crop protection products.
Efficiency is essential when it comes to industrial applica-
tions, so the properties of these biocatalysts and the 
methods to manufacture them have to be tailored 
carefully. Since February 1999, this has been the goal of
BASF research scientists in Ludwigshafen, Germany, and
staff at the Fraunhofer Institute for Interfacial Engineering
and Biotechnology in Stuttgart, Germany. They use state-
of-the-art, robot-assisted analysis methods with high
sample throughputs. The three-year project, the largest
of its kind in Europe, is also supported by the German
Federal Ministry for Education and Research.
In 1999, successful R&D projects led to a number of
capital expenditures on new products and processes
that strengthen our portfolio and boost earnings. By
2005, we will achieve additional sales of more than
€ 600 million from the projects outlined on the following
pages. They are examples of how our R&D projects are
contributing to meeting BASF’s strategic goals.
In today’s laboratories, it’s a matter of routine:
Automation greatly speeds up analysis not only
in biotechnology but also conventional synthesis.
Strengthening cyclically resilient businesses 
In the area of crop protection, our research scientists
have developed a new, patented strobilurin fungicide
that will further strengthen our position in the market for
crop protection products to combat fungi. Europe and
the Americas will be the key markets for this active
ingredient, which can be used in a wide range of crops.
At our site in Schwarzheide, Germany, we are investing
approximately € 110 million in a new plant expected to
start operations during the second half of 2001.
Building on our know-how in core businesses
In our core businesses, we are expanding our know-how
and strengthening our portfolio. In paper chemicals, for
example, we have added the new polyvinylamine prod-
uct line, which provides our customers in the paper
industry with new ways to manufacture paper more eco-
nomically and ecologically. Polyvinylamines and the
monomer vinylformamide as well as their production
process were developed in-house. At our site in Lud-
wigshafen, Germany, we have earmarked approximately
€ 50 million to implement these developments. By the
end of 2001, a vinylformamide plant with an annual
capacity of 8,000 metric tons and a polyvinylamines
plant with an annual capacity of 60,000 metric tons will
start operations.
Achieving technology and cost leadership
In addition to new products, improvements in manufac-
turing processes – also known as “silent innovations” –
are decisive for our long-term success.
BASF is one of the world’s leading producers of ultravio-
let (UV) absorbers. Thanks to our new, patented process
for the UV absorber octyl methoxycinnamate, we are
achieving technology and cost leadership. We have allo-
cated more than € 10 million to produce the UV ab-
sorber in a new plant that will be fully integrated into our
Ludwigshafen site. The new plant will start operations at
the beginning of 2001.
We are poised to become a technology and cost leader
in the synthesis of nylon 6. At our Ludwigshafen site, we
are investing more than € 50 million to radically overhaul
how we produce this versatile polymer. Nylon 6, which is
found in textile and carpet fibers as well as in plastic
components for automobiles and in food packaging, will
eventually be manufactured in new production and com-
pounding units which will start operations between 2001
and 2002.
A larger and more flexible production Verbund
We are planning to build a new plant to produce annually
20,000 metric tons of trimethylolpropane, a plastics pre-
cursor with a wide variety of applications. The plant will
rely on a new technology, which has been patented
worldwide and tested in a pilot plant at our Ludwigshafen
site. We will invest more than € 10 million in the new
plant, which is expected to start operations in early
2001. The plant fits optimally into our Ludwigshafen
site’s production Verbund since trimethylolpropane will
provide the final link in a value-adding chain that starts
with petrochemical feedstocks and finishes with polyes-
ter resins, polyurethanes and acrylates for UV-curing
coatings.
Supporting globalization
At our site in Freeport, Texas, a new plant is expected to
start operations in mid-2001 to produce annually 20,000
metric tons of hexanediol and 5,000 metric tons of cap-
rolactone. Hexanediol and caprolactone are two impor-
tant intermediates used to manufacture glues, plastics
and coatings, including coating resins. As the sole pro-
ducer of these products, we can supply our customers
with large volumes of high-quality hexanediol from this
new plant at a reasonable price. We are also expanding
our product portfolio to meet growing market demand for
caprolactone. The new plant has been designed to man-
ufacture the two products in varying amounts to suit
market requirements. We developed the process in our
own laboratories using a dicarboxylic acid mixture as a
raw material that is obtained as a by-product in our pro-
duction Verbund.
Cutting-edge technology hidden behind an unas-
suming exterior: Using simultaneous electrosynthesis,
BASF generates two useful products in each electro-
lytic cell. The electricity required is put to full use –
an ecological and economic quantum leap in indus-
trial electrochemistry.
Innovation in electrochemistry:  Using electrical energy
to convert matter is a method commonly used in chemis-
try. Developed by BASF, simultaneous electrosynthesis is
one of our research scientists’ top achievements. In con-
ventional electrosynthesis, a desired product forms at
either the anode or the cathode, while a by-product –
often hydrogen – forms at the other electrode. In simulta-
neous electrosynthesis, useful products are formed for
the first time at both electrodes. In the “Cell Room” at
BASF’s site in Ludwigshafen, Germany, each electrolytic
cell, resembling a pot-bellied oversized bottle, now yields
two products instead of one - phthalide and p-tert-butyl-
benzaldehyde. The first of these two chemicals is used to
manufacture crop protection products, such as strobi-
lurin fungicides, while the second substance can be
found in fragrances and pharmaceuticals. Producing two
chemicals through electrosynthesis rather than one cuts
energy consumption by half. In 1999, BASF presented
the developers of this top technology with the company’s
“Innovation Award.”
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New technologies open up new businesses 
We are cooperating with universities and setting up R&D
joint ventures to develop biotechnological methods in
chemistry, crop protection and pharmaceuticals.
Optically active intermediates, which are used in active
ingredients for pharmaceuticals and crop protection
products, are a fast-growing and profitable business. 
Our Ludwigshafen site will become home to the world’s
largest manufacturing plant for optically active amines.
The plant will start operations in mid-2001 and will rely
on a newly developed process employing enzymes as
catalysts. At the same time, a new plant to manufacture
an optically active herbicide precursor is being built at
our site in Geismar, Louisiana.
We have teamed up with the Fraunhofer Institute for
Interfacial Engineering and Biotechnology in Stuttgart,
Germany, to use genetic engineering as a tool to dis-
cover new enzymes for chemical synthesis. Using an
analytical method developed by BASF-LYNX Bioscience
AG, we are modifying microorganisms to develop more
efficient fermentation processes.
The companies of our R&D joint venture BASF Plant
Science GmbH are using genetic engineering to improve
seed quality.
Portfolio management
BASF and partner TOTALFINA are building a state-of-the-art steamcracker in 
Port Arthur, Texas, that is expected to start operations in early 2001. TOTALFINA’s
Port Arthur refinery will supply naphtha to the steamcracker for processing into
ethylene and propylene. BASF will transport the ethylene and propylene via pipe-
line to its sites in Freeport, Texas, and Geismar, Louisiana, for use in manufac-
turing products such as plastics, coatings, solvents and crop protection agents.
We are actively managing
our portfolio, achieving 
our strategic goals through
capital expenditures 
as well as acquisitions, 
divestitures and 
cooperations.
We have:
• acquired promising businesses,
• divested non-strategic businesses, and
• established cooperations that enhance our 
fundamental strengths.
Acquisitions
We acquired:
• a 40 percent ownership stake in the Swedish seed
company Svalöf Weibull AB,
• the ABS plastics business of DSM N.V. of the Nether-
lands, 
• the polyethylene glycol business of BP Amoco Chemi-
cals of the United Kingdom,
• coil coatings businesses from Norsk Hydro of Norway
as well as Rohm and Haas of the United States,
• the worldwide zinc oxide-based UV absorbers busi-
ness of sunSmart Incorporated of the United States,
• the 50 percent ownership stake of Degussa-Hüls of
Germany in the engineering plastics joint ventures
Ultraform GmbH of Ludwigshafen, Germany, and 
Ultraform Company of Theodore, Alabama, 
• the 40 percent ownership stake of Sümer Holding of
Turkey in BASF-Sümerbank of Gebze, Turkey, a pro-
duction company within the Colorants & Finishing
Products segment,
• Takeda Kagaku Shiryo, a Japanese manufacturer of
animal nutrition products. 
We intend to purchase the U.S. company Chemdal and
its global superabsorbers business to strengthen our
position. Chemdal is a subsidiary of AMCOL International
Corporation of the United States. Pending antitrust ap-
proval, we expect to complete the transaction during the
first half of 2000.
Divestitures
We sold:
• our holding in Aral AG and the Oil & Gas segment’s
refinery and marketing business, including the Lingen
refinery, to Veba Oel AG as well as our Canadian oil and
gas operations to Startech Energy Inc. of Canada,
• the COMPO® specialty fertilizers business and our fer-
tilizer production site in Krefeld, Germany, to K+S
Aktiengesellschaft; the marketing and sales of agricul-
tural fertilizers manufactured by BASF were also trans-
ferred to K+S at the end of 1999,
• the Styrocolor® range of EPS dyes to Sunpor Kunst-
stoff GmbH of Austria.
We intend to sell our masterbatch business, which is
comprised of the production and marketing of specialty
pigment formulations.
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Cooperations
• Solvin GmbH & Co. KG, a joint venture in PVC manu-
facturing in which Solvay S.A. of Belgium holds a 75
percent ownership stake and BASF a 25 percent
ownership stake, began operations on August 1, 1999.
The company was founded retroactive to January 1,
1999, and is based in Hanover, Germany.
• Together with the Algerian oil and gas company 
SONATRACH, we established the joint venture BASF
SONATRACH Propanchem S.A. to manufacture propy-
lene at our site in Tarragona, Spain (BASF ownership
stake: 51 percent).
• Together with Shell, we intend to combine the Elenac,
Montell and Targor companies in a new polyolefin joint
venture based in the Netherlands. In order to con-
tribute the former Targor joint venture, we acquired at
the end of 1999 the share of Targor previously held by
Hoechst/Celanese in order to contribute all of it to the
new joint venture.
• BASF South East Asia and Shell Eastern Petroleum
(Pte) Ltd. formed the joint venture BASELL Eastern
(Pte) Ltd. to produce styrene and propylene oxide in
Singapore (BASF ownership stake: 50 percent).
• We intend to establish a joint venture with Shell Chemi-
cal Company and TOTALFINA to produce butadiene at
TOTALFINA’s refinery in Port Arthur, Texas. Shell will
own 60 percent of the company, BASF 24 percent and
TOTALFINA 16 percent.
• In Australia, we are planning a joint venture with Akzo
Nobel Pty. Ltd. of Melbourne to manufacture auto-
motive OEM coatings. 
• We are examining the possibility of forming a joint ven-
ture that would merge all our coatings operations in
Japan with those of Nippon Oil and Fats Corporation
(NOF) of Tokyo.
• Together with Huntsman Polyurethanes of Everberg,
Belgium, Nippon Polyurethane Industry Co. Ltd. (NPU)
of Tokyo and Chinese partners, we intend to set up a
joint venture at the Caojing site, near Shanghai, to build
and operate plants for the basic polyurethane products
TDI and MDI.
• We intend to build a Verbund site in Nanjing, China,
with our partner China Petrochemical Corporation 
(SINOPEC). The new joint venture is expected to begin
in mid-2000, and the first manufacturing plants are
expected to start operations in 2004 or 2005.
• We established BASF Plant Science GmbH with Svalöf
Weibull AB of Sweden to conduct plant biotechnology
research (BASF ownership stake: 85 percent).
• During the second half of 2000, we intend to combine
our textile dye operations with those of DyStar, a 
50-50 joint venture between Bayer and Hoechst.
Finance
Statements of cash flow 1
Million € 1999 1998
Net income 1,237 1,699
Depreciation of fixed assets 2,690 2,289
Changes in net current assets 172 181
Miscellaneous items – 844 – 425
Cash provided by operating activities 3,255 3,744
Additions to tangible and 
intangible fixed assets – 2,939 – 2,722
Acquisitions and divestitures, net 696 – 760
Financial investments and other items 144 255
Cash used in investing activities – 2,099 – 3,227
Proceeds from capital increases –176 27
Changes in financial indebtedness – 95 – 95
Dividends paid – 697 – 630
Cash used in financing activities – 968 – 698
Changes in cash assets 
affecting liquidity 188 –181
Initial cash assets 
and other changes 802 938
Cash and cash equivalents at year-end 990 757
1 Full version, see page 57
Financing
Cash provided by operating activities was € 3.255 bil-
lion, a decline of € 489 million from the previous year. 
An increase in current assets – primarily due to higher
receivables arising from strong business in the fourth
quarter – offset an increase in accounts payable. The
fines and claims for damages related to violations of 
antitrust laws in the vitamins business are generally not
expected to affect liquidity until 2000.
Cash used in investing activities, after deducting income
from divestitures, totaled € 2.099 billion. Expenditures
on tangible and intangible fixed assets totaled € 2.939
billion before any additions resulting from acquisitions.
We spent € 397 million on acquisitions in 1999, con-
siderably less than the previous year’s level of € 969 mil-
lion. We received significant cash inflow totaling
€ 1.094 billion from various divestitures last year, an 
increase of € 885 million from 1998.
Financial activities led to a cash outflow of € 968 million.
Our share buy-back program accounted for € 256 mil-
lion of this amount. The exercising of warrants led to a
cash inflow of € 80 million. We paid out € 697 million in
dividends. The balance of these financial flows led to an
increase of € 188 million in cash and cash equivalents
(excluding securities). We had a net liquidity of
€ 1.508 billion when including securities.
Financial indebtedness at the end of 1999 was € 1.294
billion, of which € 577 million is repayable within one
year and € 478 million is repayable between 2001 and
2004. Approximately 55.4 percent of our financial indebt-
edness was denominated in U.S. dollars, approximately
14.2 percent in Chinese renminbi and approximately 
9.3 percent in euros.
Cash provided by operating activities was 3.3 billion,
meeting all our financial requirements for capital ex-
penditures and financing. We achieved a return on 
assets before income taxes and interest expenses of
10.2 percent. Earnings per share were 2.00, while
earnings per share according to U.S. GAAP would
have been 2.14.
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Balance sheet 
Assets
Million € 1999 % 1998 %
Intangible assets 2,147 7.2 7.4
Tangible assets 12,416 41.4 40.3
Financial assets 1,507 5.0 6.8
Fixed assets 16,070 53.6 54.5
Inventories 4,028 13.4 13.9
Accounts receivable, trade 4,966 16.5 15.0
Other receivables 2,212 7.4 7.0
Deferred tax assets 1,225 4.1 4.0
Cash and cash equivalents 1,508 5.0 5.6
Current assets* 13,939 46.4 45.5
Assets 30,009 100.0 100.0
Equity and liabilities
Million € 1999 % 1998 %
Paid-in capital 4,265 14.2 15.7
Retained earnings 9,002 30.0 32.6
Currency translation adjustment 549 1.8 0.1
Minority interests 329 1.1 1.2
Equity 14,145 47.1 49.6
Long-term provisions 5,812 19.4 20.8
Long-term financial indebtedness 717 2.4 2.5
Other long-term liabilities 1,000 3.3 2.5
Long-term liabilities 7,529 25.1 25.8
Short-term financial indebtedness 577 1.9 2.4
Accounts payable, trade 2,292 7.7 7.0
Other short-term liabilities 
and provisions 5,466 18.2 15.2
Short-term liabilities 8,335 27.8 24.6
Liabilities* 15,864 52.9 50.4
Equity and liabilities 30,009 100.0 100.0
* Including deferred tax assets and other prepaid expenses and deferred income
We expect to be able to finance our capital expenditures
on tangible assets planned for 2000 through cash from
operations. As a result of our low financial indebtedness
and our strong equity position, we have sufficient finan-
cial means for additional capital expenditures and 
acquisitions.
Total assets rose € 3.307 billion to € 30.009 billion. Tan-
gible assets increased € 1.661 billion to € 12.416 billion
due to capital expenditures exceeding depreciation and
changes in the scope of consolidation. Tangible assets
represented 41.4 percent of total assets compared with
40.3 percent in 1998. The equity ratio fell from 49.6 per-
cent to 47.1 percent, while long-term liabilities as a per-
centage of total assets were 25.1 percent compared with
25.8 percent in 1998. Short-term liabilities accounted for
27.8 percent of total assets compared with 24.6 percent
in 1998.
Returns
The return on assets before income taxes and interest
expenses fell from 11.9 percent to 10.2 percent. Apart
from lower earnings, the main reason for the decline was
higher fund commitments. When adjusted for special
items, the return on assets was 10.9 percent compared
with 11.1 percent in 1998.
We achieved a return on sales of 6.8 percent, down from
9.5 percent in the previous year. The sharp decline was
due to the special items that burdened income from
operations. Adjusted for special items, return on sales
was 10.0 percent compared with 9.2 percent in 1998.
Earnings per share were € 2.00, a decline of € 0.73 from
the previous year due to higher taxes and special items
that burdened profits. When U.S. GAAP is applied,
earnings per share would have been € 2.14 in 1999, a
decline of € 0.70 per share, or 25 percent less than in
1998. This reconciliation is still subject to review by the
U.S. Securities and Exchange Commission as part of the
registration of BASF American Depositary Receipts
(ADRs).
Return on assets before 
income taxes and 
interest expenses
(Percent)
11.9 11.1* 10.2 10.9*
’98 ’99
* Before special items
Return on sales
(Income from operations
as percentage of sales)
9.5 9.2* 6.8 10.0*
’98 ’99
* Before special items
Economic situation and business trends
The starting position for 2000 is highly promising. General
economic conditions have improved. The world economy
is on a firmer footing and global economic growth will be
higher than last year. Thanks to a series of measures, we
are well positioned to take advantage of the recovery.
In Western Europe, business is becoming increasingly
buoyant. We are benefiting from a sound cyclical upturn 
in Germany and in particular from strong growth trends 
in exports. We are set to take advantage of these 
opportunities. 
In North America, the overall economic situation contin-
ued to improve in 1999. For 2000, we expect higher inter-
est rates and less dynamic economic growth. For 2001
and 2002, however, growth will accelerate again due to 
favorable developments in domestic demand.
On a U.S. dollar basis, we want to increase our sales
this year in North America by approximately 10 percent
and continue to strengthen our market position. We are
starting operations at our new world-scale plants and
expanding our Verbund sites in Freeport, Texas;
Geismar, Louisiana; and Altamira, Mexico. We are also
intensifying our cooperation with partners and reviewing
potential acquisitions.
The outlook for South America is unclear due to uncer-
tainties about currency developments. We expect a
period of consolidation, particularly in Brazil, but want to
improve our earnings.
In Asia, with the exception of Japan, economic growth
will keep expanding this year. In the medium term, how-
ever, growth rates will not be as high as before the
region’s financial crisis but still significantly higher than
those in the OECD countries.
Business picked up noticeably in the fourth quarter
of 1999 and at the start of the current year. In 2000,
we want to generate higher sales on a comparable
basis and achieve higher earnings than in 1999.
Outlook
New York is home to the world’s largest stock market, the New York Stock Exchange (our photo). We plan to list BASF’s American Depositary Receipts (ADRs) on the NYSE in June 2000. 
Forward-looking statements 
This Annual Report contains certain forward-looking
statements and information relating to BASF Group 
based on current expectations, estimates and projec-
tions of its management and information currently avail-
able to the company. There are a number of risk factors,
including the ones named above, which could have a
considerable negative impact on the expected develop-
ments and results. These statements reflect the current
views of BASF with respect to future events, are not
guarantees of future performance and involve certain
risks and uncertainties that are difficult to predict. In
addition, certain forward-looking statements are based
upon assumptions as to future events that may not prove
to be accurate. We do not assume any obligation to
update the forward-looking statements contained in this
Annual Report.
The reports on BASF Group and BASF Aktiengesell-
schaft have been combined in Management’s Analysis 
of this Annual Report.
Risks of future developments
Like any global company, BASF is exposed to risks
arising from developments in the national economies
of the countries and regions in which it operates. 
Particular uncertainties result from the greatly
increased raw material prices that, up to now, we have
not been able to pass on in higher product prices to
the extent economically necessary. Further risks may
occur particularly in the Chemicals and Plastics &
Fibers segments due to temporary surplus production
capacity in these industries resulting from the startup
of world-scale plants. Important BASF customers are
active in the automotive, construction, electrical and
textile industries, among others. The changes in eco-
nomic conditions in these industries affect the future
development of our business. In the Pharmaceuticals
division, the relationship between company size and
the necessary research and marketing expenditures
requires us to make special efforts. BASF and other
companies are the targets of investigations by various
countries concerning antitrust law violations in the vi-
tamins business. These investigations will lead to fur-
ther costs that we cannot at the moment quantify. In
the Oil & Gas segment, volatility in oil prices and de-
regulation pose challenges for our business.
Against the background of our financial stability, our
intensive research and development, our closeness to
customers and the strategic alignment of our portfolio
lead us to believe that we are well equipped to deal
with future risks.
In Japan, the slight upturn that began in 1999 as a result
of comprehensive fiscal programs will gain some mo-
mentum during 2000. In the medium term, growth will be
moderate since the necessary fiscal consolidation will
require massive spending cutbacks.
In the medium and long term, we will expand our busi-
ness in the Asia-Pacific region considerably, even if
short-term market disturbances cannot be ruled out 
due to radical structural changes and the process of
consolidation.
Strategic goals and planning
We are consistently pursuing our strategic goals: We will
achieve sustainable profitable growth by expanding our
core operations and strengthening cyclically resilient
businesses. In our businesses sensitive to economic 
cycles, we will improve our cost efficiency and strength-
en our market presence. We will strategically expand our
businesses in growth regions.
We are providing a foundation for profitable growth by
building new plants that utilize state-of-the-art tech-
nology. In 1998 and 1999, we allocated particularly high
funds for capital expenditures. Now that many major
projects have been completed, we will reduce capital
expenditures.
Our research and development activities are shaping the
future of BASF. We are constantly seeking to transform
our customers’ requirements into innovative products
and processes. As in 1999, we will continue to provide
the same high level of resources to meet these objectives
in the coming years.
We will keep improving our internal structures and busi-
ness processes to remain among the best in our industry
and in international comparison.
Outlook for 2000 and 2001
BASF is on the right track. We have strengthened our
competitiveness and will continue to optimize our port-
folio. We have divested some businesses. As a result of
these portfolio changes, we want to increase sales and
earnings in 2000 and 2001 on a comparable basis.
We are determined to grow faster than the market.
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Statement by the Board of Executive Dire c t o r s
The Board of Executive Directors of BASF Aktiengesell-
schaft is responsible for drawing up the Consolidated
Financial Statements and Management's Analysis of
BASF Group. The Consolidated Financial Statements
w e re pre p a red in accordance with the principles of gen-
erally accepted accounting as outlined in the pro v i s i o n s
of the German Commercial Code (Handelsgesetzbuch)
and the Stock Corporations Act. We have implemented
U.S. generally accepted accounting principles (U.S.
GAAP) as far as possible within the scope off e red by the
accounting and valuation options available under Ger-
man commercial law. A reconciliation of net income and
stockholders’ equity is provided to show adjustments
re q u i red by U.S. GAAP but not permitted under Germ a n
c o m m e rcial law.
We have established effective internal re p o rting and
accounting systems to ensure that the Consolidated
Financial Statements and Management's Analysis
a d h e re to applicable accounting rules and company
re p o rting systems. The Internal Auditing depart m e n t
works to ensure that our businesses worldwide comply
with BASF’s effective and reliable uniform accounting
and re p o rting guidelines.
Our risk management system conforms with the re q u i re-
ments of the German Act on Verification and Tr a n s p a r-
ency in the Corporate Sector (Paragraph 91, Section 2,
Stock Corporations Act). The system identifies substan-
tial risks in a timely manner so that the Board of Execu-
tive Directors can take any appropriate action re q u i re d .
Deloitte & Touche GmbH Wi rt s c h a f t s p r ü f u n g s g e s e l l -
schaft has examined BASF’s Consolidated Financial
Statements and Management's Analysis and appro v e d
them free of qualification.
The Consolidated Financial Statements, Management’s
Analysis and the auditors’ re p o rt were discussed in
detail in the presence of the auditors at a Superv i s o ry
B o a rd meeting. For the results of the Superv i s o ry
B o a rd ’s examination, please refer to the Report of the
S u p e rv i s o ry Board .
D r. Jürgen F. Stru b e Max Dietrich Kley
C h a i rman of the Board Deputy Chairman of the 
of Executive Dire c t o r s B o a rd of Executive Dire c t o r s
R e p o rt of Independent Auditors
We have audited the Consolidated Financial Statements of BASF Group that were
p re p a red by BASF Aktiengesellschaft as well as the Management’s Analysis of 
BASF Aktiengesellschaft and BASF Group for the business year from January 1 to
December 31, 1999. The Board of Executive Directors of BASF Aktiengesellschaft is
responsible for preparing the Consolidated Financial Statements and Management’s
Analysis in accordance with German commercial law. It is our task, on the basis of
the audit we have carried out, to give an assessment of the Consolidated Financial
Statements and Management’s Analysis.
Pursuant to Paragraph 317 of the German Commercial Code, we have audited the
Consolidated Financial Statements of BASF Group in accordance with the generally
accepted standards of auditing laid down by the German Institute of Auditors.
A c c o rding to these principles, the audit is to be planned and carried out in such a
way that inaccuracies and violations are recognized with reasonable certainty that
could have a major effect on the view of the net assets, financial position and re s u l t s
of operations conveyed by the Consolidated Financial Statements – taking into con-
sideration generally accepted accounting principles – and Management’s Analysis.
The determination of the action for this audit takes into account knowledge of the
business and BASF’s economic and legal environment as well as expectations of
possible errors. In the audit, the effectiveness of the internal checking system and
p roof of the details provided in the Consolidated Financial Statements and
M a n a g e m e n t ’s Analysis are assessed predominantly on the basis of spot checks.
The audit encompasses an assessment of the financial statements of the compa-
nies included in the Consolidated Financial Statements, a definition of the scope of
consolidation, a review of the accounting and consolidation principles employed, 
the main judgments made by the Board of Executive Directors, and an appre c i a t i o n
of the overall presentation of the Consolidated Financial Statements and
M a n a g e m e n t ’s Analysis. In our opinion, we believe that our audit provides a re a s o n-
able basis for our assessment.
Our audit has not given rise to any re s e rv a t i o n s .
It is our opinion that these Consolidated Financial Statements, taking into considera-
tion generally accepted accounting principles, convey a true and fair view of the net
assets, financial position and results of operations of BASF Gro u p .
M a n a g e m e n t ’s Analysis of BASF Aktiengesellschaft and BASF Group conveys in all
an accurate presentation of the situation of BASF and accurately shows the risks to
f u t u re development.
F r a n k f u rt, March 1, 2000
Deloitte & Touche GmbH
Wi rt s c h a f t s p r ü f u n g s g e s e l l s c h a f t
P rofessor Dr. Emmerich K o m p e n h a n s
A u d i t o r A u d i t o r
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BASF GROUP CONSOLIDATED FINANCIAL STAT E M E N T S
Consolidated Statements of Income
Year ended De c e m b e r 3 1
Million e
Explanations in Note 19 9 9 19 9 8
S a l e s 3 1,3 18 . 2 2 9,2 4 5 . 6
– Petroleum and natural gas taxes ( 1,8 4 5 . 5 ) ( 1,6 0 2 . 7 )
Sales, net of petroleum and natural gas taxes 2 9,4 7 2 . 7 27,6 4 2 . 9
Cost of sales 18,3 9 1 . 3 17,27 4 . 5
G ross profit on sales 11,0 8 1 . 4 10,3 6 8 . 4
Selling expenses 5 , 27 9 . 9 4 , 9 6 3 . 2
General and administrative expenses 6 7 7. 0 7 7 2 . 5
R e s e a rch and development expenses 1,3 3 3 . 0 1,3 0 9 . 3
Other operating income ( 7 ) 9 7 8 . 2 1,13 6 . 9
Other operating expenses ( 8 ) 2,7 6 1 . 0 1,8 3 6 . 6
Income from operations 2,0 0 8 . 7 2,6 2 3 . 7
Income from financial assets 7 27. 4 8 7. 7
Write-downs of, and losses from, re t i rement of financial
assets as well as securities held as current assets 2 2 . 2 4 8 . 4
I n t e rest re s u l t –10 8 . 4 10 7. 8
Financial re s u l t ( 9 ) 5 9 6 . 8 14 7.1
Income before taxes and minority intere s t s * 2,6 0 5 . 5 2,7 7 0 . 8
Income taxes ( 10 ) 1,3 6 0 . 8 1,10 6 . 8
Income before minority intere s t s 1,2 4 4 . 7 1,6 6 4 . 0
Minority intere s t s ( 11 ) 7. 9 – 3 5 . 4
Net income 1,2 3 6 . 8 1,6 9 9 . 4
E a rnings per share (e) 2 . 0 0 2 . 7 3
* Income from ord i n a ry operations
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Consolidated Balance Sheets at December 31
Million e
A s s e t s
Explanations in Note 19 9 9 19 9 8
Intangible assets ( 14 ) 2,14 6 . 8 1,9 6 4 . 9
Tangible assets ( 15 ) 12,4 16 . 3 10,7 5 4 . 5
Financial assets ( 16 ) 1,5 0 6 . 6 1,8 2 6 .1
Fixed assets 16,0 6 9 . 7 14,5 4 5 . 5
I n v e n t o r i e s ( 17 ) 4,0 27. 7 3,7 0 3 . 4
Accounts receivable, trade 4,9 6 6 . 7 4,0 17. 4
Receivables from affiliated companies 7 2 4 . 5 6 4 6 . 8
Miscellaneous receivables and other assets 1,3 5 7. 2 1,0 7 3 . 6
Receivables and other assets ( 18 ) 7,0 4 8 . 4 5,7 3 7. 8
Marketable securities ( 19 ) 5 17. 4 7 4 5 . 7
Cash and cash equivalents 9 9 0 . 2 7 5 6 . 9
C u rrent assets 12,5 8 3 . 7 10,9 4 3 . 8
D e f e rred taxes ( 10 ) 1,2 2 5 . 4 1,0 7 7. 3
P repaid expenses ( 2 0 ) 13 0 . 2 13 5 .1
Total assets 3 0,0 0 9 . 0 2 6,7 0 1 . 7
Stockholders’ equity and liabilities
Explanations in Note 19 9 9 19 9 8
Subscribed capital ( 2 1 ) 1,5 8 9 . 7 1,5 9 4 . 7
Capital surplus ( 2 1 ) 2,6 7 5 . 2 2,5 9 0 .1
Retained earnings ( 2 1 ) 9,0 0 1 . 7 8,6 9 5 .1
C u rrency translation adjustments 5 4 9 . 3 3 9 . 5
Minority intere s t s ( 2 2 ) 3 2 9 . 3 3 3 0 . 7
Stockholders’ equity 14,14 5 . 2 13,2 5 0 .1
P rovisions for pensions and similar obligations ( 2 3 ) 4,17 0 . 0 4,0 6 2 . 5
P rovisions for taxes 6 6 2 . 6 4 8 7. 3
Other pro v i s i o n s ( 2 4 ) 3,8 0 5 .1 3,19 6 .1
P ro v i s i o n s 8,6 3 7. 7 7,7 4 5 . 9
Bonds and other liabilities to capital market 5 16 . 7 5 9 0 . 5
Liabilities to credit institutions 7 7 7. 7 7 2 5 . 3
Accounts payable, trade 2,3 16 . 0 1,8 71 . 2
Liabilities to affiliated companies 2 0 8 . 0 2 0 2 . 8
Miscellaneous liabilities 3,2 17. 4 2,115 .1
L i a b i l i t i e s ( 2 5 ) 7,0 3 5 . 8 5,5 0 4 . 9
D e f e rred i n c o m e 19 0 . 3 2 0 0 . 8
Stockholders’ equity and liabilities 3 0,0 0 9 . 0 2 6,7 0 1 . 7
Consolidated Statements of Changes in Stockholders’ Equity
Year ended De c e m b e r3 1
Million e
Number of S u b s c r i b e d C a p i t a l R e t a i n e d C u rre n c y M i n o r i t y To t a l
s u b s c r i b e d c a p i t a l s u r p l u s e a rn i n g s t r a n s l a t i o n i n t e re s t s s t o c k h o l d e r s ’
s h a re s a d j u s t m e n t s e q u i t y
o u t s t a n d i n g
As of January 1, 19 9 9 6 2 3,7 9 4,15 0 1,5 9 4 . 7 2,5 9 0 .1 8,6 9 5 .1 3 9 . 5 3 3 0 . 7 13,2 5 0 .1
Issuance of new shares fro m
conditional capital through the
e x e rcise of warrants attached to
the 1986/2001 3% U.S. Dollar
Option Bond of BASF Finance 
E u rope N.V. 5,0 8 6,6 9 0 13 . 0 6 7.1 8 0 .1
S h a re buy-back and cancellation
of own share s – 7,8 9 6,2 0 0 – 2 0 . 2 2 0 . 2 – 2 5 5 . 6 – 2 5 5 . 6
Capital increase in BASF
Aktiengesellschaft to re c o n c i l e
nominal value of BASF share s
to E 2.56 per share 2 . 2 – 2 . 2
Dividends paid – 6 9 2 . 8 – 4 . 7* – 6 9 7. 5
Net income 1,2 3 6 . 8 7. 9 1,2 4 4 . 7
I n c rease of foreign curre n c y
translation adjustments 5 0 9 . 8 3 2 . 3 5 4 2 .1
Changes in scope of consoli-
dation and other changes 18 . 2 – 3 6 . 9 –18 . 7
As of December 31, 19 9 9 6 2 0,9 8 4,6 4 0 1,5 8 9 . 7 2,6 7 5 . 2 9,0 0 1 . 7 5 4 9 . 3 3 2 9 . 3 14,14 5 . 2
As of December 31, 19 9 7 6 2 2,0 6 2,6 8 0 1,5 9 0 . 2 2,5 6 7. 2 7,4 17. 9 2 0 0 . 3 2 5 4 . 8 12,0 3 0 . 4
Valuation adjustment to
U.S. GAAP 2 3 8 .1 – 43.3 19 4 . 8
As of January 1, 19 9 8 6 2 2,0 6 2,6 8 0 1,5 9 0 . 2 2,5 6 7. 2 7,6 5 6 . 0 2 0 0 . 3 2 11 . 5 12,2 2 5 . 2
Issuance of new shares fro m
conditional capital through the
e x e rcise of warrants attached to
the 1986/2001 3% U.S. Dollar
Option Bond of BASF Finance 
E u rope N.V. 1,7 3 1,4 6 0 4 . 5 2 2 . 9 27. 4
Issuance of new shares fro m
conditional capital to form e r
Wintershall shareholders as 
compensation for Wi n t e r s h a l l
s h a res outstanding from 19 6 8
tender off e r 10
Dividends paid – 6 3 6 .1 5 . 7* – 6 3 0 . 4
Net income 1,6 9 9 . 4 – 3 5 . 4 1,6 6 4 . 0
I n c rease of foreign curre n c y
translation adjustments –16 0 . 8 5 . 4 –15 5 . 4
Changes in scope of consoli-
dation and other changes – 2 4 . 2 14 3 . 5 119 . 3
As of December 31, 19 9 8 6 2 3,7 9 4,15 0 1,5 9 4 . 7 2,5 9 0 .1 8,6 9 5 .1 3 9 . 5 3 3 0 . 7 13,2 5 0 .1
* Profit and loss transfer to minority intere s t s
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Consolidated Statements of Cash Flows
Year ended December 31
Million Û
19 9 9 19 9 8
Net income 1,2 3 6 . 8 1,6 9 9 . 4
D e p reciation of fixed assets 2,6 9 0 . 0 2,2 8 8 . 7
Changes in long-term pro v i s i o n s 2 0 4 . 5 – 2 2 9 . 7
Other non-cash items – 4 1 . 9 – 4 7. 4
Gains(–)/losses (+) from disposals of fixed assets and securities –1 , 0 0 6 . 6 –14 8 . 4
Changes in inventories – 2 18 . 5 9 3 .1
Changes in receivables –1,3 2 6 . 6 3 3 6 . 8
Changes in other operating liabilities 1,717. 3 – 2 4 8 . 0
Cash provided by operating activities 3,2 5 5 . 0 3,7 4 4 . 5
Additions to tangible and intangible fixed assets – 2,9 3 8 . 7 – 2,7 2 2 . 2
Additions to financial assets and securities – 8 7 7. 7 –1,17 7. 0
Payments related to acquisitions – 3 9 7. 3 – 9 6 8 . 9
P roceeds from divestiture s 1,0 9 3 . 5 2 0 8 . 6
P roceeds from the disposition of fixed assets and securities 1,0 2 1 . 7 1,4 3 2 . 4
Cash used in investing activities – 2,0 9 8 . 5 – 3,2 27.1
P roceeds from capital incre a s e s –17 5 . 5 27. 3
P roceeds from the addition of financial indebtedness 2,3 5 0 . 9 3 3 6 . 9
Repayment of financial indebtedness – 2,4 4 6 . 2 – 4 3 1 . 6
Dividends paid
• To shareholders of BASF Aktiengesellschaft – 6 9 2 . 8 – 6 3 6 .1
• To minority share h o l d e r s – 4 . 7 5 . 7
Cash used in financing activities – 9 6 8 . 3 – 6 9 7. 8
Net change in cash and cash equivalents 18 8 . 2 –18 0 . 4
E ffects on cash and cash equivalents
• From foreign exchange rates 19 . 6 –17.1
• From changes in scope of consolidation 2 5 . 5 111 . 6
Cash and cash equivalents as of beginning of year 7 5 6 . 9 8 4 2 . 8
Cash and cash equivalents as of end of year 9 9 0 . 2 7 5 6 . 9
Marketable securities 5 17. 4 7 4 5 . 7
Liquid funds as shown on the balance sheet 1,5 0 7. 6 1,5 0 2 . 6
19 9 9
The following companies were consolidated for the first
t i m e :
• BA S E L L C . V. of Rotterdam, the Netherlands, a joint 
v e n t u re with Shell that has been consolidated since
the startup of the styrene and propylene oxide plant.
• Salchi Spa of Italy, an industrial coatings manufacture r
a c q u i red in 1998 and now known as BASF Coatings
Spa of Burago Molgora, Milan, Italy.
• Wintershall Energía S.A. of Buenos Aires, Arg e n t i n a .
The operation was taken over in 1998 when Deminex
was split between the part n e r s .
• Another 23 subsidiaries previously not consolidated,
mainly in the Pharmaceuticals and Polyurethanes 
d i v i s i o n s .
The following companies, in addition to deconsolidations 
resulting from re s t ructuring measures, are no longer 
consolidated because they have been sold:
• BASF Hort i c u l t u re et Jardin S.A. of Levallois, France.
• Wintershall Canada Ltd. of Calgary, Alberta, Canada.
• The former joint venture Ultrasorb Chemikalien GmbH
of Ludwigshafen, Germ a n y.
19 9 8
The following companies were consolidated for the first
t i m e :
• Elenac Group of Kehl, Germ a n y, and Strasbourg ,
France. Elenac is a 50-50 joint venture with Shell that
began operations on March 1, 1998. BASF contribut-
ed its European polyethylene business and Shell con-
tributed the polyethylene business acquired from the
Montell Polyolefine Company of the Netherlands. The
joint venture consists of Elenac GmbH of Germ a n y,
f o rmerly known as Rheinische Olefinwerke GmbH of
Wesseling, Germ a n y, and Elenac S.A. of France. The
joint venture, including its subsidiaries, is pro p o rt i o n a l l y
consolidated. Elenac acquired the Hostalen business
of Hoechst, including the affiliate Hostalen Poletileno
S.L. of Barcelona, Spain, effective December 31,
1998, which has been consolidated since that time.
• M i c ro Flo Company of Lakeland, Florida. BASF ac-
q u i red Micro Flo, a generic crop protection pro d u c t s
s u p p l i e r, as of June 30, 19 9 8 .
• Another six companies based in Korea, Japan, China
and Singapore due to their increased import a n c e .
Notes to the BASF Group Consolidated Financial
S t a t e m e n t s
Accounting principles
The BASF Group Consolidated Financial Statements are
p re p a red in accordance with the provisions of the Ger-
man Commercial Code (Handelsgesetzbuch) and the
Stock Corporations Act. Since January 1, 1998, BASF
has considered U.S. generally accepted accounting prin-
ciples (U.S. GAAP) to the extent permissible under the
G e rman Commercial Code. Remaining significant devia-
tions to U.S. GAAP are described in a reconciliation that
includes net income and stockholders’ equity in accor-
dance with U.S. GAAP (Note 5 to the Consolidated Fi-
nancial Statements). Since January 1, 1999, the Consoli-
dated Financial Statements have been re p o rted in euro s
(e). The 1998 Financial Statements, which were originally
re p o rted in German marks (DM), have been convert e d
into euros at the official rate of e 1 = DM 1.95583. The
Notes to the BASF Group Consolidated Financial State-
ments have been modified in anticipation of BASF listing
its American Depositary Receipts (ADRs) in June 2000
on the New York Stock Exchange. As a result, the Notes
do not contain any information about the results of BASF
Aktiengesellschaft for the first time.
(1) Scope of consolidation
Significant domestic and foreign subsidiaries are includ-
ed in the Group Consolidated Financial Statements in
full, while 50 percent owned joint ventures are included
on a pro p o rtional consolidation basis. Subsidiaries and
joint ventures that are immaterial individually or in the 
a g g regate are not consolidated.
The changes in the numbers of consolidated companies
w e re as follows:
19 9 9 19 9 8
As of January 1 13 2 12 4
• T h e reof pro p o rtional consolidation 17 9
First-time consolidations 2 6 19
• T h e reof pro p o rtional consolidation 2 8
D e c o n s o l i d a t i o n s 8 11
• T h e reof pro p o rtional consolidation 3 –
As of December 31 15 0 13 2
• T h e reof pro p o rtional consolidation 16 17
In principle, the non-consolidated and associated com-
panies in which BASF’s equity interest is at least 20 per-
cent are accounted for in accordance with the equity
method. In total, this involves:
19 9 9 19 9 8
S u b s i d i a r i e s 2 5 3 2
Joint venture s 7 8
Other associated companies 3 1
To t a l 3 5 4 1
The following companies, in addition to deconsolidations
resulting from re s t ructuring measures, are no longer con-
solidated because they have been sold or BASF re d u c e d
its share h o l d i n g :
• Chemag AG of Frankfurt, Germ a n y.
• C o m p a rex Informationssysteme GmbH of Mannheim,
G e rmany (including four subsidiaries).
The changes in the scope of consolidation, acquisitions
and divestitures had the following impact on the BASF
G roup Consolidated Balance Sheets and sales:
P ro p o rtionally consolidated companies
The companies pro p o rtionally consolidated contributed
the following amounts to the Group Consolidated Finan-
cial Statements:
(2) Consolidation methods
Balance sheet date: The individual financial statements
of the consolidated companies within the Group are 
p re p a red as of the same date. In certain cases, interim 
financial statements or adjusted statements are pre p a re d
as of the balance sheet date of the Group Consolidated
Financial Statements.
U n i f o rm valuation: Assets and liabilities of consolidated
companies are accounted for and valued uniformly in 
a c c o rdance with the principles described here and in
Note 3.
W h e re the accounting and valuation methods applied in
the financial statements of the consolidated companies
d i ffer from these principles, appropriate adjustments are
made to the relevant items. For companies accounted
for under the equity method, significant deviations in the
valuation methods are adjusted.
E l i m i n a t i o n s : Transactions between consolidated com-
panies are eliminated in full and those for joint venture s
on a pro p o rtional basis. Inter-company profits re s u l t i n g
f rom deliveries and services between consolidated com-
panies are eliminated unless they originate from the con-
s t ruction of plants under normal market conditions and
a re of minor import a n c e .
With re g a rd to the companies accounted for under the
equity method, inter-company profits resulting from deliv-
eries and services under normal market conditions are
not eliminated because the amounts are insignificant or
because determining them would involve a dispro p o r-
tionate amount of eff o rt .
Capital consolidation: Capital consolidation is based
on the book value method at the time of acquisition,
which is equivalent to the purchase method re q u i re d
under U.S. GAAP. The acquisition cost of part i c i p a t i o n s
is offset against the pro p o rtionate share of equity 
a c q u i red. Any diff e rences arising – taking into account
d e f e rred taxes from January 1, 1998 – are allocated to
the assets and liabilities to be acquired, up to their fair
values, or capitalized as intangible fixed assets.
D i ff e rences that are not allocated to individual assets are
capitalized as goodwill and amortized within the expect-
ed useful life of seven to 15 years. For participations ac-
q u i red through December 31, 1997, goodwill is generally
a m o rtized within five years.
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19 9 9 19 9 8
Million Û % Million Û % 
Fixed assets 5 0 5 . 9 3.5 1 , 3 6 3 . 2 10 . 7
• T h e reof tangible assets 3 4 3 . 0 3 . 2 7 9 6 . 0 8 . 8
Inventories and re c e i v a b l e s – 3 18 . 7 – 3 . 0 18 9 . 7 1 . 9
Liquid assets 711 .1 4 7. 3 – 6 4 5 . 2 – 3 5 . 0
A s s e t s 8 9 8 . 3 3 . 4 9 0 7. 7 3 . 7
E q u i t y 4 0 0 . 3 3 . 0 2 6 0 . 6 2 . 2
Financial liabilities 10 7. 6 8 . 2 3 3 8 . 7 3 0 .1
Other liabilities 3 9 0 . 4 3 . 2 3 0 8 . 4 2 . 7
Equity and liabilities 8 9 8 . 3 3 . 4 9 0 7. 7 3 . 7
S a l e s 8 6 9 3 .1 4 8 3 1 . 7
T h e re o f :
• A c q u i s i t i o n s 6 2 7 9 6 3
• D i v e s t i t u re s – 3 3 1 – 6 27
• Changes in scope of
c o n s o l i d a t i o n 5 7 3 14 7
Balance sheet
Million Û 19 9 9 19 9 8
Fixed assets 860.4 5 6 6 . 2
C u rrent assets 6 5 8 . 7 5 11 . 9
A s s e t s 1 , 5 19 .1 1 , 0 7 8 .1
Stockholders’ equity 4 4 1 . 9 4 3 0 . 6
P ro v i s i o n s 2 3 3 . 5 10 4 . 9
Other liabilities 8 4 3 . 7 5 4 2 . 6
Equity and liabilities 1 , 5 19 .1 1 , 0 7 8 .1
Statement of income
Million Û 19 9 9 19 9 8
S a l e s 1 , 8 8 5 . 7 1 , 716 . 6
Income from operations 15 6 . 8 10 8 . 2
Net income 113 . 7 8 7. 0
List of share h o l d i n g s : A list of companies included in
the BASF Group Consolidated Financial Statements as
well as a list of all companies in which BASF has a part i-
cipation, have been deposited at the Commercial Regis-
t ry HRB 3000 in Ludwigshafen, Germ a n y, as re q u i red by
the German Commercial Code, Section 313 (2).
(3) Accounting and valuation methods
Revenue re c o g n i t i o n : Revenue is realized when pro d-
ucts or goods are delivered, or the services are per-
f o rmed. Possible discounts or other price concessions
a re shown separately. Provisions are made for probable 
risks resulting from product re t u rns, warranties or other
claims in accordance with the principle of individual 
v a l u a t i o n .
Intangible assets: Intangible assets are valued at 
acquisition cost less scheduled straight-line amortization. 
Special write-downs are made in cases of expected per-
manent impairment of value. The average weighted
a m o rtization period for both 1999 and 1998 was eight
years, and was based on the following expected useful
l i v e s :
Ye a r s
G o o d w i l l 5 – 15
P roduct rights and licenses 3 – 15
Marketing, supply and similar rights 4 – 2 0
Know-how and patents 5 – 15
Concessions, exploration rights
and similar rights 3 – 2 5
S o f t w a re 3 –  5
Other rights and values 5 – 2 5
Tangible assets: P ro p e rt y, plant and equipment are
stated at acquisition or production cost less scheduled
d e p reciation over their estimated useful lives. Special
write-downs are also made in cases of expected perm a-
nent impairment of value, if re c o v e ry of the book value
can no longer be expected in the individual case. Low-
value assets are fully depreciated in the year of acquisi-
tion and are shown as re t i rements. Movable depre c i a b l e
fixed assets that are functionally integrated are treated 
as a single asset item.
The cost of self-constructed plants includes direct costs
and an appropriate pro p o rtion of the production over-
head but excludes financing costs for the period of 
c o n s t ru c t i o n .
Movable fixed assets are mostly depreciated by the de-
clining balance method, with a change to straight-line
d e p reciation if this results in higher depreciation rates.
Long-distance natural gas pipelines and immovable 
fixed assets are depreciated using the straight-line 
m e t h o d .
The average weighted periods of depreciation are as 
f o l l o w s :
19 9 9 19 9 8
Buildings and stru c t u r a l
i n s t a l l a t i o n s 22 years 22 y e a r s
Industrial plant and machinery 9 y e a r s 9 y e a r s
Long-distance natural gas 
p i p e l i n e s 25 y e a r s 25 y e a r s
Working and office equipment
and other facilities 8 y e a r s 8 y e a r s
BASF follows the successful eff o rts method of account-
ing for its oil and gas activities. Under this method, costs
of successful oil and gas drilling operations are capital-
ized as tangible assets. They are depreciated accord i n g
to the declining balance method over the estimated use-
ful lives of eight years (for drilling operations in old fields)
or 15 years. In certain regions, they are depreciated on
the unit of production basis. Geophysical expenditure s ,
including exploratory and dry-hole costs, are charg e d
against income.
Financial assets: S h a res in affiliated and associated
companies not accounted for by the equity method and
other participations and securities held as fixed assets
a re shown at acquisition cost or, in the case of other than
t e m p o r a ry impairment of value, at the appropriate lower
v a l u e s .
The acquisition cost of the affiliated and associated com-
panies accounted for by the equity method is incre a s e d
or decreased yearly by the pro p o rtionate change in equi-
t y. In addition, goodwill is amortized within the expected
useful life of five to 10 years. Goodwill related to part i c i-
pations acquired through December 31, 1997, is mostly
a m o rtized over a period of five years. The capital consoli-
dation of the companies accounted for by the equity
method at the time of acquisition is based on the same
principles as those of a full consolidation.
Loans are stated at acquisition cost or, in the case of
n o n - i n t e rest-bearing loans or loans at below market
i n t e rest rates, at their present value. Foreseeable risks
a re covered by unscheduled write-downs.
I n v e n t o r i e s : Inventories are carried at the lower of ac-
quisition or production cost or market values, as appro-
priate. These lower values are the replacement costs of
raw materials and factory supplies and merchandise and,
in the case of work in process and finished products, the
expected sales proceeds less costs to be incurred prior
to sale and an average profit margin or cost of re p ro d u c-
tion. Production costs include, in addition to direct costs,
an appropriate allocation of production overhead using
n o rmal utilization rates of the production plants. Financ-
ing costs are not included.
C o n s t ruction in pro g ress relates mainly to plants under
c o n s t ruction for third parties. Expected profits are not
recognized until the final billing and surrendering of a
p roject; expected losses are recognized by write-downs
to the lower attributable values.
Receivables and other assets: Receivables are gener-
ally carried at their nominal value; notes receivable and
loans generating no or low-interest income are discount-
ed to their present values. Risks of collectibility and
transferability are covered by appropriate valuation 
a l l o w a n c e s .
S e c u r i t i e s : Securities held as fixed assets as well as
marketable securities are valued individually at cost or at
lower quoted or market values.
D e f e rred tax assets: D e f e rred tax assets are re c o rd e d
for taxable temporary diff e rences between the valuations
of assets and liabilities in the financial statements of the
consolidated companies and the carrying amounts for
tax purposes. Country-specific tax rates are used. If the
expected future earnings of a company make it seem
likely that the tax benefits will not be realized, appro p r i a t e
value allowances are made.
P ro v i s i o n s : P rovisions for pensions of German and for-
eign subsidiaries are based on actuarial computations
a c c o rding to the projected unit credit method. Similar
obligations, especially those arising from promises made
by our North American Group companies to pay the
h e a l t h c a re costs and life insurance premiums of re t i re d
s t a ff and their dependents are shown as pension 
p ro v i s i o n s .
Tax provisions are recognized for income taxes and other
taxes in the amount necessary to meet the expected
payment obligations, less any prepayments that have
been made. Provisions for deferred taxes are re c o g n i z e d
for net liabilities from taxable temporary diff e re n c e s
between the valuation of assets and liabilities in the 
financial statements of the consolidated companies and
the carrying amounts for tax purposes, using the tax
rates applicable in the individual countries.
Other provisions exist for uncertain liabilities and likely
losses from pending transactions. Maintenance pro v i-
sions are established to cover omitted maintenance pro-
c e d u res as of the end of the year that are expected to be
i n c u rred within the first three months of the following
y e a r. The amount provided for is based on re a s o n a b l e
c o m m e rcial judgment.
P rovisions for environmental protection measures and
risks are formed if measures seem likely to be necessary
on the basis of statutory and governmental obligations or
re q u i rements or as a result of technological changes.
P rovisions for re q u i red recultivation associated with oil
and gas exploration, especially the filling of wells and
clearance of oil fields, or the operation of landfill sites are
built up in installments over the expected service lives. In
addition, provisions are accrued in installments for re g u-
lar shutdowns within prescribed intervals of certain larg e -
scale plants as re q u i red by technical surveillance 
a u t h o r i t i e s .
P rovisions for re s t ructuring measures are re c o rded when
the measures have been identified and a commitment
f rom management exists. Such provisions include sever-
ance payments or other personnel-related costs as well
as specific site re s t ructuring costs such as the cost for
demolition, closure and re l o c a t i o n .
P rovisions for long-time service and anniversary bonuses
a re actuarially calculated using an interest pre d o m i n a n t l y
of 5.5 percent. For short-time working programs for
those nearing re t i rement, the promised top-up payments
a re set aside in full and the wage and salary payments
due during the passive phase of agreements are accru e d
t h rough installments. The provisions bore an interest rate
of 5.5 percent for the first time in 19 9 9 .
As discussed in Note 28, BASF has initiated a stock
option program for 1,200 senior executives, including 
the Board of Executive Directors. Provisions for the out-
standing stock options will be accrued during the thre e -
year lock-up period based on the market value of the 
o p t i o n .
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(4) Currency translation
Translation of foreign currency items: The cost of 
assets acquired in foreign currencies as well as re v e n u e s
f rom sales in foreign currencies are re c o rded at the rates
on transaction dates.
S h o rt - t e rm foreign currency receivables and liabilities are
valued at the rate on the balance sheet date. Long-term
f o reign currency receivables are re c o rded at the rate pre-
vailing on the acquisition date or at the lower rate on the
balance sheet date. Long-term foreign currency liabilities
a re re c o rded at the rate prevailing on the acquisition date
or at the higher rate on the balance sheet date. Individu-
ally hedged receivables or liabilities are recognized at
hedge rates.
Derivative financial instruments (see Note 29):
P rofits from foreign currency derivatives that cannot be
allocated to a particular underlying transaction are re a l-
ized upon maturity. Unrealized losses associated with
c u rrency rate changes on forw a rd foreign exchange con-
tracts and currency options are re c o rded in income and
included in provisions. For interest rate and interest 
r a t e / c ross currency swaps, the interest diff e rentials are
d e f e rre d .
Translation of foreign currency financial statements:
The translation of foreign currency financial statements
c o n f o rms with Statement of Financial Accounting Stan-
d a rds (SFAS) No. 52, Foreign Currency Tr a n s l a t i o n .
The local currency is the functional currency of BASF
subsidiaries and joint ventures in North America, Japan,
K o rea and China as well as for BASF’s oil and gas 
operations in Argentina. The balance sheet items are
translated into euros at year-end rates, and expenses
and income at quarterly average rates. The effects of 
rate changes are shown as “currency translation adjust-
ment” and re p o rted as a separate component of equity.
This re p resents the diff e rence between the company’s
equity calculated at historical rates and at year-end 
c u rrent rates.
The euro is the functional currency for all other consoli-
dated subsidiaries and affiliated companies. The fixed
assets, with the exception of loans, and paid-in equity
a re converted at rates on the date of acquisition at his-
torical rates, and all other assets, liabilities and pro v i s i o n s
at year-end current rates; retained earnings is deter-
mined as the remaining balance. Expenses and income
a re converted at quarterly average rates, except when
they are derived from balance sheet items converted 
at historical rates. The changes in assets caused by
translation are included in other operating expenses or
i n c o m e .
(5) Reconciliation to U.S. GAAP
The following is a summary of the significant adjustments
to net income and stockholders’ equity that would be 
re q u i red if U.S. GAAP were to be fully applied. This re-
conciliation is still subject to review by the U.S. Securities
and Exchange Commission as part of the registration of
BASF American Depositary Receipts (ADRs).
Reconciliation of net income to U.S. GAAP
Capitalization of intere s t : In the case of tangible 
assets with a longer construction period, interest for pro-
ject costs incurred has to be capitalized and depre c i a t e d
a c c o rdingly once the plants begin operations. This inte-
rest is not shown in the present financial statements in
a c c o rdance with German GAAP.
Million e 19 9 9 19 9 8
Net income as re p o rted in the Consolidated
Financial Statements of Income under
G e rman GAAP 1 , 2 3 6 . 8 1 , 6 9 9 . 4
Additional adjustments to conform
with U.S. GAAP:
Capitalization of intere s t 2 6 .1 3 5 . 4
Valuation of pension funds 7 0 . 9 – 3 3 . 6
Valuation of long-term foreign currency items
at year-end exchange rates – 3 6 . 0 5 2 . 6
Capitalization of software developed 
for internal use 5 0 .1
Valuation of securities at year-end 
market values – 0 . 7 –1 . 4
Other adjustments –18 . 8 3 .1
D e f e rred taxes 3 .1 27. 8
Minority intere s t s – 6 . 7 –12 . 3
Net income according to U.S. GAAP 1 , 3 2 4 . 8 1 , 7 71 . 0
Basic earnings per share accord i n g
to U.S. GAAP (e) 2 .14 2 . 8 4
Diluted earnings per share accord i n g
to U.S. GAAP (e) 2 .12 2 . 7 9
Reconciliation of stockholders’ equity to U.S. GAAP
Million e 19 9 9 19 9 8
Stockholders’ equity as re p o rted in the 
Consoldiated Financial Statements under
G e rman GAAP 14 , 14 5 . 2 13 , 2 5 0 .1
Minority intere s t s – 3 2 9 . 3 – 3 3 0 . 7
Stockholders’ equity excluding minority interests 13 , 8 15 . 9 12 , 9 19 . 4
Additional adjustments to conform
with U.S. GAAP:
Capitalization of intere s t 4 7 6 . 4 4 5 0 . 3
Valuation of pension funds 7 0 0 . 2 6 2 9 . 3
Valuation of long-term foreign currency items 
at year-end exchange rates 3 3 . 3 6 9 . 3
Capitalization of software developed 
for internal use 5 0 .1
Valuation of securities at year-end 
market values 9 5 . 9 8 8 . 6
Other adjustments 14 5 . 9 16 4 . 4
D e f e rred taxes – 5 4 6 . 4 – 3 7 7. 3
Minority intere s t s –18 . 5 – 3 9 .1
Stockholders’ equity according 
to U.S. GAAP 14 , 7 5 2 . 8 13 , 9 0 4 . 9
Valuation of pension funds: Pension benefits under
company pension schemes are partly funded in a legally
independent pension fund, “BASF Pensionskasse
V VaG,” which is managed similarily to a defined contribu-
tion plan and is subject to the German Private Insurance
Companies Control Act (VA G ) .
B A S F, as the guarantor company, has entered into a
guarantee of the company pensions commitments of the
BASF Pensionskasse. It would there f o re be classified
under U.S. GAAP as a defined-benefit pension fund,
meaning that assets would have to be valued at market
values and commitments under the projected unit cre d i t
method. These revaluations result in the showing of 
advance financing of future pension payments, which
could not be shown in the present financial statements 
in accordance with German GAAP.
The resulting overview of the pension fund assets is as
f o l l o w s :
In addition to the BASF Pensionskasse, there are some
f o reign plans for which the valuation according to SFA S
No. 87 results in a prepaid pension asset that is re p o rt e d
as part of the re c o n c i l i a t i o n .
Valuation of long-term foreign currency items at
y e a r-end exchange rates: L o n g - t e rm receivables and
liabilities denominated in foreign currencies are convert e d
into euros at the exchange rates of the date when the
transaction took place or at the lower exchange rates 
at the end of the year for receivables and the higher ex-
change rate for liabilities. U.S. GAAP re q u i res the conver-
sion of such items into the re p o rting currency at the ex-
change rate in effect at the end of the year.
A provision of e 48.6 million was re c o rded as of Decem-
ber 31, 1998, for the anticipated devaluation of the 
Brazilian real. Since the expected exchange losses fro m
U . S . - d o l l a r-denominated liabilities of BASF’s Brazilian
s u b s i d i a ry became effective only in the first quarter of
1999, after the real was allowed to float against other
c u rrencies, the exchange loss would be charged to 
1999 net income under U.S. GAAP. As a result, income
a c c o rding to U.S. GAAP would have been higher in 
1998 and lower in 19 9 9 .
Capitalization of software developed for intern a l
u s e : A c c o rding to U.S. GAAP, the cost of computer soft-
w a re developed for internal use is re q u i red to be capital-
ized for the first time in 1999 and depreciated over the
expected useful life of the software. Since the capitaliza-
tion of these costs is not allowed under German 
G A A P, BASF treats than as an expense in the Germ a n
GAAP financial statements.
Valuation of securities at year-end market values:
Under U.S. GAAP, available-for-sale securities are shown
at market values on the balance sheet date. The effect of
the change in valuation of unrealized profits is immedi-
ately recognized in stockholders’ equity. Realized pro f i t s
or losses are credited or charged to income, as are
changes in depreciation amounts due to permanent 
i m p a i rments of value.
Under German GAAP, such securities are valued at the
lower of acquisition cost or market value at the closing
d a t e .
Other adjustments: These adjustments include in
p a rticular valuation adjustments to U.S. GAAP in the
case of affiliated and associated companies accounted
for by the equity method and the elimination of pro v i s i o n s
re q u i red under German GAAP for deferred maintenance
expense to be incurred within the first three months of
the following business year.
D e f e rred taxes: Adjustments for deferred taxes primari-
ly relate to the aforementioned U.S. GAAP re c o n c i l i n g
items. In addition, German GAAP does not allow compa-
nies to recognize tax assets on tax loss carry f o rw a rd s .
Such deferred tax assets were e 162.6 million in 19 9 9
and e 114 .1 million in 1998. In addition, this item also
contains deferred taxes related to foreign currency trans-
lation adjustments.
Minority intere s t s : The share of minority share h o l d e r s
in the aforementioned reconciliation items to U.S. GAAP
of net income and stockholders’ equity is re p o rted 
s e p a r a t e l y.
Other comprehensive income: C e rtain expenditure s
or income are re c o rded according to U.S. GAAP outside
the Consolidated Financial Statements:
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Million e 19 9 9 19 9 8
Plan assets as of 
December 31 4 , 2 8 0 . 5 3 , 5 6 8 . 0
P rojected benefit obligations
as of December 31 3 , 2 0 5 . 9 3 , 0 2 9 . 7
Funded status 1 , 0 7 4 . 6 5 3 8 . 3
U n recognized actuarial
g a i n s – 5 4 5 . 5 – 2 8 . 4
P repaid pension assets 5 2 9 .1 5 0 9 . 9
Million e 19 9 9 19 9 8
Net income according to U.S. GAAP 1 , 3 2 4 . 8 1 , 7 71 . 0
C u rrency translation adjustments 5 2 9 . 8 –16 0 . 8
U n realized holding gains on securities 8 . 0 4 2 . 9
Reduction in deferred taxes –171 .1 – 4 . 3
Other comprehensive income, net of tax 3 6 6 . 7 –12 2 . 2
E a rnings according to U.S. GAAP 1 , 6 9 1 . 5 1 , 6 4 8 . 8
Million e 19 9 9 19 9 8
Stockholders’ equity according 
to U.S. GAAP ( b e f o re accumulated other
c o m p rehensive income) 14 , 2 8 6 . 5 13 , 8 0 5 . 3
C u rrency translation adjustments 5 6 9 . 2 3 9 . 4
U n realized holding gains on securities 9 6 . 8 8 8 . 8
D e f e rred taxes –19 9 . 7 – 2 8 . 6
Other changes to stockholders’ equity, 
a c c u m u l a t e d 4 6 6 . 3 9 9 . 6
Total stockholders’ equity accord i n g
to U.S. GAAP 14 , 7 5 2 . 8 13 , 9 0 4 . 9
The Fertilizers division will be dissolved as an operating
division in 2000. At the end of 1999, BASF sold its 
C O M P O® business in specialty fertilizers for the home
and garden to K+S Aktiengesellschaft of Kassel, 
G e rm a n y, which also took over the marketing and sales
of agricultural fertilizers manufactured by BASF. As a 
result, BASF has transferred the sales, earnings and 
assets of the Fertilizers division to “Other” for 1999 and
has adjusted the 1998 re s u l t s .
“Other” also included exploratory re s e a rch costs of 
E 124 million in 1999 and E 121 million in 19 9 8 .
(6) Segment and regional data
S e g m e n t s
19 9 9 C h e m i c a l s Plastics & Colorants & Health & Oil & Gas O t h e r B A S F
F i b e r s F i n i s h i n g N u t r i t i o n G ro u p
Million E P ro d u c t s
S a l e s 4,3 9 3 8,5 3 3 6,3 9 5 5,6 0 2 3,0 5 1 1,4 9 9 2 9,4 7 3
Change in % 3 . 2 12 . 6 3 . 3 9 . 9 13 . 6 –18 . 7 6 . 6
Intersegment transfers 1,8 4 8 4 2 1 2 5 9 8 6 17 7 2 9 6 3,0 8 7
Sales including transfers 6,2 4 1 8,9 5 4 6,6 5 4 5,6 8 8 3,2 2 8 1,7 9 5 3 2,5 6 0
Income from operations 6 9 8 6 4 0 6 0 8 – 5 8 8 7 4 1 – 9 0 2,0 0 9
Change in % – 2 4 . 3 18 . 7 – 5 . 3 . 16 8 , 5 . – 2 3 . 4
A s s e t s 4,0 5 0 6,8 11 4,3 4 3 5,17 4 3,0 0 3 6,6 2 8 3 0,0 0 9
R e t u rn on operational assets 
in % 18 . 9 10 . 9 14 . 6 . 2 6 . 3 . 8 . 6
R e s e a rch and development 
e x p e n s e s 14 9 18 0 16 0 6 6 4 4 7 13 3 1,3 3 3
Additions to tangible and
intangible assets 7 6 3 9 9 8 3 2 4 2 8 1 5 2 4 3 6 3 3,2 5 3
D e p reciation of tangible and 
intangible assets 4 8 2 5 9 5 4 2 3 7 8 4 2 8 1 9 7 2,6 6 2
19 9 8 C h e m i c a l s Plastics & Colorants & Health & Oil & Gas O t h e r B A S F
F i b e r s F i n i s h i n g N u t r i t i o n G ro u p
Million E P ro d u c t s
S a l e s 4,2 5 5 7,5 7 3 6,18 8 5,0 9 7 2,6 8 5 1,8 4 5 27,6 4 3
Change in % – 4 . 8 2 . 4 – 5 . 4 11 .1 –16 . 0 – 2 0 . 8 – 3 .1
Intersegment transfers 1,9 3 5 4 14 2 9 1 9 3 2 3 5 27 0 3,2 3 8
Sales including tranfers 6,19 0 7,9 8 7 6,4 7 9 5,19 0 2,9 2 0 2,115 3 0,8 8 1
Income from operations 9 2 2 5 3 9 6 4 2 3 8 3 27 6 –13 8 2,6 2 4
Change in % –15 . 3 4 6 . 5 3 3 . 8 10 .1 – 4 1 . 7 . – 3 . 9
A s s e t s 3,3 5 4 4,9 5 7 3,9 8 1 4,8 8 2 2,6 2 2 6,9 0 6 2 6,7 0 2
R e t u rn on operational assets
in % 2 8 . 4 11 . 5 16 . 0 8 . 6 10 . 8 . 12 . 7
R e s e a rch and development
e x p e n s e s 14 8 18 8 15 8 6 3 4 5 0 13 1 1,3 0 9
Additions to tangible and
intangible assets 5 8 7 7 4 6 3 4 8 1,0 0 2 5 0 5 5 3 4 3,7 2 2
D e p reciation on tangible and 
intangible assets 4 5 2 5 6 2 3 8 2 5 3 4 2 3 8 9 2 2,2 6 0
R e g i o n s
(7) Other operating income
Million e 19 9 9 19 9 8
Release of pro v i s i o n s 14 2 .1 3 8 9 . 3
Income from miscellaneous
revenue-generating activities 7 4 . 8 15 4 . 8
Gains from foreign curre n c y
conversion and translation
a d j u s t m e n t s 3 2 3 . 8 19 3 .1
Gains from disposal of assets 2 6 6 . 9 15 3 . 7
Other 17 0 . 6 2 4 6 . 0
To t a l 9 7 8 . 2 1 , 13 6 . 9
P rovision releases relate principally to the enviro n m e n t a l
p rotection and remediation provision, sales and pur-
chase provisions, litigation and claims provision, shut-
down and re s t ructuring provision, maintenance pro v i s i o n
and the re s e rve for income tax audit liabilities.
Income from miscellaneous revenue-generating activities
includes, in part i c u l a r, the sale of energy and raw mater-
ials as well as rental income.
Gains from the disposal of assets arose in 1999 from the
sale of BASF’s COMPO® business in specialty fert i l i z e r s ;
the company’s oil refining business, including a re f i n e ry in
Lingen, Germany; and the Canadian oil and gas pro d u c-
tion activities of the Oil & Gas segment. In 1998, BASF
had gains from the sale of various business units within
its Coatings division; the glass mat re i n f o rced therm o-
plastics business of the Styrenic Polymers division; a 
35 percent interest in Comparex Inform a t i o n s s y s t e m e
GmbH; and contribution of the polyethylene business to
the Elenac joint venture .
Other income arose from income from management and
marketing services, income from divestitures other than
the disposal of fixed assets, various other items and 
income from the adjustment of valuation allowances of
accounts receivable, particularly in 19 9 8 .
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19 9 9 E u ro p e T h e re o f N o rt h S o u t h Asia, Pacific B A S F
G e rm a n y A m e r i c a A m e r i c a A rea, Africa G ro u p
Million E ( N A F TA )
Location of customer
S a l e s 17,0 4 1 7,14 7 6,7 6 5 1,8 3 7 3,8 3 0 2 9,4 7 3
Change in % 2 . 2 1 . 9 8 . 2 12 . 0 2 4 . 2 6 . 6
S h a re in % 5 8 2 4 2 3 6 13 10 0
Location of company
S a l e s 19,119 12,718 6,7 8 3 1,4 8 4 2,0 8 7 2 9,4 7 3
Sales including transfers 2 0,8 5 3 – 7,15 6 1,5 5 6 2,3 2 9 3 1,8 9 4
Income from operations 1,2 5 8 5 4 2 4 8 1 12 6 14 4 2,0 0 9
Additions to tangible and intangible
fixed assets 1,9 5 0 1,5 9 5 1,10 5 8 3 115 3,2 5 3
A s s e t s 18,7 4 4 12,9 5 9 7,0 6 2 1,4 3 8 2,7 6 5 3 0,0 0 9
19 9 8 E u ro p e T h e re o f N o rt h S o u t h Asia, Pacific B A S F
G e rm a n y A m e r i c a A m e r i c a A rea, Africa G ro u p
Million E ( N A F TA )
Location of customer
S a l e s 16,6 7 2 7,0 11 6,2 4 9 1,6 4 0 3,0 8 2 27,6 4 3
Change in % – 4 . 4 – 4 . 6 4 . 7 – 2 .1 –10 . 3 – 3 .1
S h a re in % 6 0 2 5 2 3 6 11 10 0
Location of company
S a l e s 18,5 0 8 12,18 8 6,2 10 1,3 0 5 1,6 2 0 27,6 4 3
Sales including transfers 2 0,10 2 – 6,5 16 1,3 9 8 1,8 0 9 2 9,8 2 5
Income from operations 2,0 3 3 1,3 0 1 5 15 16 6 0 2,6 2 4
Additions to tangible and intangible
fixed assets 2,2 14 1,8 4 0 1,0 9 2 6 9 3 4 7 3,7 2 2
A s s e t s 17,8 4 2 12,3 13 5,4 7 8 1,0 6 5 2,3 17 2 6,7 0 2
(9) Financial re s u l t
In 1999, income from participating interests and similar
income included special income from the sale of BASF’s
stake in IVAX Corporation as well as its stake in Aral AG
and its re f i n e ry business to Veba Oel AG.
A m o rtization of goodwill of companies accounted for 
under the equity method totaling e 21 million in 1999 and
e 41 million in 1998 as well as income from the release of
negative goodwill are included in income/losses fro m
companies accounted for under the equity method.
The interest income for 1998 includes a one-time profit of
e 122 million from the sale of securities and swaps.
(8) Other operating expenses
Million e 19 9 9 19 9 8
Costs of re o rganization, shutdowns,
severance packages and other
personnel obligations 2 4 8 . 6 2 9 0 .1
E n v i ronmental protection and safety 
m e a s u res, costs of demolition of 
fixed assets and costs related to
the preparation of capital  
e x p e n d i t u re pro j e c t s 2 6 3 . 2 2 12 . 3
Losses from foreign currency 
conversion and translation
a d j u s t m e n t s 2 8 7.1 3 5 7. 2
Costs from miscellaneous re v e n u e
generating activities 6 5 . 3 15 0 . 8
A m o rtization of goodwill 2 6 0 . 3 17 0 . 9
Losses from disposals of assets 3 0 . 0 3 3 . 0
O t h e r 1 , 6 0 6 . 5 6 2 2 . 3
To t a l 2,761.0 1 , 8 3 6 . 6
In 1999, costs for re s t ructuring and shutdown measure s
related primarily to BASF’s multi-division site in Medellin,
Colombia; the Colorants division’s site in Ellesmere Port ,
England; the Pharmaceutical division’s sites in Beeston,
England; and the fertilizer production site in Ostend, 
Belgium. In 1998, the charges consisted mainly of ex-
pected shutdown expenses for two North American sites
in the Colorants & Finishing Products segment as well as
m e a s u res in the Plastics & Fibers segment at BASF’s
Verbund sites in Ludwigshafen, Germ a n y, and Antwerp,
B e l g i u m .
The costs from miscellaneous revenue-generating activ-
ities relate to the items shown under other operating 
i n c o m e .
Other expenditures arose in 1999 primarily due to fines
and compensation payments associated with the vita-
mins antitrust proceedings in the United States and vari-
ous other countries along with payments resulting fro m
lawsuits involving the drug Synthro i d®. This line item is
comprised of several other items, including valuation 
allowances on doubtful accounts and liquidation of 
i n v e n t o r i e s .
Million e 19 9 9 19 9 8
Income from participating interests and 
similar income 7 3 1 . 2 6 1 . 3
• Thereof from affiliated companies 1 6 . 8 3 6 . 4
Income from profit transfer agre e m e n t s 6 .1 11 . 2
Losses from profit transfer agre e m e n t s 11 . 3 2 1 . 5
Losses/income from companies accounted
for under the equity method 1 . 4 3 6 . 7
Net income from financial assets 7 27. 4 8 7. 7
Write-down of and losses from re t i re m e n t
of financial assets as well as securities
held as current assets 2 2 . 2 4 8 . 4
Income from other securities and
financial assets 6 4 . 6 6 9 . 5
• T h e reof from affiliated companies 1 4 . 0 2 0 . 6
Other interest, income from sale of marketable
securities and similar income 12 3 . 0 3 10 .1
• T h e reof from affiliated companies 4 . 7 14 . 7
I n t e rest and similar expenses 2 9 6 . 0 271 . 8
• T h e reof to affiliated companies 5 . 0 6 . 6
I n t e rest re s u l t –10 8 . 4 10 7. 8
Financial result 5 9 6 . 8 14 7.1
( 10) Taxes on income
Million e 19 9 9 19 9 8
G e rman corporation tax 5 9 1 . 3 4 2 1 . 8
G e rman trade income tax 17 8 .1 16 8 . 3
F o reign income taxes 4 6 0 . 4 4 0 1 . 6
Taxes on oil-producing operations non-
compensable with German corporation tax 16 5 . 0 6 2 . 8
Utilization of loss carry f o rw a rd s –14 .1 – 3 3 . 9
C u rrent taxes 1 , 3 8 0 . 7 1 , 0 2 0 . 6
D e f e rred taxes –19 . 9 8 6 . 2
Taxes on income 1 , 3 6 0 . 8 1 , 10 6 . 8
Other taxes 14 9 . 3 12 1 . 9
Tax expense 1 , 5 10 .1 1 ,2 2 8 . 7
Other taxes include, in part i c u l a r, land taxes and other 
comparable taxes; these taxes are allocated to the operating 
function costs.
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( 12) Employees
Personnel costs
Million e 19 9 9 19 9 8
Wages and salaries 4 , 9 3 4 . 7 4 , 8 4 0 . 3
Social security contributions
and expenses for pensions
and assistance 1 , 2 4 4 . 8 1 , 16 9 . 7
• Thereof for pension benefits 3 8 8 . 7 3 0 8 . 6
To t a l 6 , 17 9 . 5 6 , 0 10 . 0
The short-time contracts for employees nearing re t i re-
ment and other early re t i rement programs led to a re d u c-
tion of pension liabilities because payments associated
with the period between re t i rement and entry into the
state pension program no longer apply. Pension costs for
1998 include a credit of e 86.3 million resulting from an
a g reement between BASF Aktiengesellschaft and other
G e rman subsidiaries with the BASF Pensionskasse for it
to assume the legal liability resulting from adjusting pen-
sions granted every third year to the general develop-
ment of net wages in Germ a n y. BASF Aktiengesellschaft
and other subsidiaries in Germany previously carried this
liability on their balance sheets for the portion of pension
benefits granted by the BASF Pensionskasse. 
G e rman Group companies incurred costs for employees’
re p resentatives to comply with statutory regulations of 
e 10 .1 million in 1999 and e 10.7 million in 19 9 8 .
Average number of employees
The above number of employees of pro p o rtionally con-
solidated companies are given in full; if they are taken 
into account at 50 percent, the average number of 
employees for BASF Group was 10 7 , 163 in 1999 and
106,928 in 19 9 8 .
Fully consolidated P ro p o rt i o n a l l y
c o m p a n i e s c o n s o l i d a t e d
c o m p a n i e s
BASF Gro u p 19 9 9 19 9 8 19 9 9 1998 
E u ro p e 7 3 , 9 5 7 7 5 , 3 14 3 , 4 5 6 2 , 9 7 5
• Thereof Germ a n y 5 8 , 0 8 3 5 9 , 2 15 2 , 9 6 2 2 , 5 9 6
N o rth America (NAFTA ) 15 , 6 6 8 15 , 4 3 8 7 4 4 8 0 7
South America 6 , 9 0 2 6 , 4 4 9 – –
Asia, Pacific Area, Africa 8 , 4 5 3 7 , 6 5 6 16 6 3 6 0
To t a l 10 4 , 9 8 0 10 4 , 8 5 7 4 , 3 6 6 4 , 14 2
• Thereof with trainee contracts 3 , 2 0 8 3 , 0 6 0 1 5 0 14 8
• Thereof with limited-term contracts 3 , 1 9 8 3 , 10 7 7 2 2 3
The regional breakdown of income before taxes was as
f o l l o w s :
Million e 19 9 9 19 9 8
G e rm a n y 1 , 2 11 . 5 1 , 5 7 9 . 3
F o re i g n 1,394.0 1 , 19 1 . 5
To t a l 2 , 6 0 5 . 5 2 , 7 7 0 . 8
D e f e rred tax assets and liabilities are calculated with the
tax rate applicable in the individual countries, and they
averaged 36.0 percent in 1999 and 31.2 percent in 19 9 8 .
For German companies, the provision was based on a
tax rate of 52 percent in 1999 and 56 percent in 19 9 8 .
Income taxes on oil-producing operations in certain 
regions, which can amount to up to 85 percent, may be
compensated up to an equivalent level with German 
corporation tax. The non-deductible amount is shown
separately above.
D e f e rred taxes arise from the following temporary diff e r-
ences between valuations in the commercial and tax 
balance sheets:
D e f e rred tax assets
Million e 19 9 9 19 9 8
Intangible assets 2 2 5 . 3 10 4 . 3
Tangible assets –16 4 . 3 – 2 3 5 . 8
Financial assets – 6 7. 0 5 3 . 7
Inventories and accounts
re c e i v a b l e 16 0 . 3 17 3 . 0
P rovisions for pensions
and similar obligations 5 0 7. 6 6 0 1 . 8
Other pro v i s i o n s 5 5 0 . 9 3 9 6 . 9
O t h e r 12 . 6 –16 . 6
To t a l 1 , 2 2 5 . 4 1 , 0 7 7. 3
• Thereof short term 3 9 0 . 6 3 3 3 . 7
D e f e rred tax liabilities
Million e 19 9 9 19 9 8
Tangible assets 16 4 . 0 10 1 . 5
O t h e r 6 8 . 0 5 2 . 4
To t a l 2 3 2 . 0 15 3 . 9
• Thereof short term 1 1 0 . 4 5 8 . 0
The provisions for deferred taxes are shown under the
tax pro v i s i o n s .
( 11) Minority intere s t s
Million e 19 9 9 19 9 8
Minority interests in pro f i t s 4 3 . 2 3 2 . 4
Minority interests in losses 3 5 . 3 6 7. 8
7. 9 – 3 5 . 4
P rofits from minority interests relate in particular to com-
panies active in natural gas trading and Knoll Pharm a-
ceuticals Ltd. of India. Losses from minority interests 
relate primarily to Ta rgor GmbH and its subsidiaries.
( 13) Remuneration of Board of Executive Directors and 
S u p e rv i s o ry Board
In 1999, the members of the Board of Executive Directors were
granted 16 6 , 6 16 option rights under the BASF stock option pro-
gram (BOP). These option rights entitle the purchase, if certain 
objectives are achieved, of a maximum of 333,232 shares at a 
p re f e rential price. Personnel costs in 1999 related to issuing these
options totaled e 0.9 million. A list of the members of the Super-
v i s o ry Board and Board of Executive Directors and their mandates
announced to the company can be found on pages 83 and 86-87.
( 14) Intangible assets
Developments in 19 9 9 Patents, licenses, G o o d w i l l A d v a n c e To t a l
t r a d e m a r k s p a y m e n t s
and similar
Million e r i g h t s *
Acquisition costs
Balance as of January 1, 19 9 9 2,2 4 9 . 5 8 3 8 . 2 7. 4 3,0 9 5 .1
Changes in scope of
c o n s o l i d a t i o n 7 2 . 8 13 9 . 9 0 . 4 2 13 .1
A d d i t i o n s 2 18 . 3 2 6 5 . 7 5 . 5 4 8 9 . 5
D i s p o s a l s 8 1 . 0 12 . 0 1 . 3 9 4 . 3
Transfers, including exchange
rate changes 13 0 . 3 12 5 . 9 – 4 . 2 2 5 2 . 0
Balance as of December 31, 19 9 9 2,5 8 9 . 9 1,3 5 7. 7 7. 8 3,9 5 5 . 4
Accumulated amort i z a t i o n
Balance as of January 1, 19 9 9 8 4 2 . 9 2 8 6 . 2 1 .1 1,13 0 . 2
Changes in scope of
c o n s o l i d a t i o n 9 . 5 5 2 . 4 – 6 1 . 9
A d d i t i o n s 3 8 3 . 5 2 6 0 . 3 0 . 2 6 4 4 . 0
D i s p o s a l s 7 2 . 2 12 . 7 – 8 4 . 9
Wr i t e - b a c k s 1 .1 – – 1 .1
Transfers, including exchange
rate transfers 3 6 . 7 2 1 . 8 – 5 8 . 5
Balance as of December 31, 19 9 9 1,19 9 . 3 6 0 8 . 0 1 . 3 1,8 0 8 . 6
Net book value as of 
December 31, 19 9 9 1,3 9 0 . 6 7 4 9 . 7 6 . 5 2,14 6 . 8
* Including licenses in such rights and values
Million e 19 9 9 19 9 8
S u p e rv i s o ry Board emoluments 1 . 6 1 . 6
B o a rd of Executive Directors emoluments 9 . 2 12 . 5
Pensions for former members of the Board of Executive
D i rectors and their surviving dependents 5 . 7 4 . 4
Pension provisions for former members of the Board
of Executive Directors and their surviving dependents 5 0 . 2 4 1 . 6
Loans to members of the Board of Executive Dire c t o r s – –
Commitments in favor of members of the Board of
Executive Directors and Superv i s o ry Board – –
Changes in scope of consolidation in 1999 related pri-
marily to gas concessions of Wintershall Energía S.A. of
A rgentina and the goodwill of newly consolidated 
companies in the Pharmaceuticals division. Additions 
included BASF Corporation’s rights to purchase pro p y -
lene oxide from Lyondell Chemical Company of Houston,
Texas, and goodwill associated with the purchase of
H o e c h s t / C e l a n e s e ’s stake in Ta rg o r.
Unscheduled write-downs were made for expected long-
t e rm value impairments of _ 16 1 .1 million in 1999 on 
intangible assets, especially those of the lysine business.
Changes in scope of consolidation in 1998 resulted primarily
f rom changes in the scope of consolidation, especially 
Hokuriku Seiyaku Co. Ltd. of Japan in the Pharm a c e u t i c a l s
division. Additions included the acquisition of the lysine busi-
ness of the Daesang Group of Korea, the acquisition of
H o e c h s t ’s polyethylene business through Elenac and the 
acquisition of the remaining 50 percent ownership stake
held by Hyosung T&C Co. Ltd. of Korea in BASF Styre n i c s
K o rea Ltd. (merged into BASF Company Ltd. Korea as of
December 31, 19 9 8 ) .
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Developments in 19 9 8 Patents, licenses, G o o d w i l l A d v a n c e To t a l
t r a d e m a r k s p a y m e n t s
and similar
Million e r i g h t s *
Acquisition costs
Balance as of January 1, 19 9 8 1,6 6 5 . 4 5 11 . 6 8 1 . 2 2,2 5 8 . 2
Changes in scope of
c o n s o l i d a t i o n 9 5 . 7 4 7. 3 0 .1 14 3 .1
A d d i t i o n s 4 9 6 . 8 3 2 1 . 8 4 . 2 8 2 2 . 8
D i s p o s a l s 3 2 . 0 17. 3 – 4 9 . 3
Transfers, including exchange
rate changes 2 3 . 6 – 2 5 . 2 – 7 8 .1 – 7 9 . 7
Balance as of December 31, 19 9 8 2,2 4 9 . 5 8 3 8 . 2 7. 4 3,0 9 5 .1
Accumulated amort i z a t i o n
Balance as of January 1, 19 9 8 6 2 1 . 5 13 8 . 7 0 . 9 7 6 1 .1
Changes in scope of
c o n s o l i d a t i o n 18 . 6 7. 2 – 2 5 . 8
A d d i t i o n s 2 4 5 . 7 17 0 . 8 0 . 2 4 16 . 7
D i s p o s a l s 2 9 . 5 2 5 . 5 – 5 5 . 0
Wr i t e - b a c k s – – – –
Transfers, including exchange
rate changes –13 . 4 – 5 , 0 – –18 . 4
Balance as of December 31, 19 9 8 8 4 2 . 9 2 8 6 . 2 1 .1 1,13 0 . 2
Net book value as of 
December 31, 19 9 8 1,4 0 6 . 6 5 5 2 . 0 6 . 3 1,9 6 4 . 9
* Including licenses in such rights and values
Developments in 19 9 8 Lands, land rights M a c h i n e ry M i s c e l l a n e o u s Advance payments To t a l
and buildings* and technical equipment and and constru c t i o n
Million e e q u i p m e n t f i x t u re s in pro g re s s
Acquisition costs
Balance as of January 1, 19 9 8 5,7 3 8 . 3 2 2,2 4 2 .1 3 , 0 5 6 . 4 1,3 8 7. 4 3 2,4 2 4 . 2
Changes in scope of 
c o n s o l i d a t i o n 2 9 3 . 5 4 10 . 9 4 0 . 8 2 0 5 . 4 9 5 0 . 6
A d d i t i o n s 8 1 . 8 7 8 1 . 7 18 8 . 7 1,8 4 7.1 2,8 9 9 . 3
D i s p o s a l s 10 5 . 4 6 17. 5 2 9 1 . 9 19 . 2 1,0 3 4 . 0
Transfers, including exchange
rate changes 2 0 8 . 7 1,113 . 9 12 6 . 9 –1,7 3 9 .1 – 2 8 9 . 6
Balance as of December 31, 19 9 8 6,2 16 . 9 2 3,9 3 1 .1 3,12 0 . 9 1,6 8 1 . 6 3 4,9 5 0 . 5
Accumulated depre c i a t i o n
Balance as of January 1, 19 9 8 3,5 9 0 . 7 17,2 8 9 . 5 2 , 4 3 1 . 5 3 6 . 8 2 3,3 4 8 . 5
Changes in scope of 
c o n s o l i d a t i o n 5 8 . 5 2 10 . 3 2 5 . 3 – 2 9 4 .1
A d d i t i o n s 19 2 . 7 1,3 4 1 . 2 3 0 8 . 8 0 . 6 1,8 4 3 . 3
D i s p o s a l s 6 8 . 8 5 6 7. 4 2 6 0 . 9 – 8 9 7.1
Wr i t e - b a c k s 0 . 3 0 . 4 – 0 .1 0 . 8
Transfers, including exchange
rate changes –18 4 . 0 –15 5 . 8 –15 . 5 – 3 6 . 7 – 3 9 2 . 0
Balance as of December 31, 19 9 8 3,5 8 8 . 8 18,117. 4 2,4 8 9 . 2 0 . 6 2 4,19 6 . 0
Net book value as of
December 31, 19 9 8 2,6 2 8 .1 5,8 13 . 7 6 3 1 . 7 1 , 6 8 1 . 0 10,7 5 4 . 5
* Including construction on non-BASF pro p e rt i e s
In 1999, unscheduled write-downs for likely permanent impair-
ment of value of e 4 6 .1 million related to production sites in 
Medellin, Colombia; Ellesmere Port, England; Fre e p o rt, Te x a s ;
and Yokkaichi, Japan. Unscheduled depreciation of e 28.3 mil-
lion in 1998 related primarily to measures taken at two BASF
Corporation sites in North America.
Developments in 19 9 9 Lands, land rights M a c h i n e ry M i s c e l l a n e o u s Advance payments To t a l
and buildings* and technical equipment and and constru c t i o n
Million e e q u i p m e n t f i x t u re s in pro g re s s
Acquisition costs
Balance as of January 1, 19 9 9 6,2 16 . 9 2 3,9 3 1 .1 3,12 0 . 9 1,6 8 1 . 5 3 4,9 5 0 . 4
Changes in scope of 
c o n s o l i d a t i o n 4 6 .1 5 2 9 . 4 3 1 . 7 2 2 9 .1 8 3 6 . 3
A d d i t i o n s 7 6 . 5 7 0 1 . 4 15 7.1 1,8 2 8 . 6 2,7 6 3 . 6
D i s p o s a l s 15 8 . 0 1,3 4 4 . 3 2 8 3 . 9 11 . 4 1,7 9 7. 6
Transfers, including exchange
rate changes 5 2 3 . 2 2,13 5 .1 3 0 0 . 2 –1,4 5 0 . 9 1,5 0 7. 6
Balance as of December 31, 19 9 9 6,7 0 4 . 7 2 5,9 5 2 . 7 3,3 2 6 . 0 2,27 6 . 9 3 8,2 6 0 . 3
Accumulated depre c i a t i o n
Balance as of January 1, 19 9 9 3,5 8 8 . 8 18,117. 4 2,4 8 9 . 2 0 . 6 2 4,19 6 . 0
Changes in scope of 
c o n s o l i d a t i o n 13 . 7 4 19 .1 2 1 . 0 – 4 5 3 . 8
A d d i t i o n s 2 0 7. 9 1,4 9 5 . 8 3 11 . 8 2 . 7 2,0 18 . 2
D i s p o s a l s 110 . 5 1,2 14 . 3 2 6 5 . 8 – 1,5 9 0 . 6
Wr i t e - b a c k s 0 . 6 3 . 8 – – 4 . 4
Transfers, including exchange
rate changes 14 0 .1 5 19 . 0 112 . 5 – 0 . 6 7 71 . 0
Balance as of December 31, 19 9 9 3,8 3 9 . 4 19,3 3 3 . 2 2,6 6 8 . 7 2 . 7 2 5,8 4 4 . 0
Net book value as of
December 31, 19 9 9 2,8 6 5 . 3 6,6 19 . 5 6 5 7. 3 2,27 4 . 2 12,4 16 . 3
( 15) Tangible assets
( 16) Financial assets
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Developments in 19 9 9 S h a res in affiliated S h a res in S h a res in Securities held P a rt i c i p a t i o n s
P a rticipations and securities c o m p a n i e s a s s o c i a t e d p a rt i c i p a t i n g as fixed assets and securities
held as fixed assets c o m p a n i e s i n t e re s t s held as fixed
Million e a s s e t s
Acquisition costs
Balance as of January 1, 19 9 9 7 9 6 . 8 19 7.1 2 6 0 . 7 4 1 . 7 1 , 2 9 6 . 3
Changes in scope of
c o n s o l i d a t i o n –10 3 . 3 2 .1 1 . 7 0 . 5 – 9 9 . 0
A d d i t i o n s 2 5 2 . 4 19 1 . 9 4 7. 8 3 . 4 4 9 5 . 5
D i s p o s a l s 2 2 . 0 8 1 . 4 15 2 .1 7. 7 2 6 3 . 2
Transfers, including exchange
rate changes –13 .1 –15 8 . 7 3 4 . 8 – 6 . 7 –14 3 . 7
Balance as of December 31, 19 9 9 9 10 . 8 15 1 . 0 19 2 . 9 3 1 . 2 1 , 2 8 5 . 9
Accumulated depre c i a t i o n
Balance as of January 1, 19 9 9 17. 4 2 0 . 9 8 6 . 7 3 . 5 12 8 . 5
Changes in scope of
c o n s o l i d a t i o n – 2 . 3 – – – – 2 . 3
A d d i t i o n s 1 . 8 3 . 4 12 . 3 0 . 3 17. 8
D i s p o s a l s 3 . 8 6 . 7 8 5 . 8 1 . 8 9 8 .1
Wr i t e - b a c k s – – – – –
Transfers, including exchange
rate changes 0 . 5 – –1 . 2 0 .1 – 0 . 6
Balance as of December 31, 19 9 9 13 . 6 17. 6 12 . 0 2 .1 4 5 . 3
Net book value as of
December 31, 19 9 9 8 9 7. 2 13 3 . 4 18 0 . 9 2 9 .1 1 , 2 4 0 . 6
Developments in 19 9 9 Loans to affiliated Loans to Other loans Loans and Total financial
Loans and other c o m p a n i e s a s s o c i a t e d and investments i n v e s t m e n t s a s s e t s
i n v e s t m e n t s companies and
p a rticipating 
Million e i n t e re s t s
Acquisition costs
Balance as of January 1, 19 9 9 4 3 5 . 4 9 0 . 0 13 7. 3 6 6 2 . 7 1,9 5 9 . 0
Changes in scope of 
c o n s o l i d a t i o n – – 2 8 . 5 0 . 7 – 27. 8 –12 6 . 8
A d d i t i o n s 3 . 5 2 4 . 3 2 3 .1 5 0 . 9 5 4 6 . 4
D i s p o s a l s 4 15 . 9 1 . 2 19 . 9 4 3 7. 0 7 0 0 . 2
Transfers, including exchange
rate changes – 0 . 3 0 . 6 2 1 . 5 2 1 . 8 –12 1 . 9
Balance as of December 31, 19 9 9 2 2 . 7 8 5 . 2 16 2 . 7 27 0 . 6 1,5 5 6 . 5
Accumulated depre c i a t i o n
Balance as of January 1, 19 9 9 0 . 2 0 . 4 3 . 8 4 . 4 13 2 . 9
Changes in scope of 
c o n s o l i d a t i o n – – – – – 2 . 3
A d d i t i o n s – – 1 . 4 1 . 4 19 . 2
D i s p o s a l s – – 0 . 7 0 . 7 9 8 . 8
Wr i t e - b a c k s – 0 . 4 0 .1 0 . 5 0 . 5
Transfers, including exchange
rate changes – – – – – 0 . 6
Balance as of December 31, 19 9 9 0 . 2 – 4 . 4 4 . 6 4 9 . 9
Net book value as of 
December 31, 19 9 9 2 2 . 5 8 5 . 2 15 8 . 3 2 6 6 . 0 1,5 0 6 . 6
Additions in 1999 to shares in affiliated companies were re-
lated to capital increases for construction projects at BASF’s
Verbund site in Kuantan, Malaysia. The Kuantan site is oper-
ated by BASF Petronas Chemicals Sdn. Bhd, a joint venture
in which BASF holds a 60 percent ownership stake, and
BASF Services (Malaysia), a company based in Petaling
Jaya, Malaysia, in which BASF holds a 100 percent owner-
ship stake. These enterprises have not yet been consolidat-
ed. Other additions to shares in associated companies 
included the acquisition of a 40 percent ownership stake in
Svalöf Weibull, a seed breeding company based in Svalöv,
Sweden. Goodwill from the capital consolidation of compa-
nies accounted for by the equity method for the first time in
1999 was e 156.9 million.
The 1998 additions related to the acquisition of the industrial
coatings manufacturer Salchi Spa of Burago Malgora, Milan,
I t a l y, which is now known as BASF Coatings Spa. They also
related to the Wintershall Explorations- und Pro d u k t i o n s b e -
teiligungsgesellschaft mbH, which was created after the dis-
solution of the Deminex joint venture; this company took
over the former joint venture operations in Argentina, Russia
and Azerbaijan.
Developments in 19 9 8 S h a res in affiliated S h a res in S h a res in Securities held P a rt i c i p a t i o n s
P a rticipations and securities c o m p a n i e s a s s o c i a t e d p a rt i c i p a t i n g as fixed assets and securities
held as fixed assets c o m p a n i e s i n t e re s t s held as fixed
Million e a s s e t s
Acquisition costs
Balance as of January 1, 19 9 8 9 5 8 . 7 3 3 4 . 7 2 5 8 . 3 2 6 . 8 1 , 5 7 8 . 5
Changes in scope of
c o n s o l i d a t i o n – 3 4 6 . 9 –13 . 9 – 7. 2 – 3 5 3 . 6
A d d i t i o n s 27 9 . 6 2 2 . 8 2 0 .1 8 . 4 3 3 0 . 9
D i s p o s a l s 3 6 . 2 12 0 . 9 14 . 7 1 .1 17 2 . 9
Transfers, including exchange
rate changes – 5 8 . 4 – 2 5 . 6 – 3 . 0 0 . 4 – 8 6 . 6
Balance as of December 31, 19 9 8 7 9 6 . 8 19 7.1 2 6 0 . 7 4 1 . 7 1 , 2 9 6 . 3
Accumulated depre c i a t i o n
Balance as of January 1, 19 9 8 6 1 . 0 2 8 . 4 8 6 . 7 1 . 3 17 7. 4
Changes in scope of
c o n s o l i d a t i o n 0 . 2 – – 0 . 9 1 .1
A d d i t i o n s 4 . 7 13 . 4 – 1 . 2 19 . 3
D i s p o s a l s 0 . 9 1 .1 – – 2 . 0
Transfers, including exchange
rate changes – 4 7. 6 –19 . 8 – 0 .1 – 6 7. 3
Balance as of December 31, 19 9 8 17. 4 2 0 . 9 8 6 . 7 3 . 5 12 8 . 5
Net book value as of 
December 31, 19 9 8 7 7 9 . 4 17 6 . 2 17 4 . 0 3 8 . 2 1 , 16 7. 8
Developments in 19 9 8 Loans to affiliated Loans to Other loans Loans and Total financial
Loans and other c o m p a n i e s a s s o c i a t e d and investments i n v e s t m e n t s a s s e t s
i n v e s t m e n t s companies and
p a rticipating 
Million e i n t e re s ts
Acquisition costs
Balance as of January 1, 19 9 8 5 3 6 . 4 4 2 . 8 15 5 .1 7 3 4 . 3 2 , 3 12 . 8
Changes in scope of
c o n s o l i d a t i o n – – 3 .1 – 2 .1 – 5 . 2 – 3 5 8 . 8
A d d i t i o n s 2 . 3 6 0 . 5 14 . 8 7 7. 6 4 0 8 . 5
D i s p o s a l s 10 6 . 6 8 . 2 15 . 9 13 0 . 7 3 0 3 . 6
Transfers, including exchange
rate changes 3 . 3 – 2 . 0 –14 . 6 –13 . 3 – 9 9 . 9
Balance as of December 31, 19 9 8 4 3 5 . 4 9 0 . 0 13 7. 3 6 6 2 . 7 1 , 9 5 9 . 0
Accumulated depre c i a t i o n
Balance as of January 1, 19 9 8 – – 3 . 5 3 . 5 18 0 . 9
Changes in scope of
c o n s o l i d a t i o n – – – – 1 .1
A d d i t i o n s 0 . 2 0 . 4 0 . 8 1 . 4 2 0 . 7
D i s p o s a l s – – 0 . 5 0 . 5 2 . 5
Transfers, including exchange
rate changes – – – – – 6 7. 3
Balance as of December 31, 19 9 8 0 . 2 0 . 4 3 . 8 4 . 4 13 2 . 9
Net book value as of 
December 31, 19 9 8 4 3 5 . 2 8 9 . 6 13 3 . 5 6 5 8 . 3 1 , 8 2 6 .1
( 17) Inventories
Million e 19 9 9 19 9 8
Raw materials and factory supplies 9 4 3 . 4 8 3 4 . 6
Work in process, finished goods
and merc h a n d i s e 3 , 0 2 9 . 6 2 , 8 0 8 . 8
C o n s t ruction in pro g re s s 4 7. 4 4 6 . 8
Advance payments 7. 3 13 . 2
To t a l 4 , 0 27. 7 3 , 7 0 3 . 4
“ Work in process” and “Finished goods and merc h a n -
dise” are combined into one item due to the pro d u c t i o n
conditions in the chemical industry.
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( 18) Receivables and other assets
19 9 9 19 9 8
T h e reof with T h e reof with 
a remaining a remaining 
t e rm of more t e rm of more
Million e than one year than one year
Accounts receivable, trade 4 , 9 6 6 . 7 4 7. 4 4 , 0 17. 4 2 1 . 7
Receivables from affiliated companies 7 2 4 . 5 3 . 6 6 4 6 . 8 3 . 8
Receivables from associated companies and other
p a rticipating intere s t s 3 8 9 . 4 – 2 0 5 .1 –
Other assets 9 6 7. 8 12 3 . 8 8 6 8 . 5 118 . 8
Miscellaneous receivables and other assets 1 , 3 5 7. 2 12 3 . 8 1 , 0 7 3 . 6 118 . 8
To t a l 7 , 0 4 8 . 4 17 4 . 8 5 , 7 3 7. 8 14 4 . 3
Composition of other assets
Million e 19 9 9 19 9 8
Tax refund claims 2 8 2 . 2 119 . 2
I n t e rest re c e i v a b l e s 18 9 . 3 3 9 . 8
Receivables from commission sales 5 3 . 9 4 8 . 9
Receivables from the sale of non-trade assets 4 7. 4 7 0 . 6
Employee re c e i v a b l e s 3 2 . 4 3 0 . 7
Rent and deposits 3 1 . 0 7 0 . 7
Insurance claims 10 . 9 3 3 . 2
O t h e r 3 2 0 . 7 4 5 5 . 4
To t a l 9 6 7. 8 8 6 8 . 5
The accrued items, in particular accrued interest, 
amounted to e 35.7 million in 1999 and e 40.9 million in
19 9 8 .
The acquisition or production cost of raw materials, work
in process, finished goods and merchandise is mainly
d e t e rmined by the “last-in-first-out” (LIFO) method. Fac-
t o ry supplies are carried predominantly at average cost.
Inventories of e 2,441.7 million, or 61 percent of total in-
ventories, in 1999 and inventories of e 2,356.7 million, or
64 percent of total inventories, in 1998 were valued ac-
c o rding to the LIFO method.
LIFO re s e rves in 1999 were e 148.0 million compare d
with e 121.7 million in 19 9 8 .
The book and market value of available-for-sale securi-
ties held as fixed assets and shares in participating inter-
ests is summarized below:
Million E 19 9 9 19 9 8
Book value Market value U n re a l i z e d Book value Market value U n re a l i z e d
p ro f i t p ro f i t
Fixed-rate securities – – – 1 . 7 1 . 7 –
Mutual funds – – – 2 2 . 7 2 2 . 9 0 . 2
Other shareholdings and securities 2 10 . 0 2 10 . 4 0 . 4 18 7. 8 2 2 4 .1 3 6 . 3
To t a l 2 10 . 0 2 10 . 4 0 . 4 2 12 . 2 2 4 8 . 7 3 6 . 5
Valuation allowances on doubtful re c e i v a b l e s
Additions and releases not affecting income relate primarily
to translation adjustments and write-offs of re c e i v a b l e s
p reviously provided for. Valuation allowances for trade 
accounts receivables take into consideration risks asso-
ciated with the political and economic conditions in cert a i n
countries, especially with re g a rd to the availability of fore i g n
exchange for the remittance of the owed accounts.
( 19) Marketable securities
The disposal of available-for-sale securities generated
p roceeds of e 744.2 million with gains of e 27.7 million
in 1999 and proceeds of e 1,041.7 million in 1998 and
gains of e 5 7.3 million in 19 9 8 .
Discounts arising primarily from the issue of the 3% U.S.
Dollar Option Bond 1986/2001 of BASF Finance Euro p e
N . V. is capitalized and amortized as interest expense
over the term of the underlying obligations.
Million e 19 9 9 19 9 8
Accounts receivable, trade
as of January 1, 19 9 9 3 2 0 . 8 3 2 3 . 3
Changes affecting income 4 1 . 7 – 0 . 9
Changes not affecting income 5 . 7 –1 . 6
As of December 31, 19 9 9 3 6 8 . 2 3 2 0 . 8
Miscellaneous re c e i v a b l e s 7 4 .1 7 8 . 7
To t a l 4 4 2 . 3 3 9 9 . 5
19 9 9 19 9 8
Book value Market value U n re a l i z e d Book value Market value U n re a l i z e d
Million e g a i n s g a i n s
F i x e d - t e rm securities 7 4 . 9 7 4 . 9 – 2 5 9 . 7 2 6 0 . 2 0 . 5
S h a re s 3 8 8 . 2 4 0 2 . 9 14 . 7 3 8 7. 4 4 3 7.1 4 9 . 7
Mutual funds 3 8 . 4 4 3 . 2 4 . 8 9 3 . 8 9 5 . 4 1 . 6
Other securities 15 . 9 15 . 9 – 4 . 8 6 .1 1 . 3
To t a l 5 17. 4 5 3 6 . 9 19 . 5 7 4 5 . 7 7 9 8 . 8 5 3 .1
(20) Prepaid expenses
19 9 9 19 9 8
T h e reof with T h e reof with
a re m a i n i n g a re m a i n i n g
Million e t e rm of less t e rm of less
than one year than one year
D i s c o u n t 9 . 8 7. 8 17. 4 7. 9
M i s c e l l a n e o u s 12 0 . 4 8 5 . 9 117. 7 3 7. 7
To t a l 13 0 . 2 9 3 . 7 13 5 .1 4 5 . 6
(21) Subscribed capital, capital surplus and 
retained earn i n g s
Subscribed capital: The total number of issued BASF
s h a res as of December 31, 1999, was 620,984,640 com-
p a red with 623,794,150 as of December 31, 19 9 8 .
BASF Aktiengesellschaft has re p u rchased a total of
7,896,200 shares under its share buy-back pro g r a m ,
which reduced the share capital by e 20.2 million. 
Acquisition costs of e 255.6 million were charg e d
against retained earn i n g s .
The exercising of warrants related to the 3% U.S. Dollar
Option Bond 1986/2001 of BASF Finance Europe N.V.
resulted in the issue of 5,086,690 shares in 1999 and
1,731,460 shares in 1998. As a result, the share capital
rose e 13.0 million in 1999 and _ 4.5 million in 1998. A
total of e 6 7.1 million was transferred to capital surplus in
1999 and e 22.9 million in 19 9 8 .
The Annual Meeting on April 29, 1999, approved an in-
c rease of e 2.2 million in the subscribed capital thro u g h
a transfer from capital surplus to maintain a two-digit
cent per share figure of e 2.56 after the conversion to
e u ros from German marks.
S h a re re p u rc h a s e : The Board of Executive Directors re-
ceived approval at the Annual Meeting on May 19, 19 9 8 ,
to re p u rchase BASF shares to a maximum amount of 
10 percent of issued shares. If BASF shares are pur-
chased on a stock exchange, the price paid for the
s h a res may not be higher than the highest market price
at the Frankfurt Stock Exchange on the buying day and it
may not be lower than 75 percent of that market price. In
the case of a public purchase off e r, the price off e red by
BASF may be a maximum of 25 percent higher than the
highest market price on the third trading day prior to the
publishing of the public purchase off e r.
The Board of Executive Directors is authorized to cancel
re p u rchase shares without further shareholder appro v a l .
As a result, BASF re p u rchased between January 13 and 
F e b ru a ry 19, 1999, a total of 7,896,200 shares, or 1.3
p e rcent of the issued shares, at an average price of 
e 32.37 per share and then canceled the re p u rc h a s e d
s h a res as authorized.
The Annual Meeting on April 29, 1999, approved a new
resolution authorizing the Board of Executive Directors to
re p u rchase a maximum 10 percent of the issued share s
until October 1, 2000, under the same price limits out-
lined in the resolution approved in 1998, which is other-
wise replaced by the new re s o l u t i o n .
Conditional capital: The conditional capital of BASF
Aktiengesellschaft as of December 31, 1999, was 
e 16 4 .1 million compared with e 138.5 million as of 
December 31, 19 9 8 .
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As of December 31, 1999, the share capital can be con-
ditionally increased by up to e 23.3 million compare d
with e 36.2 million as of December 31, 1998, due to the
e x e rcising of warrants related to the 3% U.S. Dollar 
Option Bond 1986/2001 of BASF Finance Europe N.V.
Less than e 0 .1 million is related to the conversion rights
of former shareholders of Wintershall AG as of December
31, 1998, and December 31, 19 9 9 .
The Annual Meeting on May 9, 1996, gave the Board of
Executive Directors power for an additional conditional
i n c rease in the subscribed capital of up to e 102.4 mil-
lion to fulfil the exercising of warrants related to the 
option bonds.
In addition, the Annual Meeting on April 29, 1999, 
a p p roved an increase in the conditional capital of up to 
e 38.4 million to fulfill stock options granted to the mem-
bers of the Board of Executive Directors and other senior
executives of BASF and its subsidiaries.
Authorized capital: The authorized capital of BASF 
Aktiengesellschaft was e 500.0 million as of December
31, 1999, compared with e 306.8 million as of Decem-
ber 31, 19 9 8 .
At the Annual Meeting of April 29, 1999, share h o l d e r s
authorized the Board of Executive Directors, with the 
a p p roval of the Superv i s o ry Board, to increase sub-
scribed capital by issuing new shares in the amount of
up to e 500.0 million against cash or contribution in kind
until May 1, 2004. The Board of Executive Directors is
e m p o w e red to decide on the exclusion of share h o l d e r s ’
subscription rights for these new share s .
Capital surplus: Capital surplus includes pre m i u m s
f rom the issuing of shares, compensation for stock 
options and warrants as well as negative goodwill fro m
the capital consolidation resulting from the acquisition of
subsidiaries against issue of BASF shares at par value.
Retained earn i n g s
Million e 19 9 9 19 9 8
Legal re s e rv e s 2 3 3 . 8 2 2 8 . 3
Other retained earn i n g s
and profit re t a i n e d 8 , 7 6 7. 9 8 , 4 6 6 . 8
To t a l 9 ,0 0 1 . 7 8 , 6 9 5 .1
• Thereof proposed dividend 7 0 1 . 7 6 9 2 . 8
P roposed dividend per share (e) 1 .13 1 .12
In 1999, the legal re s e rves rose by e 4.9 million com-
p a red to an increase in 1998 of e 4 7.1 million due to
transfers from other retained earnings and profit re t a i n e d
and in 1999 by e 0.6 million compared with e 2.6 million 
in 1998 due to changes in the scope of consolidation.
(22) Minority intere s t s
Minority interests in stockholders’ equity of consolidated 
subsidiaries is primarily attributable to the following companies:
On December 17, 1999, BASF acquired the remaining 
50 percent ownership stake in Ta rgor GmbH.
(23) Provisions for pensions and similar obligations
Most employees are entitled to company pension bene-
fits resulting from defined contribution and defined bene-
fit plans. The benefits granted vary according to the 
legal, fiscal and economic conditions of the countries
w h e re subsidiaries and affiliated companies are located.
Benefits generally depend on years of service and com-
pensation during the final years of employment. The pen-
sion plans for BASF Aktiengesellschaft and most other
G e rman subsidiaries include a funded plan, BASF Pen-
sionskasse, which is maintained as a legally independent
fund. Employees and their respective companies make
contributions to this fund.
For German Group companies, additional company pen-
sion commitments are financed primarily by pension 
p rovisions. In the case of foreign Group companies, pen-
sion entitlements are covered in some cases by pension
p rovisions, but mainly by external life insurance or exter-
nally financed pension funds.
Pension plans and their respective costs are pre d o m i-
nantly determined using the “projected unit credit meth-
od” as defined by SFAS No. 87. The average rates used
for calculating the principal re t i rement plans are as 
f o l l o w s :
19 9 9 19 9 8
% %
I n t e rest rate 6 . 4 5 . 9
P rojected increase of wages
and salaries 3 . 4 3 .1
P rojected pension incre a s e 1 . 4 1 .1
Expected re t u rn on plan assets 8 . 4 8 . 5
The change in the projected benefit obligation 
is as follows:
Million e 19 9 9 19 9 8
P rojected benefit obligation as of January 1 5 , 9 4 2 . 6 5 , 8 6 0 . 5
S e rvice cost 13 6 . 6 12 0 . 0
I n t e rest cost 3 5 4 . 7 3 6 3 . 2
Benefits paid – 3 5 3 . 2 – 3 3 1 . 5
P a rticipants’ contributions 6 . 6 6 . 3
Change in actuarial assumptions –17 5 . 4 19 2 . 6
Settlements and other charg e s – 8 6 . 7 –14 6 .1
C u rrency exchange 3 7 3 .1 –12 2 . 4
Projected benefit obligation as of
December 31 6 , 1 9 8 . 3 5 , 9 4 2 . 6
The change in plan assets is as follows:
Million e 19 9 9 19 9 8
Plan assets as of January 1 2 , 2 6 3 . 2 2 , 0 8 9 . 5
Actual re t u rn on plan assets 3 6 8 . 0 2 6 9 . 0
Employers’ contributions 18 . 2 12 6 . 2
P a rticipants’ contributions 6 . 6 6 . 3
Benefits paid –15 0 . 0 –119 . 0
C u rrency exchange 3 4 2 . 6 –118 . 0
Other changes –14 .1 9 . 2
Plan assets as of December 31 2 , 8 3 4 . 5 2 , 2 6 3 . 2
P re-paid pension assets of foreign plans – 2 8 2 . 3 –119 . 4
Plan assets as of December 31
excluding pre-paid pension assets 2 , 5 5 2 . 2 2 , 14 3 . 8
The valuation of the pension fund assets of foreign 
pension funds under SFAS 87 showed the pre - f i n a n c i n g
shown above.
C o m p a n y Other share h o l d e r s Equity stake 19 9 9 Equity stake 19 9 8
% %
Wingas GmbH, Z a ru b e z h g a z
Kassel, Germ a n y E rdgashandel GmbH,
Berlin, Germ a n y 3 5 . 0 8 0 . 2 3 5 . 0 7 8 . 2
Ta rgor GmbH, Celanese/Hoechst AG
Mainz, Germ a n y, and subsidiaries F r a n k f u rt, Germ a n y – – 5 0 . 0 5 8 . 5
Hokuriku Seiyaku Co. Ltd.,
Katsuyama-Shi, Fukui, Japan Publicly traded share s 3 5 . 9 14 5 . 3 3 5 . 9 111 . 5
Yangzi-BASF Styrenics Co. Ltd., Yangzi Petrochemicals Corp.,
Nanjing, China Nanjing, China 4 0 . 0 4 8 . 8 4 0 . 0 3 6 . 5
Knoll Pharmaceuticals Ltd.,
Mumbai (Bombay), India Publicly traded share s 4 9 . 0 2 0 . 9 4 9 . 0 15 . 5
BASF India Ltd.,
Mumbai (Bombay), India Publicly traded share s 5 0 . 0 15 . 0 5 0 . 0 15 .1
O t h e r s 19 .1 15 . 4
To t a l 3 2 9 . 3 3 3 0 . 7
Similar obligations refer to commitments by BASF’s
N o rth American Group companies to provide for the
costs of medical and life insurance benefits for employ-
ees and dependents after re t i rement. They are valued in
a c c o rdance with actuarial rules, allowing for future cost
t rends using a discount rate of 7.50 perc e n t .
(24)  Other pro v i s i o n s
19 9 9 19 9 8
T h e reof likely T h e reof likely
use within one use within one
Million e y e a r y e a r
Oil and gas production 3 5 0 . 2 – 3 2 6 . 3 3 .1
E n v i ronmental protection and remediation costs 2 5 5 .1 12 5 . 8 2 9 3 . 4 12 0 . 6
Personnel costs 1 , 12 9 . 2 7 0 9 . 8 9 8 3 . 5 5 9 9 . 9
Sales and purchase risks 5 3 3 . 7 5 2 6 . 8 4 19 . 9 4 0 1 .1
Shutdown and re s t ructuring costs 2 2 2 . 7 16 4 . 6 2 0 7. 3 16 0 . 9
Legal, damage claims and related commitments 7 2 6 . 7 2 6 5 . 8 4 4 8 . 3 9 5 . 4
Maintenance and repair costs 12 5 . 5 6 1 .1 17 2 . 6 10 7. 8
O t h e r 4 6 2 . 0 4 3 1 .1 3 4 4 . 8 3 0 4 . 4
To t a l 3 , 8 0 5 .1 2 , 2 8 5 . 0 3 , 19 6 .1 1 , 7 9 3 . 2
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This resulted in the following pension pro v i s i o n s :
Million e 19 9 9 19 9 8
Cash value of future benefits as of
December 31 6 , 19 8 . 3 5 , 9 4 2 . 6
Less pension fund assets as of
December 31 2 , 5 5 2 . 2 2 , 14 3 . 8
3 , 6 4 6 .1 3 , 7 9 8 . 8
U n recognized actuarial gains and losses 2 0 4 . 7 3 . 0
P rovisions for pensions 3 , 8 5 0 . 8 3 , 8 0 1 . 8
Similar obligations 3 19 . 2 2 6 0 . 7
P rovisions for pensions and
similar obligations 4 , 17 0 . 0 4 , 0 6 2 . 5
The components of the net periodic pension cost are as follows:
Million e 19 9 9 19 9 8
S e rvice cost 13 6 . 6 12 0 . 0
I n t e rest cost 3 5 4 . 7 3 6 3 . 2
Expected re t u rn on plan assets –18 2 . 4 –14 9 . 5
A m o rtization costs 0 .1 –
Settlement gain commitments – 2 6 . 0 –14 5 . 7
Expenses from defined-benefit plan
c o m m i t m e n t s 2 8 3 . 0 18 8 . 0
Expenses from defined-contribution plan
c o m m i t m e n t s 8 2 . 3 9 7. 6
Expenses from similar obligations 2 3 . 4 2 3 . 0
Expenses for pension benefits and
similar obligations 3 8 8 . 7 3 0 8 . 6
In the case of oil and gas production, the expected costs for filling in wells and removing pro d u c-
tion equipment after the end of production are accumulated by installments during the expected
p roduction period.
P rovisions for environmental protection measures include costs for rehabilitating contaminated
sites, water protection, recultivating landfills and similar measure s .
The provision for personnel obligations includes long-time service bonuses and anniversary pay-
ments, vacation pay, variable compensation, social security contributions and other accru e d
costs. Most BASF Group companies in Germany have various programs that entitle employees
who are at least 55 years old to reduce their working hours to 50 percent for up to five years.
Under this arrangement, most employees work full time during the first half of the transition 
period and leave the company at the start of the second period. Employees receive a minimum 
85 percent of their net salary throughout the transition period.
The provision for sales and purchases includes risks arising from warranties or product liability, 
together with discounts or other price concessions to be granted and commissions or likely 
losses from contractual agre e m e n t s .
The provision for shutdown and re s t ructuring measures includes severance payments for 
employees leaving the company or contractual agreements, relocation costs, site closures or
demolition commitments and comparable charges. These developed as follows:
Additions in 1999 are related to the shutdown of the multi-division site in Medellin, Colombia; the
Colorants division’s site in Ellesmere Port, England; the pharmaceutical production site in 
Beeston, England; and the fertilizer site in Ostend, Belgium.
Additions in 1998 related to measures for two North American sites of the Colorants & Finishing
P roducts segment.
The provision for maintenance and repairs includes, in addition to deferred maintenance work, the
accumulation of provisions for the inspection of large-scale plants officially re q u i red at specified
i n t e rv a l s .
Other provisions relate in particular to invoices not yet received for goods and services and similar
i t e m s .
19 9 9 As of Use of Other changes As of D e c e m b e r
Million e J a n u a ry 1, 19 9 9 p ro v i s i o n s 31, 19 9 9
S e v e r a n c e 5 3 .1 4 2 . 5 10 9 . 5 12 0 .1
Site closures and demolition
c o m m i t m e n t s 12 4 . 2 3 9 . 2 – 2 0 . 8 6 4 . 2
Other 3 0 . 0 11 . 3 19 . 7 3 8 . 4
Total 2 0 7. 3 9 3 . 0 10 8 . 4 2 2 2 . 7
19 9 8 As of Use of Other changes As of December
Million e J a n u a ry 1, 19 9 8 p ro v i s i o n s 31, 19 9 8
Severance 5 7. 6 2 0 .1 15 . 6 5 3 .1
Site closures and demolition
c o m m i t m e n t s 14 7. 9 6 4 . 3 4 0 . 6 12 4 . 2
Other 6 8 . 0 4 5 . 4 7. 4 3 0 . 0
Total 27 3 . 5 12 9 . 8 6 3 . 6 2 0 7. 3
Residual terms of liabilities
S e c u red liabilities
Million e 19 9 9 19 9 8
Liabilities to credit institutions 2 2 . 7 27. 6
Miscellaneous liabilities 17. 4 4 4 .1
To t a l 4 0 .1 71 . 7
Liabilities are collateralized by mortgages, land charg e s
or securities. In addition, negative declarations were
made with re g a rd to adherence to certain balance sheet
r a t i o s .
19 9 9 19 9 8
Million e Up to M o re than Up to M o re than
one year five years one year five years
Bonds and other liabilities to the
capital market 3 5 .1 2 17. 8 19 1 . 6 16 9 . 4
Liabilities to credit institutions 5 4 2 .1 13 . 6 4 6 0 . 6 8 8 .1
Accounts payable, trade 2 , 2 9 1 . 6 5 . 0 1 , 8 5 5 . 0 –
Liabilities to affiliated companies 14 3 . 3 – 16 2 . 0 –
Advances received on account of ord e r s 8 1 .1 – 7 0 . 3 –
Liabilities on bills 3 1 . 3 – 27. 9 –
Liabilities to companies in which 
p a rticipations are held 17 0 . 2 – 13 1 . 6 –
Other liabilities 2 , 14 7. 5 5 5 9 . 2 1 , 2 6 8 . 7 3 4 4 . 7
Total 5 , 4 4 2 . 2 7 9 5 . 6 4 , 16 7. 7 6 0 2 . 2
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(25) Liabilities
Financial liabilities
Million e 19 9 9 19 9 8
3% U.S. Dollar Option Bond
1986/2001 of
BASF Finance Europe N.V. 2 2 9 . 2 19 6 . 8
Other bonds 2 2 1 . 6 3 27. 0
C o m m e rcial paper 6 5 . 9 6 6 . 7
Bonds and other liabilities to the
capital market 5 16 . 7 5 9 0 . 5
Liabilities to credit 
i n s t i t u t i o n s 7 7 7. 7 7 2 5 . 3
To t a l 1 ,2 9 4 . 4 1 , 3 15 . 8
The financial liabilities are denominated mainly 
in the following curre n c i e s :
Million e 19 9 9 19 9 8
U.S. dollars 716 . 6 7 7 7. 2
E u ro s 12 1 . 0 19 9 . 8
Chinese re n m i n b i 18 3 . 9 15 9 . 6
O t h e r 27 2 . 9 17 9 . 2
To t a l 1 , 2 9 4 . 4 1 , 3 15 . 8
The weighted average interest rate on short - t e rm cre d i t
b o rrowings was 6.4 percent as of December 31, 1999, 
c o m p a red with 5.6 percent as of December 31, 19 9 8 .
The 3% U.S. Dollar Option Bond 1986/2001 of BASF Fi-
nance Europe N.V. with a nominal value of $235 million is
traded on the Luxembourg Stock Exchange. A warr a n t
p rovides the right to acquire 10 BASF shares at a price of
e 15 7.48 (DM 308.00). The warrant may be exerc i s e d
until April 9, 2001.
A 7% U.S. Dollar Bond of BASF Finance Europe N.V.
19 9 2 / 1999 with a value of $200 million was redeemed on
August 19, 19 9 9 .
Miscellaneous liabilities
Million e 19 9 9 19 9 8
Advances received on account
of ord e r s 9 1 . 8 7 8 . 5
Liabilities on bills 4 1 . 6 4 1 . 0
Liabilities to companies
in which part i c i p a t i o n s
a re held 17 0 . 3 13 2 . 9
Miscellaneous liabilities 2 , 9 13 . 7 1 , 8 6 2 . 7
• T h e reof taxes 6 2 1 . 6 6 3 2 . 5
• T h e reof liabilities re l a t i n g
to social security 1 0 3 . 6 15 9 . 3
Total miscellaneous liabilities 3 , 2 17. 4 2 , 115 .1
(26) Contingent liabilities and other financial 
c o m m i t m e n t s
Contingent liabilities
Million e 19 9 9 19 9 8
Contingent liabilities on bills
of exchange 12 0 .1 8 9 . 2
• T h e reof to aff i l i a t e d
c o m p a n i e s 3 . 2 1 . 0
Contingent liabilities from guarantees 2 4 5 . 5 13 7. 6
Contingent liabilities fro m
w a rr a n t i e s 6 2 . 5 2 6 .1
Contingent liabilities from the
granting of securities for third
p a rty liabilities 4 . 7 4 . 4
To t a l 4 3 2 . 8 2 5 7. 3
Other financial obligations
Million e 19 9 9 19 9 8
Remaining cost of constru c t i o n
in pro g re s s 3 , 10 4 . 0 3 , 18 5 . 9
• T h e reof purchase commitments 1,098.1 1 , 112 . 9
Commitments from long-term
rental and leasing contracts 6 5 3 . 8 9 5 0 . 0
• T h e reof payable during the 
following year 1 6 6 . 5 2 0 5 .1
• T h e reof payable during the 2nd to
5th years 2 7 5 . 2 4 0 7. 3
• T h e reof payable during five years
or longer 2 1 2 . 2 3 3 7. 6
Other commitments 5 7 3 .1 2 . 2
To t a l 4 , 3 3 0 . 9 4 , 13 8 .1
“Other commitments” is comprised of receivables and
s e c u r i t i e s .
P u rchase commitments for raw materials and natu-
ral gas under long-term contracts: BASF has entere d
into long-term purchase contracts for natural gas, the
vast majority of which are coupled with long-term supply
contracts to customers. BASF purchases raw materials
g l o b a l l y, both on the basis of long-term contracts and in
spot markets. The fixed and determinable portions of
l o n g - t e rm supply agreements with a remaining term of
m o re than one year as of December 31, 1999, were as
f o l l o w s :
Million e
2 0 0 0 1 , 718
2 0 0 1 1 , 7 4 0
2 0 0 2 1 , 4 3 3
2 0 0 3 1 , 2 9 2
2 0 0 4 1 , 3 7 0
2005 and later residual periods 12 , 12 8
( 27) Litigation and claims
In the context of its ord i n a ry business operations, BASF
is a defendant in class-action lawsuits brought before
United States federal courts and individual actions before
labor courts and civil courts or comparable institutions 
in Germany and abroad. Significant proceedings are 
discussed below.
Vitamin antitrust proceedings: On May 20, 1999, in a
settlement with the United States of America, BASF 
Aktiengesellschaft agreed to plead guilty to certain viola-
tions of antitrust laws involving the sale of vitamins in the
United States and to cooperate with the investigation by
the U.S. Department of Justice. On September 17, 19 9 9
a federal court approved the plea agreement and im-
posed the agreed-upon fine of $225 million.
In accordance with an agreement reached with the 
Canadian Attorney General, a Canadian federal court on 
September 22, 1999, ord e red BASF Aktiengesellschaft
to pay C$19 million for violating Canadian antitrust laws.
G o v e rnment investigations continue in the European 
Union, Australia, Mexico and Brazil. 
Various class-action lawsuits have been filed against
BASF and other vitamin producers in the United States
demanding compensation for violations of antitrust laws.
As part of a settlement, which has not yet been ap-
p roved by a court, seven vitamin manufacturers agre e d
to pay $1.17 billion, including attorneys’ fees, to pay
compensation to customers who had purchased vita-
mins directly from the manufacturers. BASF’s share of
this settlement is $287 million. Some of the customers
have decided to opt out of the class.
These liabilities are accounted for as obligations or pro v i-
sions. In addition, a number of indirect purchasers of vi-
tamins have filed claims for damages in courts in various
U.S. states. Similar civil suits have been filed in courts in
Canada and Australia. We have established pro v i s i o n s
for the costs that we can currently anticipate. We do not
believe that the additional charges will have a substantial
impact on the profitability of BASF Gro u p .
Class-action lawsuits involving Synthro i d®: On 
October 30, 1997, Knoll Pharmaceutical Company an-
nounced that a United States district court in Chicago
gave pre l i m i n a ry approval of a proposed settlement of a
series of class-action lawsuits involving its thyroid medi-
cation Synthro i d®. The lawsuits challenged Knoll’s 
delaying publication of the Dong et al. s t u d y, which com-
p a red Synthro i d® to certain branded and generic pro d-
ucts. The study concluded that Synthro i d® and some
competing products are bioequivalent. Although Knoll
believes the study was flawed and the conclusion incor-
rect, Knoll agreed to the proposed settlement to avoid
b u rdensome and expensive litigation.
Under terms of the proposed settlement, consumers
who bought Synthro i d® between January 1, 1990, and
October 30, 1997, would have been eligible to receive a
p ro p o rtionate share of a settlement fund consisting of
$98 million in cash. If as many as five million claimants 
had participated, eligible claimants would have re c e i v e d
a payment of $19.60, less a pro p o rtionate share of
c o u rt - a w a rded attorneys’ fees and related costs. If the
number of eligible claimants had exceeded five million,
Knoll would have contributed additional payments to the
settlement fund until the fund reached a maximum of
$ 135 million.
For various reasons, including the unclear position of
t h i rd - p a rty payors, final approval of the proposed settle-
ment was not granted. Knoll subsequently negotiated a
new proposed settlement with consumers and third - p a r-
ty payors providing for a payment of $26 million in addi-
tion to the $98 million paid into escrow in 1997 (plus the
a c c rued interest thereon). The United States district
c o u rt in Chicago granted pre l i m i n a ry approval of the new
p roposed settlement on October 8, 19 9 9 .
In 1999, additional payments were made in a new settle-
ment with the state attorneys general of U.S. states that
had filed lawsuits. In addition, a provision was made to
pay for a settlement with the Institute for Advancement of
Community Pharmacy (IACP).
(28) BASF stock option program and BASF “plus”
incentive pro g r a m
BASF stock option program: The Annual Meeting of
April 29, 1999, approved the BASF stock option pro g r a m
(BOP) for senior executives of the company worldwide
and also approved an increase in conditional capital to
p rovide shares to fulfill the execution of eligible option
rights. Approximately 1,200 senior executives, including
the Board of Executive Directors, are authorized to par-
ticipate in this pro g r a m .
To participate in the BOP program, each participant must
make an individual investment in BASF shares in the
amount of 10 to 30 percent of their individual variable
compensation. The selected amount is used to purc h a s e
BASF shares at the market price of the first business day
after the Annual Meeting, which was _ 41.60 on April 30,
1999. For each BASF share purchased, a participant 
receives four options to purchase a maximum of two
BASF shares (Share A and Share B) at a price lower than
the market price if, on the exercise date of the option,
the perf o rmance targets have been met.
S h a re A may be purchased if the market price of BASF
s h a res has increased more than 30 percent over the
grant price set on April 30, 1999. The purchase price of
S h a re A will be the market price at the exercise date of
the options minus the share price increase since granting
the option (this reduction is limited to 100 percent of the
grant price). Share B may be purchased if the cumulative
p e rcentage perf o rmance of BASF shares exceeds the
p e rcentage perf o rmance of the Dow Jones EURO
S T O X Xs m. The purchase price of Share B will be the mar-
ket price at the exercise date of the option minus twice
the percentage outperf o rmance of BASF shares com-
p a red to the EURO STOXXs m i n d e x .
Each option right may only be exercised if one of the per-
f o rmance targets is achieved and may only be exerc i s e d
once, meaning that if only one perf o rmance target has
been reached, the other option right expires. The maxi-
mum gain for a participant from the BOP program is 
limited to 10 times the individual investment.
The options granted under the 1999 BOP program may
be exercised during the period at any time between the
day after the Annual Meeting in 2002 and the 15th day
after the Annual Meeting in 2005 except in the four- w e e k
periods prior to the announcement of BASF’s quart e r l y
and annual financial results and the six-week periods
prior to the Annual Meeting. The options granted are not
transferable and lapse if the participants sell the share s
f rom their investment or leave BASF.
As of April 30, 1999, a total of 1,178,440 option rights
w e re granted, enabling senior executives to buy up to
2,356,880 shares, conditional on the perf o rmance 
t a rgets being achieved.
As of December 31, 1999, a total of 5,712 option rights
had lapsed because the option holders no longer worked
for BASF or had sold some of their shares. Overall, a to-
tal of 1,172,728 option rights still exist.
BASF “plus” incentive share program: In 1999, BASF
s t a rted an incentive share program called “plus” for all 
eligible employees except the senior executives entitled
to participate in the BASF stock option pro g r a m .
Employees of BASF companies in Germany are curre n t l y
authorized to participate in “plus,” and further sub-
sidiaries outside of Germany are planning to join the 
p rogram in 2000.
Each participant must make an individual investment in
BASF shares from their variable compensation. For each
10 BASF shares purchased in the program, a part i c i p a n t
receives one BASF share at no cost after one, three, five,
seven and 10 years of holding the BASF shares. The
right to receive free BASF shares expires if a part i c i p a n t
sells their individual investment in BASF shares, if the
p a rticipant stops working for the company or one year
after the participant re t i re s .
On April 30, 1999, employees of BASF companies in
G e rmany bought 222,900 BASF shares with the right to
receive free shares. As of December 31, 1999, a total of
18,338 of these shares holding the right to receive fre e
s h a res had expired, so the total amount of shares quali-
fying under the “plus” program is 204,562.
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Composition of the derivative financial 
i n s t ru m e n t s
Nominal values Market values
December 31, December 31,
Million e 19 9 9 19 9 8 19 9 9 19 9 8
F o rw a rd exchange contracts 2 , 4 16 . 0 2 , 4 0 2 . 3 – 71 .1 – 3 . 8
C u rrency options 19 3 . 4 5 3 6 .1 – 2 . 5 0 . 3
I n t e rest rate swaps 14 7. 7 11 .1 2 . 0 – 0 . 2
Combined intere s t /
c ro s s - c u rrency swaps 1 , 4 0 9 . 0 9 8 0 . 5 – 2 27. 9 – 5 8 . 3
Other derivatives 6 2 . 6 2 4 7. 4 2 4 . 9 14 . 8
Total financial derivatives 4 , 2 2 8 . 7 4 , 17 7. 4 – 27 4 . 6 – 4 7. 2
The nominal values are the totals of the purchases and
sales of the particular derivatives on a gross basis. The
fair market values correspond to the diff e rence between
the cost and resale value, which is determined from mar-
ket quotations or by the use of option pricing models or,
in the case of unlisted contracts, the yield in the event of
p re m a t u re cancellation. Offsetting valuation develop-
ments from the underlying transactions are not taken 
into account.
The negative market value of foreign currency derivatives
relates primarily to the financing of BASF’s North Ameri-
can business with inter-company loans hedged by 
f o reign currency swaps. BASF’s assets in North America
i n c reased accordingly due to the rise in the U.S. dollar
exchange rate after the loans were taken up.
(29) Derivative financial instru m e n t s
Use of derivative financial instru m e n t s : BASF is 
exposed to foreign curre n c y, interest rate and commodity
price risks during the normal course of business. In cases
w h e re BASF intends to hedge against these risks, finan-
cial derivatives are used, including forw a rd exchange
contracts, currency options, interest rate/currency swaps
or combined instruments. In addition, derivative instru-
ments are used to replace transactions in original 
financial instruments, such as shares or fixed-interest 
securities. Exclusive use is made of commonly used in-
s t ruments with sufficient market liquidity. Derivative finan-
cial instruments are only used if they have a corre s p o n d-
ing underlying position arising from the operating
business, cash investments and financing. The leverage
e ffect that can be achieved with derivatives is deliberately
not used. The derivative instruments held by BASF are
solely held for purposes other than trading.
W h e re financial derivatives have a positive market value,
BASF is exposed to credit risks in the event of non-per-
f o rmance of their counterparts. The credit risk is mini-
mized by exclusively trading contracts with major cre d i t-
w o rthy financial institutions.
To ensure efficient risk management, market risks are
centralized at BASF Aktiengesellschaft and other subsidi-
aries designated for this purpose. BASF has developed
and implemented internal guidelines based on the princi-
ples of separation of functions for completion and execu-
tion of derivative instru m e n t s .
The risks arising from changes in exchange rates and
i n t e rest rates as a result of the underlying transactions
and the derivative transactions concluded to secure
them are monitored constantly. For this purpose, market
quotations or computer or mathematical models are
used to determine the current market values not only of
the underlying transactions but also of the derivative
transactions, and these are compared with each other.
W h e re derivative instruments are completed as re p l a c e-
ment for original financial instruments, market trends are
also monitored constantly.
F o reign exchange and interest rate risk manage-
m e n t : F o reign currency derivatives are aimed at hedging
the exchange rate risk against the U.S. dollar, the British
pound and the Japanese yen.
I n t e rest derivatives or combined intere s t / c ro s s - c u rre n c y
derivatives were concluded to secure credits extended to
G roup companies. Interest rate caps were concluded to
hedge an anticipated borrowing position against rising
i n t e rest rates. As far as other derivatives are concern e d ,
index swaps were used to create synthetic share invest-
ments with a guarantee of the capital invested. In addi-
tion, interest rate derivatives were used in combination
with investments at variable interest rates in order to
c reate fixed-interest security investments.
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Members of the Board of Executive Memberships on statutorily constituted superv i s o ry
D i rectors of BASF Aktiengesellschaft b o a rds and similar controlling bodies of other Germ a n
and non-German companies
(December 31, 19 9 9 )
D r. Jürgen F. Stru b e Allianz Lebensversicherungs-AG ( S u p e rv i s o ry Board member)
C h a i rm a n C o m m e rzbank AG ( S u p e rv i s o ry Board member)
Hapag-Lloyd AG ( S u p e rv i s o ry Board member)
Hochtief AG ( S u p e rv i s o ry Board member)
D r. Hanns-Helge Stechl MAN AG ( S u p e rv i s o ry Board member)
Deputy Chairm a n P f l e i d e rer AG ( S u p e rv i s o ry Board member)
(Until April 29, 19 9 9 ) P f l e i d e rer Untern e h m e n s v e rwaltung GmbH & Co. KG 
( S u p e rv i s o ry Board member)
Max Dietrich Kley BASF Coatings AG ( S u p e rv i s o ry Board member)
Deputy Chairm a n Bayerische Hypo- und Ve reinsbank AG ( S u p e rv i s o ry Board 
( F rom April 30, 19 9 9 ) m e m b e r )
G e r l i n g - K o n z e rn Speziale Kre d i t v e r s i c h e ru n g s -
Aktiengesellschaft ( S u p e rv i s o ry Board member)
Landesbank Rheinland-Pfalz (Administrative Council member)
Lausitzer Braunkohle AG ( S u p e rv i s o ry Board member)
Mannesmann Demag Krauss Maffei AG 
( S u p e rv i s o ry Board member)
VIAG AG ( S u p e rv i s o ry Board member)
Wintershall AG ( S u p e rv i s o ry Board member)
Helmut Becks BASF Schwarzheide GmbH ( S u p e rv i s o ry Board member)
D r. John Feldmann –
(As of January 1, 2000)
D r. Jürgen Hambre c h t BASF Antwerpen N.V. ( C h a i rman of the Administrative 
C o u n c i l )
Deutsche Gesellschaft für Kunststoff-Recycling mbH
( S u p e rv i s o ry Board member)
D r. Stefan Marc i n o w s k i BASF Coatings AG ( S u p e rv i s o ry Board member)
Knoll AG ( S u p e rv i s o ry Board member)
Peter Oakley –
D r. Volker Tr a u t z –
E g g e rt Vo s c h e r a u BASF Española S.A. (Administrative Council chairm a n )
D resdner Bank Lateinamerika AG ( S u p e rv i s o ry Board 
m e m b e r )
Knoll AG ( S u p e rv i s o ry Board member)
BOARD OF EXECUTIVE DIRECTORS:
Memberships on Superv i s o ry Board s
BOARD OF EXECUTIVE DIRECTORS, DIVISION PRESIDENTS AND ORGANIZAT I O N
(As of December 31, 19 9 9 )
B o a rd of Executive Dire c t o r s Operating Divisions  
R e s s o rt I
D r. Jürgen F. Stru b e
C h a i rm a n
R e s s o rt II F e rt i l i z e r s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Andreas Kre i m e y e r
E g g e rt Vo s c h e r a u C rop Pro t e c t i o n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Friedrich Vo g e l
Fine Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Christian Dudeck
P h a rm a c e u t i c a l s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Thorlef Spickschen
R e s s o rt III C o a t i n g s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Klaus Peter Löbbe
Max Dietrich Kley Oil & Gas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H e r b e rt Dethard i n g
Deputy Chairm a n Raw Materials Purc h a s i n g . . . . . . . . . . . . . . . . . . . . . . Wolfgang Mörike
R e s s o rt IV S t y renic Polymers . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. We rner Prätorius
D r. Volker Tr a u t z Engineering Plastics . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Ehrenfried Baumgart n e r
D r. John Feldmann P o l y u re t h a n e s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J e a n - P i e rre Dhanis
( F rom May 1, 2 0 0 0 )
R e s s o rt V
Helmut Becks
Ludwigshafen Site Dire c t o r
R e s s o rt VI Industrial Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Rainer Strickler
D r. Jürgen Hambre c h t I n t e rm e d i a t e s. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Dietrich Lach
P e t rochemicals & Inorg a n i c s . . . . . . . . . . . . . .  . . . . . . D r. Rolf Niess
R e s s o rt VII Fiber Pro d u c t s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Wolfgang Hapke
Peter Oakley
R e s s o rt VIII D i s p e r s i o n s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Josef F. Kohnle
D r. Stefan Marc i n o w s k i C o l o r a n t s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Walter Gramlich
R e s e a rch Executive Dire c t o r Specialty Chemicals . . .  . . . . . . . . . . . . . . . . . . . . . . . D r. Siegfried Riedmüller
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Regional Divisions  Corporate and Functional Divisions
Legal, Taxes & Insurance . . . . . . . . . . . . . . . . . . D r. Eckart Sünner
Planning & Contro l l i n g . . . . . . . . . . . . . . . . . . . . D r. Elmar Fro m m e r
Corporate Development . . . . . . . . . . . . . . . . . . . D r. John Feldmann
(Until April 30, 2000) (B o a rd member
since January 1, 2000)
S o u t h e rn Euro p e . . . . . . . . . . . . . . . José-Maria Bach Main Laboratory . . . . . . . . . . . . . . . . . . . . . . . . D r. We rner Küsters
N o rt h e rn Euro p e . . . . . . . . . . . . . . . B a rry John Stickings
Central Euro p e . . . . . . . . . . . . . . . . . D i e t e rT h o m a s c h e w s k i
East Europe, Africa, West Asia . . . . . Winfried We rw i e F i n a n c e . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Eckhard Müller
East Asia* . . . . . . . . . . . . . . . . . . . . Erich Binckli Polymers Laboratory . . . . . . . . . . . . . . . . . . . . . D r. Hans-Uwe Schenck
J a p a n *. . . . . . . . . . . . . . . . . . . . . . . D r. Dietmar Nissen
Southeast Asia/Australia* . . . . . . . . . D r. We rner Burg e rt
(* From May 1, 2000, to Ressort VI)
Corporate Engineering . . . . . . . . . . . . . . . . . . . . D r. Axel Anderlohr
Logistics & Inform a t i o n . . . . . . . . . . . . . . . . . . . . B e rnd Flickinger
Human Resourc e s . . . . . . . . . . . . . . . . . . . . . . . . D r. Hans-Hermann Dehmel
E n v i ronment, Safety & Energ y . . . . . . . . . . . . . . . D r. Walter Seufert
BASF AG Site Engineering . . . . . . . . . . . . . . . . . D r. Egon Buhr
D r. We rner Wüchner
(Since January 1, 2000)
Ammonia Laboratory . . . . . . . . . . . . . . . . . . . . . D r. Dieter Degner
Antwerp . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D r. Antoon Dieusaert
( F rom May 1, 2000, to Ressort V)
South America . . . . . . . . . . . . . . . . . D r. Rolf-Dieter Acker N o rth America Finance . . . . . . . . . . . . . . . . . . . . D r. Kurt Bock
N o rth America Chemicals . . . . . . . . . D r. Carl A. Jennings
N o rth America Coatings & Colorants . Frank E. McKulka
N o rth America Polymers . . . . . . . . . . William J. Lizzi
N o rth America Consumer
P roducts & Life Science . . . . . . . . . . D r. Hans Kast
Colorants Laboratory . . . . . . . . . . . . . . . . . . . . . D r. Gerh a rd Paul
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Members of the Superv i s o ry Board Memberships on statutorily constituted superv i s o ry
of BASF Aktiengesellschaft b o a rds and similar controlling bodies of other Germ a n
and non-German companies
(December 31, 19 9 9 )
D r. Hans Albers †
Bad Dürkheim, Chairm a n
(Died October 14, 19 9 9 )
P rofessor Dr. Berthold Leibinger BMW Bayerische Motoren Werke AG (Second Deputy Superv i s o ry
Ditzingen, Chairman (As of October 27, 19 9 9 ) B o a rd chairm a n )
Managing Director of T R U M P F GmbH + Co. KG Deutsche Bank AG ( S u p e rv i s o ry Board member)
Volker Obenauer –
Ludwigshafen am Rhein, Deputy Chairm a n
C h a i rman of the Works Council of the Ludwigshafen 
Site of BASF Aktiengesellschaft
P rofessor Dr. Marcus Bierich R o b e rt Bosch GmbH ( S u p e rv i s o ry Board chairm a n )
S t u t t g a rt J .M. Voith AG ( S u p e rv i s o ry Board chairm a n )
(As of October 15, 19 9 9 ) R o b e rt Bosch AG, Zurich (Administrative Council member)
R o b e rt Bosch Internationale Beteiligungen AG, Zurich 
(Administrative Council member)
Scintilla AG (Administrative Council deputy chairm a n )
Wolfgang Daniel –
L i m b u rg e rhof, Deputy Chairman of the Works Council 
of the Ludwigshafen Site of BASF Aktiengesellschaft
Etienne Graf Davignon ARBED S.A . (Administrative Council deputy chairm a n )
B russels, President of Société Générale de Belgique C O M PAGNIE INTERNATIONALE DES WAGONS-LITS ET 
DU TOURISME S.A . (Administrative Council chairm a n )
F O RTIS AG (Administrative Council deputy chairm a n )
SIBEKA S.A . (Administrative Council chairm a n )
S u e z - Lyonnaise des Eaux S.A . (Administrative Council chairm a n )
T R A C T E B E L S .A. (Administrative Council deputy chairm a n )
UNION MINIERE S.A . (Administrative Council chairm a n )
P rofessor Dr. François N. Diederich –
Zurich, Professor at Zurich Technical University
D r. Tessen von Heydebre c k Deutsche Bank 24 AG ( S u p e rv i s o ry Board chairm a n )
F r a n k f u rt am Main, Member of the Board of Executive BVV Ve r s i c h e ru n g s v e rein des Bankgewerbes a.G. 
D i rectors of Deutsche Bank Aktiengesellschaft ( S u p e rv i s o ry Board member)
Deutsche Ausgleichsbank (Administrative Council member)
Deutsche Bank Polska S. A. ( S u p e rv i s o ry Board chairm a n )
Deutsche Bank Rt., Hungary ( S u p e rv i s o ry Board chairm a n )
Deutsche Bank Suisse S.A. (Administrative Council chairm a n )
D ü rr AG ( S u p e rv i s o ry Board chairm a n )
DWS Deutsche Gesellschaft für Wertpapiersparen mbH 
( S u p e rv i s o ry Board chairm a n )
Dyckerhoff AG ( S u p e rv i s o ry Board chairm a n )
G runer + Jahr AG ( S u p e rv i s o ry Board chairm a n )
Nestlé Deutschland AG ( S u p e rv i s o ry Board chairm a n )
Ve r s i c h e rungsholding der Deutschen Bank AG ( S u p e rv i s o ry Board 
c h a i rm a n )
D r. Wolfgang Jentzsch Linde Aktiengesellschaft ( S u p e rv i s o ry Board member)
M a n n h e i m
Rolf Kleff m a n n –
Wehrbleck, Chairman of the Works Council of 
Wintershall Aktiengesellschaft’s Barn s t o rf Oil Plant
Günter Klein GEWOGE Wo h n u n g s u n t e rnehmen der BASF GmbH 
Mutterstadt, Member of the Works Council of the ( S u p e rv i s o ry Board chairm a n )
Ludwigshafen Site of BASF Aktiengesellschaft LUWOGE Wo h n u n g s u n t e rnehmen der BASF GmbH 
(As of May 1, 19 9 9 ) ( S u p e rv i s o ry Board chairm a n )
Ulrich Küppers Verkehrsbetriebe Ludwigshafen GmbH ( S u p e rv i s o ry Board member)
Ludwigshafen, Manager of the Ludwigshafen branch of R h e i n - H a a rdtbahn GmbH ( S u p e rv i s o ry Board member)
Industriegewerkschaft Bergbau, Chemie, Energie 
(Mining, Chemical and Energy Industries Union)
Konrad Manteuff e l –
Bensheim, Member of the Works Council of the Ludwigs-
hafen Site of BASF Aktiengesellschaft (As of May 1, 19 9 9 )
D r. Karlheinz Messmer –
Weisenheim am Berg, Plant Manager at the 
Ludwigshafen Site of BASF Aktiengesellschaft
Ellen Schneider –
Wallenhorst, Chairwoman of the Joint Wo r k s
Council of Elastogran GmbH
D r. Hermann Scholl Allianz AG ( S u p e rv i s o ry Board member)
S t u t t g a rt, Managing Director of Robert Bosch GmbH Deutsche Bank AG ( S u p e rv i s o ry Board member)
R o b e rt Bosch Internationale Beteiligungen AG, Zurich 
(Administrative Council member)
D r. Henning Schulte-Noelle Allianz Versicherungs-AG ( S u p e rv i s o ry Board chairm a n )
Munich, Chairman of the Board of Executive Allianz Lebensversicherungs-AG ( S u p e rv i s o ry Board chairm a n )
D i rectors of Allianz Aktiengesellschaft D resdner Bank AG ( S u p e rv i s o ry Board member)
Linde AG ( S u p e rv i s o ry Board member)
MAN AG ( S u p e rv i s o ry Board deputy chairm a n )
Mannesmann AG ( S u p e rv i s o ry Board member)
Münchener Rückversicherungsgesellschaft AG
( S u p e rv i s o ry Board deputy chairm a n )
Siemens AG ( S u p e rv i s o ry Board member)
T h y s s e n K rupp AG ( S u p e rv i s o ry Board member)
Veba AG ( S u p e rv i s o ry Board member)
R o b e rt Studer Elf Aquitaine S. A. (Administrative Council member)
Z u r i c h Espírito Santo Financial Group S. A. (Administrative Council member)
Renault S. A. (Administrative Council member)
Schindler Holding AG (Administrative Council member)
J ü rgen Wa l t e r BASF Schwarzheide GmbH ( S u p e rv i s o ry Board member)
Neustadt am Ruebenberge, Member of the Central Board Henkel KGaA ( S u p e rv i s o ry Board member)
of Executive Directors of Industriegewerkschaft Berg b a u , R u h rfestspiele GmbH ( S u p e rv i s o ry Board member)
Chemie, Energie (Mining, Chemical and Energ y Trienekens AG ( S u p e rv i s o ry Board member)
Industries Union)
Helmut We rn e r Expo 2000 Hannover GmbH ( S u p e rv i s o ry Board chairm a n )
S t u t t g a rt E rnst & Young Deutsche Allgemeine Treuhand AG
Wi rtschaftsprüfer Gesellschaft ( S u p e rv i s o ry Board member)
Metallgesellschaft AG ( S u p e rv i s o ry Board chairm a n )
Alcatel S. A., Paris ( S u p e rv i s o ry Board member)
G e r l i n g - K o n z e rn Ve r s i c h e rungsbeteiligungs AG ( S u p e rv i s o ry Board 
m e m b e r )
Aktiebolaget SKF ( S u p e rv i s o ry Board member)
G e rh a rd Zibell S a a r b e rgwerke AG ( S u p e rv i s o ry Board member)
G a u - O d e rnheim, Regional Manager of Industrie-
gewerkschaft Bergbau, Chemie, Energie (Mining,
Chemical and Energy Industries Union) Rhineland-
Palatinate/Saar re g i o n
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Supervisory Board members retired in 1999
Lothar Hick –
L i m b u rg e rhof, Member of the Works Council of
the Ludwigshafen Site of BASF Aktiengesellschaft
(Until April 30, 19 9 9 )
G e rh a rd Sebastian –
Ludwigshafen, Member of the Works Council of
the Ludwigshafen Site of BASF Aktiengesellschaft
(Until April 30, 19 9 9 )
D r. Erich Henkel †
We mourn the loss of Dr. Erich Henkel, who died on December 12, 1999, at the
age of 77.
D r. Henkel joined BASF in 1952. He was appointed to the Board of Executive 
D i rectors in 1968 and was initially responsible for chemicals, intermediates, 
d y e s t u ffs and pharmaceuticals. From 1970 until 1980, he was in charge of non-
E u ropean regions. He then oversaw BASF’s chemicals business until he re t i re d .
BASF Group 10-year summary
Million Û 19 9 0 19 9 1 19 9 2 19 9 3 19 9 4 19 9 5 19 9 6 19 9 7 19 9 8 19 9 9
Balance sheet
Intangible assets 3 7 5 3 3 2 3 4 9 3 2 6 2 6 2 8 8 4 1,2 9 7 1,4 9 7 1,9 6 5 2,14 7
Tangible assets 6,7 7 6 7,4 8 0 7,7 7 9 9,0 6 1 8,17 7 7,8 7 3 8,2 17 9,0 7 6 10,7 5 5 12,4 16
Financial assets 8 6 6 8 6 5 1,5 11 9 8 7 1,0 5 7 1,3 3 8 2,0 9 3 2,13 2 1,8 2 6 1,5 0 7
Fixed assets 8,0 17 8,6 7 7 9,6 3 9 10,3 7 4 9,4 9 6 10,0 9 5 11,6 0 7 12,7 0 5 14,5 4 6 16,0 7 0
I n v e n t o r i e s 3,27 6 3,3 0 1 3,4 5 0 3,2 3 0 3,2 0 2 3,4 3 9 3,6 6 5 3,8 7 6 3,7 0 3 4,0 2 8
Accounts re c e i v a b l e ,
t r a d e 2,9 6 2 2,8 9 1 2,7 8 5 2,9 3 9 3,3 15 3,3 5 6 3,714 4,2 9 9 4,0 17 4,9 6 7
Other re c e i v a b l e s 1,4 8 9 1,6 5 3 1,7 2 3 1,3 7 5 1,2 5 9 1,3 7 5 1,3 4 1 1,7 6 5 1,8 5 6 2,2 11
R e c e i v a b l e s 4,4 5 1 4,5 4 4 4,5 0 8 4,3 14 4,5 7 4 4,7 3 1 5,0 5 5 6,0 6 4 5,8 7 3 7,17 8
D e f e rred taxes – – – 3 8 6 6 6 1 6 9 4 5 1,0 7 7 1,2 2 5
Cash and cash items 3,0 4 9 2,6 3 7 2,3 3 0 2,6 7 9 3,0 4 2 3,16 6 1,9 5 7 1,8 4 6 1,5 0 3 1,5 0 8
C u rrent assets1 10,7 7 6 10,4 8 2 10,2 8 8 10,2 6 1 10,8 8 4 11,3 9 7 10,7 4 6 11,8 3 1 12,15 6 13,9 3 9
A s s e t s 18,7 9 3 19,15 9 19,9 27 2 0,6 3 5 2 0,3 8 0 2 1,4 9 2 2 2,3 5 3 2 4,5 3 6 2 6,7 0 2 3 0,0 0 9
Subscribed capital 1,4 5 7 1,4 5 7 1,4 5 8 1,4 9 5 1,5 5 9 1,5 5 9 1,5 8 0 1,5 9 0 1,5 9 5 1,5 9 0
Capital surplus 2,2 12 2,2 13 2,2 14 2,2 8 2 2,4 0 5 2,4 0 5 2,5 15 2,5 6 7 2,5 9 0 2,6 7 5
Paid-in capital 3,6 6 9 3,6 7 0 3,6 7 2 3,7 7 7 3,9 6 4 3,9 6 4 4,0 9 5 4,15 7 4,18 5 4,2 6 5
Retained earn i n g s 3,6 0 7 3,7 6 9 3,7 4 0 3,9 0 1 4,3 16 5,27 5 6,2 6 2 7,4 18 8,6 9 5 9,0 0 2
C u rrency translation adjustments –119 – 2 3 2 – 2 5 4 –12 9 2 0 1 3 9 5 4 9
Minority intere s t s 6 0 4 4 4 4 8 2 9 2 18 1 2 4 8 2 5 5 3 3 1 3 2 9
Stockholders’ equity 7,3 3 6 7,4 8 3 7,4 5 6 7,6 4 1 8,14 0 9,16 6 10,4 7 6 12,0 3 1 13,2 5 0 14,14 5
Pensions and other
l o n g - t e rm pro v i s i o n s 4,9 5 8 4,7 8 2 5,10 3 5,2 0 7 5,0 4 0 4,9 9 8 5,0 5 2 4,8 2 4 5,5 6 1 5,8 12
Tax and other
s h o rt - t e rm pro v i s i o n s 1,9 5 3 2,13 1 1,9 4 0 1,9 5 4 2,12 0 2,3 9 3 2,3 9 1 2,4 6 3 2,18 5 2,8 2 6
P ro v i s i o n s 6,9 11 6,9 13 7,0 4 3 7,16 1 7,16 0 7,3 9 1 7,4 4 3 7,2 8 7 7,7 4 6 8,6 3 8
Financial liabilities 1,7 2 3 2,0 0 7 2,5 3 7 2,7 4 2 1,8 5 7 1,4 4 8 1,0 4 2 1,12 6 1,3 16 1,2 9 4
Accounts payable,
t r a d e 1,7 3 1 1,6 4 8 1,4 7 9 1,4 3 3 1,5 3 1 1,4 17 1,6 2 8 1,9 7 2 1,8 71 2,3 16
Other liabilities 1,0 9 2 1,10 8 1,4 12 1,6 5 8 1,6 9 2 2,0 7 0 1,7 6 4 2,12 0 2,5 19 3,6 16
L i a b i l i t i e s 4,5 4 6 4,7 6 3 5,4 2 8 5,8 3 3 5,0 8 0 4,9 3 5 4,4 3 4 5,2 18 5,7 0 6 7,2 2 6
Total liabilities1 11,4 5 7 11,6 7 6 12,4 71 12,9 9 4 12,2 4 0 12,3 2 6 11,8 7 7 12,5 0 5 13,4 5 2 15,8 6 4
Stockholders’ equity
and liabilities 18,7 9 3 19,15 9 19,9 27 2 0,6 3 5 2 0,3 8 0 2 1,4 9 2 2 2,3 5 3 2 4,5 3 6 2 6 , 7 0 2 3 0,0 0 9
1 Including deferred taxes and other prepaid expenses
Million € 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Sales and earnings
Sales 23,030 22,781 21,440 20,742 22,330 23,637 24,939 28,520 27,643 29,473
Income from operations 1,409 1,115 670 528 1,099 2,057 2,195 2,731 2,624 2,009
Income before taxes 
and minority interests 1,405 1,079 633 541 1,079 2,111 2,257 2,726 2,771 2,606
Income before minority interests 568 540 313 389 598 1,239 1,452 1,639 1,664 1,245
Net income 566 531 314 439 656 1,263 1,427 1,654 1,699 1,237
Capital expenditures and depreciation
Additions to fixed assets 2,607 2,751 2,930 2,261 1,674 2,742 3,510 2,964 4,131 3,800
• Thereof tangible assets (2,279) (2,454) (2,122) (2,116) (1,384) (1,546) (1,861) (2,229) (2,899) (2,764)
Depreciation 
of fixed assets 1,684 1,771 1,810 1,709 2,239 1,885 1,874 2,048 2,280 2,681
• Thereof tangible assets (1,547) (1,624) (1,707) (1,623) (2,059) (1,707) (1,606) (1,732) (1,843) (2,018)
Number of employees 
• At year-end1 134,647 129,434 123,254 112,020 106,266 106,565 105,589 104,979 105,945 104,628
• Annual average1 136,295 130,328 126,028 117,368 107,716 107,320 108,266 105,885 106,928 107,163
Personnel costs 5,758 5,757 5,712 5,507 5,313 5,531 5,637 5,790 6,010 6,180
Key data
Earnings per share (€) 0.99 0.93 0.55 0.76 1.10 2.07 2.32 2.67 2.73 2.00
Earnings per share 
in accordance with U.S. GAAP 2.84 2.14
Cash provided by
operating activities2 2,569 2,436 2,276 2,370 2,845 3,256 3,476 3,291 2 3,744 2 3,255 2
Return on sales 
(Income from operations
as a percentage of sales) 6.1 4.9 3.1 2.5 4.9 8.7 8.8 9.6 9.5 3 6.8 3
Return on assets 
before income taxes 
and interest expenses (%) 9.2 7.1 4.7 3.9 6.5 11.2 11.4 12.6 11.9 4 10.2 4
Return on equity 
after taxes (%) 7.8 7.3 4.2 5.2 7.6 14.3 14.8 14.6 13.2 9.1
Appropriation of profit
Net income of 
BASF Aktiengesellschaft 532 452 394 342 465 692 870 943 1,074 1,007
Transfer to retained earnings 153 102 102 102 153 256 332 307 381 304
Dividend 379 350 291 239 312 437 537 636 693 702
Dividend per share (€) 0.66 0.61 0.51 0.41 0.51 0.72 0.87 1.02 1.12 1.13
Number of shares 
(in thousands) 569,968 570,030 570,390 584,502 609,766 609,766 618,052 622,063 623,794 620,985
1 From 1996 including employees with limited-term contracts
2 Until 1996 excluding changes in current assets
3 Comparable before special items 1999: 10.0 percent (1998: 9.2 percent)
4 Comparable before special items 1999: 10.9 percent (1998: 11.1 percent)
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